<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
    "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta name="generator" content=
"HTML Tidy for HTML5 for Mac OS X version 5.4.0" />
<title>agle-10q_20180331.htm</title>
</head>
<!-- NG Converter v4.0.8.21 -->
<body>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"border-bottom:none 0pt;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
T W</p>
<p style=
"border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:1pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
UNITED STATES</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
SECURITIES AND EXCHANGE COMMISSION</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
WASHINGTON, DC 20549</p>
<p style=
"text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:4pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
FORM 10-Q</p>
<p style=
"text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:4pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
(Mark One)</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';">
<font style=
"font-size:12pt;font-family:'Times New Roman'">☒</font></p>
</td>
<td valign="top">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:12pt;">
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934</p>
</td>
</tr>
</table>
</div>
<p style=
"text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
For the quarterly period ended March&nbsp;31, 2018</p>
<p style=
"text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
OR</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:4pt;margin-bottom:0pt;font-weight:bold;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';">
<font style=
"font-size:12pt;font-family:'Times New Roman'">☐</font></p>
</td>
<td valign="top">
<p style=
"margin-top:4pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:12pt;">
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934</p>
</td>
</tr>
</table>
</div>
<p style=
"text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
For the transition period
from&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Commission File Number: 001-37722</p>
<p style=
"text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:4pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:24pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
AEGLEA BIOTHERAPEUTICS, INC.</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
(Exact Name of Registrant as Specified in its Charter)</p>
<p style=
"text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:4pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:4pt;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:49.58%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Delaware</p>
</td>
<td valign="bottom" style="width:50.42%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
46-4312787</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:49.58%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
(State or other jurisdiction of</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
incorporation or organization)</p>
</td>
<td valign="bottom" style="width:50.42%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
(I.R.S. Employer</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Identification No.)</p>
</td>
</tr>
<tr>
<td colspan="2" valign="bottom" style="width:100%;">
<p style=
"text-align:center;margin-top:4pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
901 S. MoPac Expressway</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Barton Oaks Plaza One</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Suite 250</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Austin, TX 78746</p>
</td>
</tr>
<tr>
<td colspan="2" valign="bottom" style="width:100%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
(Address of principal executive offices including zip code)</p>
</td>
</tr>
</table>
</div>
<p style=
"text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Registrant’s telephone number, including area code: (512)
942-2935</p>
<p style=
"text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:4pt;">
&nbsp;</p>
<p style=
"margin-top:4pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days.
&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<font style=
"font-family:'Times New Roman';"><font style=
"font-size:10pt;font-family:'Times New Roman'">☒</font></font>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<font style="font-family:'Times New Roman';"><font style="font-size:10pt;font-family:'Times New Roman'">☐</font></font></p>
<p style=
"margin-top:4pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any, every
Interactive Data File required to be submitted and posted pursuant
to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during
the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such
files).&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<font style=
"font-family:'Times New Roman';"><font style=
"font-size:10pt;font-family:'Times New Roman'">☒</font></font>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<font style="font-family:'Times New Roman';"><font style="font-size:10pt;font-family:'Times New Roman'">☐</font></font></p>
<p style=
"margin-top:4pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer,
smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,” 
“smaller reporting company,” and “emerging growth company” in Rule
12b-2 of the Exchange Act.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:4pt;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:96%;">
<tr>
<td valign="top" style="width:21.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Large&nbsp;accelerated&nbsp;filer</p>
</td>
<td valign="top" style="width:0.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="top" style="width:2.06%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';">
<font style=
"font-size:10pt;font-family:'Times New Roman'">☐</font></p>
</td>
<td valign="top" style="width:33.14%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;&nbsp;</p>
</td>
<td valign="top" style="width:40%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Accelerated&nbsp;filer</p>
</td>
<td valign="top" style="width:0.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="top" style="width:2.4%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';">
<font style=
"font-size:10pt;font-family:'Times New Roman'">☐</font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:21.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Non-accelerated filer</p>
</td>
<td valign="top" style="width:0.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="top" style="width:2.06%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';">
<font style=
"font-size:10pt;font-family:'Times New Roman'">☒</font></p>
</td>
<td valign="top" style="width:33.14%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:-94.5pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;&nbsp;</p>
</td>
<td valign="top" style="width:40%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:-0.5pt;;text-indent:0.5pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(Do not check if a smaller reporting company)</p>
</td>
<td valign="top" style="width:0.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="top" style="width:2.4%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:21.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Smaller&nbsp;reporting&nbsp;company</p>
</td>
<td valign="top" style="width:0.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="top" style="width:2.06%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';">
<font style=
"font-size:10pt;font-family:'Times New Roman'">☐</font></p>
</td>
<td valign="top" style="width:33.14%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="top" style="width:40%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Emerging growth&nbsp;company</p>
</td>
<td valign="top" style="width:0.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="top" style="width:2.4%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';">
<font style=
"font-size:10pt;font-family:'Times New Roman'">☒</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:4pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act.&nbsp;&nbsp;<font style=
"font-family:'Times New Roman';"><font style=
"font-size:10pt;font-family:'Times New Roman'">☒</font></font></p>
<p style=
"margin-top:4pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange
Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<font style=
"font-family:'Times New Roman';"><font style=
"font-size:10pt;font-family:'Times New Roman'">☐</font></font>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<font style="font-family:'Times New Roman';"><font style="font-size:10pt;font-family:'Times New Roman'">☒</font></font></p>
<p style=
"margin-top:4pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
As of May 4, 2018, the registrant had 21,858,874 shares of common
stock, $0.0001 par value per share, outstanding.</p>
<p style=
"border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:8pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:4pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:4pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:4pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU2" id=
"_AEIOULastRenderedPageBreakAEIOU2"></a><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AEGLEA
BIOTHERAPEUTICS, INC.</font></p>
<p style=
"text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
QUARTERLY REPORT ON FORM 10-Q</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
FOR THE QUARTER ENDED MARCH&nbsp;31, 2018</p>
<p style=
"text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
TABLE OF CONTENTS</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style=
"width:7.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style=
"width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style=
"width:84.54%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style=
"width:6.56%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Page&nbsp;No.</p>
</td>
</tr>
<tr>
<td colspan="3" valign="top" style="width:93.44%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#PART_I_FINANCIAL_INFORMATION"><font style=
"text-decoration:underline;">PART&nbsp;I. FINANCIAL
INFORMATION</font></a></p>
</td>
<td colspan="2" valign="bottom" style=
"width:6.56%; border-top:solid 0.75pt #000000;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:-8.8pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;1.</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#ITEM_1_FINANCIAL_STATEMENTS"><font style=
"text-decoration:underline;">Financial Statements
(Unaudited)</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#CONDENSED_CONSOLIDATED_BALANCE_SHEETS"><font style=
"text-decoration:underline;">Condensed Consolidated Balance Sheets
as of March 31, 2018 and December&nbsp;31, 2017</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#CONDENSED_CONSOLIDATED_STATEMENTS_OPERAT"><font style=
"text-decoration:underline;">Condensed Consolidated Statements of
Operations for the Three Months Ended March 31, 2018 and
2017</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
2</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#CONDENSED_CONSOLIDATED_STATEMENTS_COMPRE"><font style=
"text-decoration:underline;">Condensed Consolidated Statements of
Comprehensive Loss for the Three Months Ended March 31, 2018 and
2017</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
3</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#CONDENSED_CONSOLIDATED_STATEMENTS_CASH_F"><font style=
"text-decoration:underline;">Condensed Consolidated Statements of
Cash Flows for the Three Months Ended March 31, 2018 and
2017</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
4</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN"><font style=
"text-decoration:underline;">Notes to Condensed Consolidated
Financial Statements</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
5</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:-8.8pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;2.</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#ITEM_2_MANAGEMENTS_DISCUSSION_ANALYSIS_F"><font style=
"text-decoration:underline;">Management’s Discussion and Analysis
of Financial Condition and Results of Operations</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
14</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:-8.8pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;3.</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#ITEM_3_QUANTITATIVE_QUALITATIVE_DISCLOSU"><font style=
"text-decoration:underline;">Quantitative and Qualitative
Disclosures About Market Risk</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
21</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:-8.8pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;4.</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#ITEM_4_CONTROLS_PROCEDURES"><font style=
"text-decoration:underline;">Controls and Procedures</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
21</p>
</td>
</tr>
<tr>
<td colspan="3" valign="top" style="width:93.44%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td colspan="3" valign="top" style="width:93.44%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#PART_II_OR_INFORMATION"><font style=
"text-decoration:underline;">PART&nbsp;II. OTHER
INFORMATION</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
22</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;1.</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#ITEM_1_LEGAL_PROCEEDINGS"><font style=
"text-decoration:underline;">Legal Proceedings</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
22</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:6.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:0.18%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:-8.8pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;1A.</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#ITEM_1A_RISK_FACTORS"><font style=
"text-decoration:underline;">Risk Factors</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
22</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:-8.8pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;2.</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#ITEM_2_UNREGISTERED_SALES_EQUITY_SECURIT"><font style=
"text-decoration:underline;">Unregistered Sales of Equity
Securities and Use of Proceeds</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
59</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:-8.8pt;;font-weight:bold;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:-8.8pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;3.</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#ITEM_3_DEFAULTS_UPON_SENIOR_SECURITIES"><font style=
"text-decoration:underline;">Defaults Upon Senior
Securities</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
59</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:-8.8pt;;font-weight:bold;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:-8.8pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;4.</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#ITEM_4_MINE_SAFETY_DISCLOSURES"><font style=
"text-decoration:underline;">Mine Safety Disclosures</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
59</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:-8.8pt;;font-weight:bold;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:-8.8pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;5.</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#ITEM_5_OR_INFORMATION"><font style=
"text-decoration:underline;">Other Information</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
60</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:8.8pt;;text-indent:-8.8pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;6.</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#ITEM_6_EXHIBITS"><font style=
"text-decoration:underline;">Exhibits</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
61</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" style="width:7.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1.28%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:84.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a href="#SIGNATURES"><font style=
"text-decoration:underline;">Signatures</font></a></p>
</td>
<td colspan="2" valign="bottom" style="width:6.56%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
62</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU3" id=
"_AEIOULastRenderedPageBreakAEIOU3"></a><font style=
"font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">NOTE
ABOUT FORWARD-LOOKING STATEMENTS</font></p>
<p style=
"Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
This quarterly report contains forward-looking statements. All
statements other than statements of historical fact are 
“forward-looking statements” for purposes of this Quarterly Report
on Form 10-Q. These forward-looking statements may include, but are
not limited to, statements regarding our future results of
operations and financial position, business strategy, market size,
potential growth opportunities, clinical development activities,
efficacy and safety profile of our product candidates, our ability
to maintain and recognize the benefits of certain designations
received by product candidates, the timing and results of clinical
trials and potential regulatory approval and commercialization of
product candidates. The words “believe,” “may,” “will,” 
“potentially,” “estimate,” “continue,” “anticipate,” “predict,” 
“target,” “intend,” “could,” “would,” “should,” “project,” “plan,” 
“expect,” and similar expressions that convey uncertainty of future
events or outcomes are intended to identify forward-looking
statements, although not all forward-looking statements contain
these identifying words.</p>
<p style=
"Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style="Background-color:#FFFFFF;">These forward-looking
statements are subject to a number of risks, uncertainties and
assumptions, including those described in “Risk Factors” and
elsewhere in this quarterly report. Moreover, we operate in a very
competitive and rapidly changing environment, and new risks emerge
from time to time. It is not possible for our management to predict
all risks, nor can we assess the impact of all factors on our
business or the extent to which any factor, or combination of
factors, may cause actual results to differ materially from those
contained in any forward-looking statements we may make. In light
of these risks, uncertainties and assumptions, the forward-looking
events and circumstances discussed in this quarterly report may not
occur and actual results could differ materially and adversely from
those anticipated or implied in the forward-looking
statements.</font></p>
<p style=
"Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
You should not rely upon forward-looking statements as predictions
of future events. Although we believe that the expectations
reflected in the forward-looking statements are reasonable, we
cannot guarantee that the future results, levels of activity,
performance or events and circumstances reflected in the
forward-looking statements will be achieved or occur. We undertake
no obligation to update publicly any forward-looking statements for
any reason after the date of this report to conform these
statements to actual results or to changes in our expectations,
except as required by law.</p>
<p style=
"Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
As used in this Quarterly Report on Form 10-Q, the terms “Aeglea,” 
“the Company,” “we,” “us,” and “our” refer to Aeglea
BioTherapeutics, Inc. and, where appropriate, its consolidated
subsidiaries, unless the context indicates otherwise.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU4" id=
"_AEIOULastRenderedPageBreakAEIOU4"></a><a name=
"PART_I_FINANCIAL_INFORMATION" id=
"PART_I_FINANCIAL_INFORMATION"></a><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="PART_I_FINANCIAL_INFORMATION"
id="PART_I_FINANCIAL_INFORMATION"></a>PART I. –
FINANC</font><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">IAL
INFORMATION</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.06%;white-space:nowrap">
<p style=
"margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;1.</font></p>
</td>
<td valign="top">
<p style=
"margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
<a name="ITEM_1_FINANCIAL_STATEMENTS" id=
"ITEM_1_FINANCIAL_STATEMENTS"></a><a name=
"ITEM_1_FINANCIAL_STATEMENTS" id=
"ITEM_1_FINANCIAL_STATEMENTS"></a>Financial Statements</p>
</td>
</tr>
</table>
</div>
<p style=
"text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Aeglea BioTherapeutics, Inc.</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="CONDENSED_CONSOLIDATED_BALANCE_SHEETS" id=
"CONDENSED_CONSOLIDATED_BALANCE_SHEETS"></a><a name=
"CONDENSED_CONSOLIDATED_BALANCE_SHEETS" id=
"CONDENSED_CONSOLIDATED_BALANCE_SHEETS"></a>Condensed Consolidated
Balance Sheets</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
(Unaudited)</p>
<p style=
"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
(In thousands, except share and per share amounts)</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
March&nbsp;31,</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
December 31,</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2018</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2017</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
ASSETS</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
CURRENT ASSETS</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Cash and cash equivalents</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
10,760</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
12,817</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Marketable securities</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
32,715</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
37,482</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Accounts receivable - grant</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
3,373</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
3,078</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Prepaid expenses and other current assets</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,995</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,614</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total current assets</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
48,843</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
54,991</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Property and equipment, net</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
810</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
854</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Other non-current assets</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
133</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
232</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
TOTAL ASSETS</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
49,786</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
56,077</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
LIABILITIES AND STOCKHOLDERS’ EQUITY</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
CURRENT LIABILITIES</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Accounts payable</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
763</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
389</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Deferred revenue</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
20</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Accrued and other current liabilities</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
5,002</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
5,220</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total current liabilities</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
5,765</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
5,629</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Other non-current liabilities</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
101</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
111</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
TOTAL LIABILITIES</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
5,866</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
5,740</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Commitments and Contingencies (Note 9)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
STOCKHOLDERS’ EQUITY</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as
of</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;&nbsp; March&nbsp;31, 2018 and December&nbsp;31, 2017; no
shares issued and</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;&nbsp; outstanding as of March&nbsp;31, 2018 and
December&nbsp;31, 2017</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Common stock, $0.0001 par value; 500,000,000 shares authorized as
of</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;&nbsp; March&nbsp;31, 2018 and December&nbsp;31, 2017;
16,809,669 shares and</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;&nbsp; 16,670,188 shares issued and outstanding as of
March&nbsp;31, 2018 and</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;&nbsp; December&nbsp;31, 2017, respectively</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
2</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
2</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Additional paid-in capital</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
124,648</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
122,950</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Accumulated other comprehensive loss</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(98</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(102</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Accumulated deficit</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(80,632</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(72,513</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
TOTAL STOCKHOLDERS’ EQUITY</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
43,920</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
50,337</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
49,786</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
56,077</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The accompanying notes are an integral part of these condensed
consolidated financial statements.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:5pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU5" id=
"_AEIOULastRenderedPageBreakAEIOU5"></a><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Aeglea
BioTherapeutics, Inc.</font></p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="CONDENSED_CONSOLIDATED_STATEMENTS_OPERAT" id=
"CONDENSED_CONSOLIDATED_STATEMENTS_OPERAT"></a><a name=
"CONDENSED_CONSOLIDATED_STATEMENTS_OPERAT" id=
"CONDENSED_CONSOLIDATED_STATEMENTS_OPERAT"></a>Condensed
Consolidated Statements of Operations</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
(Unaudited)</p>
<p style=
"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
(In thousands, except share and per share amounts)</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Three Months Ended</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
March&nbsp;31,</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2018</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2017</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Revenues:</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Grant</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,510</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
982</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Operating expenses:</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Research and development</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
6,870</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
4,949</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
General and administrative</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
2,885</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
2,364</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total operating expenses</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
9,755</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
7,313</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Loss from operations</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(8,245</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(6,331</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Other income (expense):</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Interest income</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
143</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
95</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Other expense</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(17</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(11</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total other income</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
126</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
84</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Net loss</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(8,119</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(6,247</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Net loss per share, basic and diluted</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(0.49</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(0.47</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Weighted-average common shares outstanding, basic and diluted</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
16,672,125</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
13,365,823</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The accompanying notes are an integral part of these condensed
consolidated financial statements.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">
&nbsp;</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
2</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU6" id=
"_AEIOULastRenderedPageBreakAEIOU6"></a><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Aeglea
BioTherapeutics, Inc.</font></p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="CONDENSED_CONSOLIDATED_STATEMENTS_COMPRE" id=
"CONDENSED_CONSOLIDATED_STATEMENTS_COMPRE"></a><a name=
"CONDENSED_CONSOLIDATED_STATEMENTS_COMPRE" id=
"CONDENSED_CONSOLIDATED_STATEMENTS_COMPRE"></a>Condensed
Consolidated Statements of Comprehensive Loss</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
(Unaudited)</p>
<p style=
"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
(In thousands)</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Three Months Ended</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
March&nbsp;31,</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2018</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2017</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Net loss</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(8,119</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(6,247</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Other comprehensive income (loss):</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Unrealized gain (loss) on marketable securities</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
4</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(33</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total comprehensive loss</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(8,115</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(6,280</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The accompanying notes are an integral part of these condensed
consolidated financial statements.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">
&nbsp;</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
3</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU7" id=
"_AEIOULastRenderedPageBreakAEIOU7"></a><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Aeglea
BioTherapeutics, Inc.</font></p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="CONDENSED_CONSOLIDATED_STATEMENTS_CASH_F" id=
"CONDENSED_CONSOLIDATED_STATEMENTS_CASH_F"></a><a name=
"CONDENSED_CONSOLIDATED_STATEMENTS_CASH_F" id=
"CONDENSED_CONSOLIDATED_STATEMENTS_CASH_F"></a>Condensed
Consolidated Statements of Cash Flows</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
(Unaudited)</p>
<p style=
"text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
(In thousands)</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Three Months Ended</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
March&nbsp;31,</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2018</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2017</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
CASH FLOWS FROM OPERATING ACTIVITIES</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Net loss</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(8,119</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(6,247</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Adjustments to reconcile net loss to net cash used in operating
activities:</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Depreciation and amortization</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
70</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
52</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Purchase net premium on marketable securities</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(55</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Net (accretion of discount) amortization of premium on marketable
securities</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(14</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
49</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Stock-based compensation</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
835</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
401</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Research and development services settled with stock</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
30</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Other, net</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(11</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(5</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Changes in operating assets and liabilities:</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Accounts receivable-grant</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(295</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
234</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Prepaid expenses and other assets</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(102</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
151</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Accounts payable</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
396</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
95</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Deferred revenue</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(20</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(20</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Accrued and other liabilities</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(217</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(87</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Net cash used in operating activities</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(7,447</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(5,432</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
CASH FLOWS FROM INVESTING ACTIVITIES</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Purchases of property and equipment</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(83</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(271</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Purchases of marketable securities</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(32,780</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Proceeds from maturities of marketable securities</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
4,785</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
7,440</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Net cash provided by (used in) investing activities</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
4,702</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(25,611</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
CASH FLOWS FROM FINANCING ACTIVITIES</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Proceeds from employee stock plan purchases and stock option
exercises</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
688</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
96</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Net cash provided by financing activities</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
688</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
96</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
NET DECREASE IN CASH AND CASH EQUIVALENTS</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(2,057</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(30,947</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
CASH AND CASH EQUIVALENTS</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Beginning of period</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
12,817</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
47,748</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
End of period</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
10,760</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
16,801</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Supplemental Disclosure of Non-Cash Investing and Financing
Information:</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Unpaid amounts related to purchase of property and equipment</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
4</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The accompanying notes are an integral part of these condensed
consolidated financial statements.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">
&nbsp;</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
4</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU8" id=
"_AEIOULastRenderedPageBreakAEIOU8"></a><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Aeglea
BioTherapeutics, Inc.</font></p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN" id=
"NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN"></a><a name=
"NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN" id=
"NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN"></a>Notes to Condensed
Consolidated Financial Statements</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:6pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:6pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
1.&nbsp;The Company and Basis of Presentation</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Aeglea BioTherapeutics, Inc. (“Aeglea” or the “Company”) is a
clinical-stage biotechnology company committed to developing
enzyme-based therapeutics in the field of amino acid metabolism to
treat rare genetic diseases and cancer. The Company was formed as a
Limited Liability Company (LLC) in Delaware on December 16, 2013
under the name Aeglea BioTherapeutics Holdings, LLC and was
converted from a Delaware LLC to a Delaware corporation (the “LLC
Conversion”) on March 10, 2015. The Company operates in one segment
and has its principal offices in Austin, Texas.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Stock Offering</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In April 2018, the Company issued and sold 5,046,510 shares of
common stock in an underwritten public offering (“2018 Stock
Offering”) pursuant to a shelf registration statement on Form S-3
at a public offering price of $8.00 per share, including 546,510
shares of common stock issued upon the partial exercise by the
underwriters of their option to purchase additional shares. The net
proceeds to the Company from this public offering were
approximately $37.7 million, after deducting underwriting discounts
and commissions of $2.4 million and estimated offering costs of
$280,000.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Liquidity</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
As of March&nbsp;31, 2018, the Company had working capital of $43.1
million, an accumulated deficit of $80.6 million, and cash, cash
equivalents, and marketable securities of $43.5&nbsp;million. The
Company has not generated any product revenues and has not achieved
profitable operations. There is no assurance that profitable
operations will ever be achieved, and, if achieved, could be
sustained on a continuing basis. In addition, development
activities, clinical and nonclinical testing, and commercialization
of the Company’s products will require significant additional
financing.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Company is subject to a number of risks similar to other life
science companies, including, but not limited to, risks related to
the successful discovery and development of product candidates,
raising additional capital, development of competing drugs and
therapies, protection of proprietary technology and market
acceptance of the Company’s products. As a result of these and
other factors and the related uncertainties, there can be no
assurance of the Company’s future success.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Based upon the Company’s cash, cash equivalents, and marketable
securities, in conjunction with the proceeds received in connection
with its 2018 Stock Offering, the Company believes that it has
sufficient resources to fund operations through the middle of 2020
with its existing cash, cash equivalents, and marketable
securities. The Company will need to secure additional funding in
the future, in order to carry out all of its planned research and
development activities. If the Company is unable to obtain
additional financing or generate license or product revenue, the
lack of liquidity could have a material adverse effect on the
Company’s future prospects.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Unaudited Interim Financial Information</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The interim condensed consolidated financial statements included in
this document are unaudited. The unaudited interim financial
statements have been prepared on the same basis as the annual
financial statements and reflect, in the opinion of management, all
adjustments of a normal and recurring nature that are necessary for
a fair statement of the Company’s financial position as of
March&nbsp;31, 2018, and its results of operations for the three
months ended March&nbsp;31, 2018 and 2017, and cash flows for the
three months ended March&nbsp;31, 2018 and 2017. The results of
operations for three months ended March&nbsp;31, 2018 are not
necessarily indicative of the results to be expected for the year
ending December&nbsp;31, 2018 or for any other future annual or
interim period. The December 31, 2017 balance sheet was derived
from audited financial statements, but does not include all
disclosures required by accounting principles generally accepted in
the United States (“U.S. GAAP”). These financial statements should
be read in conjunction with the audited financial statements
included in the Company’s Form 10-K for the year ended December 31,
2017 as filed with the SEC.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
2.&nbsp;Summary of Significant Accounting Policies</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Use of Estimates</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The preparation of financial statements in conformity with U.S.
GAAP requires management to make estimates and assumptions that
affect the amounts reported in the consolidated financial
statements and accompanying notes. Such management estimates
include those related to accruals of research and development
related costs, stock-based compensation, and certain company income
tax related items. Management bases its estimates on historical
experience and on various other market-specific and relevant
assumptions that management believes to be reasonable under the
circumstances. Actual results could differ significantly from those
estimates.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
5</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU9" id=
"_AEIOULastRenderedPageBreakAEIOU9"></a><font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">Cash
and Cash Equivalents</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Company considers all highly liquid investments with original
maturities of three months or less from the date of purchase to be
cash equivalents. Cash equivalents consist of money market funds
and debt securities and are stated at fair value.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Marketable Securities</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
All investments have been classified as available-for-sale and are
carried at estimated fair value as determined based upon quoted
market prices or pricing models for similar securities. Management
determines the appropriate classification of its investments in
debt securities at the time of purchase. The Company may or may not
hold securities with stated maturities greater than one year until
maturity. All available-for-sale securities are considered
available to support current operations and are classified as
current assets.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Unrealized gains and losses are excluded from earnings and are
reported as a component of accumulated comprehensive loss. Realized
gains and losses and declines in fair value judged to be other than
temporary, if any, <font style="letter-spacing:-0.1pt;">on
available-for-sale securities are included in other income</font>
<font style="letter-spacing:-0.1pt;">(expense). The cost of
securities sold is based on the specific-identification method.
There were no realized gains or losses on marketable securities for
the three months ended March&nbsp;31, 2018 and
2017</font><font style="letter-spacing:-0.05pt;">. Interest on
marketable securities is included in interest</font> income.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Concentration of Credit Risk</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Financial instruments that potentially subject the Company to a
concentration of credit risk consist of cash, cash equivalents, and
marketable securities. The Company’s investment policy limits
investments to high credit quality securities issued by the U.S.
government, U.S. government-sponsored agencies and highly rated
banks, subject to certain concentration limits and restrictions on
maturities. The Company’s cash, cash equivalents, and marketable
securities are held by financial institutions in the United States
that management believes are of high credit quality. Amounts on
deposit may at times exceed federally insured limits. The Company
has not experienced any losses on its deposits of cash and cash
equivalents and its accounts are monitored by management to
mitigate risk. The Company is exposed to credit risk in the event
of default by the financial institutions holding its cash and cash
equivalents and bond issuers.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Property and Equipment</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Property and equipment are stated at cost, net of accumulated
depreciation and amortization. Depreciation and amortization are
computed using the straight-line method over the estimated useful
lives of the assets. Repairs and maintenance that do not extend the
life or improve an asset are expensed as incurred. Upon retirement
or sale, the cost of disposed assets and their related accumulated
depreciation and amortization are removed from the balance sheet.
Any gain or loss is credited or charged to operations.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The useful lives of the property and equipment are as follows:</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="width:40.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Laboratory equipment</p>
</td>
<td valign="bottom" style="width:1.12%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:58.36%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
5 years</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:40.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Furniture and office equipment</p>
</td>
<td valign="bottom" style="width:1.12%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:58.36%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
5 years</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:40.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Computer equipment</p>
</td>
<td valign="bottom" style="width:1.12%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:58.36%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
3 years</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:40.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Software</p>
</td>
<td valign="bottom" style="width:1.12%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:58.36%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
3 years</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:40.54%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Leasehold improvements</p>
</td>
<td valign="bottom" style="width:1.12%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:58.36%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Shorter of remaining lease term or estimated useful life</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Impairment of Long-Lived Assets</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Long-lived assets are reviewed for indications of possible
impairment whenever events or changes in circumstances indicate
that the carrying amount of an asset may not be recoverable.
Recoverability is measured by comparison of the carrying amounts to
the future undiscounted cash flows attributable to these assets. An
impairment loss is recognized to the extent an asset group is not
recoverable, and the carrying amount exceeds the projected
discounted future cash flows arising from these assets. There were
no impairments of long-lived assets for the three months ended
March&nbsp;31, 2018 and 2017.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
6</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU10" id=
"_AEIOULastRenderedPageBreakAEIOU10"></a><font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">Accrued
Research and Development Costs</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Company records the costs associated with research nonclinical
studies, clinical trials, and manufacturing development as
incurred. These costs are a significant component of the Company’s
research and development expenses, with a substantial portion of
the Company’s on-going research and development activities
conducted by third-party service providers, including contract
research and manufacturing organizations.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Company accrues for expenses resulting from obligations under
agreements with contract research organizations (“CROs”), contract
manufacturing organizations (“CMOs”), and other outside service
providers for which payment flows do not match the periods over
which materials or services are provided to the Company. Accruals
are recorded based on estimates of services received and efforts
expended pursuant to agreements established with CROs, CMOs, and
other outside service providers. These estimates are typically
based on contracted amounts applied to the proportion of work
performed and determined through analysis with internal personnel
and external service providers as to the progress or stage of
completion of the services. The Company makes significant judgments
and estimates in determining the accrual balance in each reporting
period. In the event advance payments are made to a CRO, CMO, or
outside service provider, the payments will be recorded as a
prepaid asset which will be amortized as the contracted services
are performed. As actual costs become known, the Company adjusts
its accruals. Inputs, such as the services performed, the number of
patients enrolled, or the study duration, may vary from the Company’
s estimates, resulting in adjustments to research and development
expense in future periods. Changes in these estimates that result
in material changes to the Company’s accruals could materially
affect the Company’s results of operations. The Company has not
experienced any material deviations between accrued and actual
research and development expenses.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Leases</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Company entered into lease agreements for its office and
laboratory facilities. The leases are classified as operating
leases. The Company records rent expense on a straight-line basis
over the term of the leases and, accordingly records the difference
between cash rent payments and the recognition of rent expense as a
deferred rent liability. Incentives granted under the Company’s
facilities leases, including allowances to fund leasehold
improvements, are deferred and are recognized as adjustments to
rental expense on a straight-line basis over the term of the
lease.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Fair Value of Financial Instruments</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Company uses fair value measurements to record fair value
adjustments to certain financial and non-financial assets and
liabilities and to determine fair value disclosures. The accounting
standards define fair value, establish a framework for measuring
fair value, and require disclosures about fair value measurements.
Fair value is defined as the price that would be received from
selling an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date.
When determining the fair value measurements for assets and
liabilities required to be recorded at fair value, the principal or
most advantageous market in which the Company would transact are
considered along with assumptions that market participants would
use when pricing the asset or liability, such as inherent risk,
transfer restrictions, and risk of nonperformance.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The accounting standard for fair value establishes a fair value
hierarchy based on three levels of inputs, the first two of which
are considered observable and the last unobservable, that requires
an entity to maximize the use of observable inputs and minimize the
use of unobservable inputs when measuring fair value. A financial
instrument’s categorization within the fair value hierarchy is
based upon the lowest level of input that is significant to the
fair value measurement.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The three levels of inputs that may be used to measure fair value
are as follows:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:9.06%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Level&nbsp;1:</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
Observable inputs, such as quoted prices in active markets for
identical assets or liabilities.</p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:9.06%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Level&nbsp;2:</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
Observable inputs other than Level 1 prices, such as quoted prices
for similar assets or liabilities, or other inputs that are
observable or can be corroborated by observable market data for
substantially the full term of the assets or liabilities.</p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:9.06%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Level&nbsp;3:</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
Valuations based on unobservable inputs to the valuation
methodology and including data about assumptions that market
participants would use in pricing the asset or liability based on
the best information available under the circumstances.</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Financial instruments carried at fair value include cash, cash
equivalents, and marketable securities. The carrying amount of
accounts receivable, accounts payable and accrued liabilities
approximate fair value due to their relatively short
maturities.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
7</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU11" id=
"_AEIOULastRenderedPageBreakAEIOU11"></a><font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">Revenue
Recognition</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Company’s sole source of revenue is grant revenue related to a
$19.8&nbsp;million research grant received from the Cancer
Prevention and Research Institute of Texas (“CPRIT”), covering a
four-year period from June&nbsp;1, 2014 through May&nbsp;31, 2018.
Grant revenue is recognized when qualifying costs are incurred and
there is reasonable assurance that the conditions of the award have
been met for collection. Proceeds received prior to the costs being
incurred or the conditions of the award being met are recognized as
deferred revenue until the services are performed and the
conditions of the award are met (see Note&nbsp;5).</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Research and Development Costs</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Research and development costs are expensed as incurred. Research
and development costs include, but are not limited to, salaries,
benefits, travel, stock-based compensation, consulting costs,
contract research service costs, laboratory supplies and
facilities, contract manufacturing costs, and costs paid to other
third parties that conduct research and development activities on
the Company’s behalf. Amounts incurred in connection with license
agreements are also included in research and development
expense.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Certain research and development costs incurred were settled
contractually by the Company issuing a variable number of the
Company’s shares determined by dividing the fixed monetary amount
of costs incurred by the issuance-date fair value of the issuable
shares. The Company recorded research and development expense for
these costs and accrued for the fixed monetary amount as an accrued
liability as the services were rendered until the amount was
settled. In June 2015, the remaining Company obligation to settle
these costs with Company shares was converted to a cash-based
payment through a contract amendment with the service provider.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Advance payments for goods or services to be rendered in the future
for use in research and development activities are recorded as a
prepaid asset and expensed as the related goods are delivered or
the services are performed.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Stock-Based Compensation</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;letter-spacing:-0.15pt;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Company recognizes the cost of stock-based awards granted to
employees based on the estimated grant-date fair values of the
awards. The value of the award is recognized as compensation
expense on a straight-line basis over the requisite service period.
Forfeitures are recognized when they occur, which may result in the
reversal of compensation costs in subsequent periods as the
forfeitures arise. The Company recognizes the cost of stock-based
awards granted to nonemployees at their then-current fair values as
services are performed, and are remeasured through the counterparty
performance date.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Income Taxes</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Company and its seven wholly-owned subsidiary corporations use
the asset and liability method of accounting for income taxes.
Under this method, deferred tax assets and liabilities are
recognized for the expected future tax consequences of temporary
differences between the financial statements and the tax bases of
assets and liabilities. Additionally, any changes in income tax
laws are immediately recognized in the year of enactment.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
A valuation allowance is established against the deferred tax
assets to reduce their carrying value to an amount that is more
likely than not to be realized. The deferred tax assets and
liabilities are classified as noncurrent along with the related
valuation allowance. Due to a lack of earnings history, the net
deferred tax assets have been fully offset by a valuation
allowance.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Company recognizes benefits of uncertain tax positions if it is
more likely than not that such positions will be sustained upon
examination based solely on the technical merits, as the largest
amount of benefits that is more likely than not to be realized upon
the ultimate settlement. The Company’s policy is to recognize
interest and penalties related to the unrecognized tax benefits as
a component of income tax expense.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Comprehensive Loss</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;letter-spacing:-0.15pt;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Comprehensive loss is the change in stockholders’ equity from
transactions and other events and circumstances other than those
resulting from investments by stockholders and distributions to
stockholders. The Company’s other comprehensive income (loss) is
currently comprised of changes in unrealized gains and losses on
available-for-sale securities.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
8</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU12" id=
"_AEIOULastRenderedPageBreakAEIOU12"></a><font style=
"font-weight:bold;font-style:italic;color:#000000;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">Reclassification</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Certain reclassifications have been made to prior period amounts to
conform to current period presentation. These reclassifications did
not have an impact on the Company’s results of operations or
financial position as of March&nbsp;31, 2018 and December&nbsp;31,
2017.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Recent Accounting Pronouncements</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In February 2016, the FASB issued ASU No.
2016-02,&nbsp;<font style="font-style:italic;">Leases (Topic
842)</font>, which establishes a comprehensive new lease accounting
model.&nbsp;The new standard: (a) clarifies the definition of a
lease; (b) requires a dual approach to lease classification similar
to current lease classifications; and, (c) causes lessees to
recognize leases on the balance sheet as a lease liability with a
corresponding right-of-use asset for leases with a lease-term of
more than twelve months. The new standard is effective for fiscal
years and interim periods beginning after December 15, 2018 and
requires modified retrospective application. Early adoption is
permitted. The Company is currently evaluating the impact that the
adoption of ASU 2016-02 will have on its consolidated financial
statements, but expect the impact to be limited to the operating
lease agreements for the office and laboratory spaces in Austin,
Texas.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
3.&nbsp;Cash Equivalents and Marketable Securities</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The following tables summarize the estimated fair value of the
Company’s cash equivalents and marketable securities and the gross
unrealized gains and losses (in thousands):</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="14" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
March&nbsp;31, 2018</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Amortized</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Cost</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Gross</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Unrealized</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Gains</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Gross</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Unrealized</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Losses</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Estimated</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Fair Value</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Cash equivalents:</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Money market funds</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,370</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,370</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Reverse repurchase agreements</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
6,250</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
6,250</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total cash equivalents</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
7,620</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
7,620</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Marketable securities:</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
U.S. government securities</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
32,813</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(98</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
32,715</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total marketable securities</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
32,813</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(98</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
32,715</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="14" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
December&nbsp;31, 2017</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Amortized</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Cost</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Gross</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Unrealized</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Gains</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Gross</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Unrealized</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Losses</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Estimated</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Fair Value</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Cash equivalents:</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Money market funds</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,674</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,674</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Reverse repurchase agreements</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
7,250</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
7,250</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total cash equivalents</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
8,924</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
8,924</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Marketable securities:</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
U.S. treasury securities</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,502</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(1</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,501</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
U.S. government securities</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
36,082</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(101</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
35,981</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total marketable securities</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
37,584</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(102</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
37,482</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The reverse repurchase agreements are settled in cash nightly, and
as such are classified as cash equivalents.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
As of March&nbsp;31, 2018 and December&nbsp;31, 2017, all debt
securities with an unrealized loss position have been in a loss
position for less than one year. The aggregate fair value of debt
securities in an unrealized loss position as of March&nbsp;31, 2018
and December&nbsp;31, 2017 were $32.7 million and $37.5 million,
respectively, with no individual securities in a significant
unrealized loss position. The Company evaluated its securities for
other-than-temporary impairment and considered the decline in
market value for the securities to be primarily attributable to
current economic and market conditions and would not be required to
sell the securities before recovery of the amortized cost basis.
Based on this analysis, these marketable securities were not
considered to be other-than-temporarily impaired as of
March&nbsp;31, 2018 and December&nbsp;31, 2017.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
9</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU13" id=
"_AEIOULastRenderedPageBreakAEIOU13"></a><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The
following tables summarizes the contractual maturities of the
Company’s marketable securities at estimated fair value (in
thousands):</font></p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
March&nbsp;31,</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
December&nbsp;31,</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2018</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2017</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Due in one year or less</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
32,715</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
34,498</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Due in 1 - 2 years</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
2,984</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total marketable securities</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
32,715</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
37,482</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">
&nbsp;</p>
<p style=
"margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Company may sell investments at any time for use in current
operations even if they have not yet reached maturity. As a result,
the Company classifies marketable securities, including securities
with maturities beyond twelve months as current assets.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
4.&nbsp;Accrued and Other Current Liabilities</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Accrued and other current liabilities consist of the following (in
thousands):</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
March&nbsp;31,</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
December&nbsp;31,</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2018</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2017</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Accrued compensation</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,001</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,837</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Accrued contracted research and development costs</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
3,379</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
2,552</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Accrued professional and consulting fees</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
512</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
672</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Accrued other and other current liabilities</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
110</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
159</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total accrued and other current liabilities</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
5,002</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
5,220</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
5.&nbsp;Grant Revenues</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In June 2015, the Company entered into a Cancer Research Grant
Contract (“Grant Contract”) with CPRIT, under which CPRIT awarded a
grant not to exceed $19.8 million for use in developing cancer
treatments by exploiting the metabolism of cancer cells. The Grant
Contract covers a four-year period from June 1, 2014 through May
31, 2018.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Upon commercialization of the product, the terms of the Grant
Contract require the Company to pay tiered royalties in the low to
mid-single digit percentages. Such royalties reduce to less than
one percent after a mid-single-digit multiple of the grant funds
have been paid to CPRIT as royalties.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Company recognized grant revenue of $1.5 million and $1.0
million in the three months ended March&nbsp;31, 2018 and 2017,
respectively, for qualified expenditures under the grant. As of
March&nbsp;31, 2018 and December&nbsp;31, 2017, the Company had
outstanding grant receivables of $3.4 million and $3.1 million,
respectively, for the grant expenditures that were paid but had not
been reimbursed and deferred revenue of $0 and $20,000,
respectively, for proceeds received but for which the costs had not
been incurred or the conditions of the award had not been met.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
6.&nbsp;Stock-Based Compensation</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
On February 20, 2018, the Board of Directors approved and adopted
the 2018 Equity Inducement Plan (“2018 Plan”) which became
effective on the same date. The Board of Directors approved an
initial reserve of 1,100,000 shares of common stock to be used
exclusively for individuals who were not previously employees or
directors, or following a bona fide period of non-employment, as an
inducement material to the individual entering into employment with
the Company. Nonqualified stock options or restricted stock units
may be granted under the 2018 Plan at the discretion of the
Compensation Committee or the Board of Directors. The Company did
not seek stockholder approval of the 2018 Plan pursuant to Nasdaq
Rule 5635(c)(4). As of March&nbsp;31, 2018, no grants had been
awarded under the 2018 Plan.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The 2016 Equity Incentive Plan (“2016 Plan”) provides for an annual
increase in the number of shares available for issuance thereunder,
to be added on the first day of each fiscal year, beginning on
January 1, 2017 and continuing through 2023, up to 4% of the
outstanding number of shares of the Company’s common stock on the
December 31 immediately prior to the date of increase, provided
<font style="color:#000000;">that an increase is only effective if
the Company’s board of directors either confirmed the increase or
approved the increase of a lesser number of shares prior to January
1 of each relevant year</font>. As a result of this provision, on
January 1, 2018 and January 1, 2017, an additional 666,807 and
537,233 shares, respectively, became available for issuance under
the 2016 Plan.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
10</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU14" id=
"_AEIOULastRenderedPageBreakAEIOU14"></a><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During
the three months ended March&nbsp;31, 2018 and 2017, the Company
issued an aggregate of 829,500 and 772,800 options to purchase
common stock, respectiv</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ely,
under its equity incentive plans for an aggregate fair value of
$3.9 million and $4.2 million, respectively.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Under the Company’s 2016 Employee Stock Purchase Plan (“2016 ESPP”
), the Company issued and sold 30,937 shares for aggregate cash
proceeds of $78,000 during the three months ended March&nbsp;31,
2018 and 18,184 shares for aggregate cash proceeds of $78,000
during the three months ended March&nbsp;31, 2017.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total stock-based compensation expense related to the Company’s
equity incentive plans and 2016 ESPP was as follows (in
thousands):</p>
<p style=
"text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Three Months Ended</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
March&nbsp;31,</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2018</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2017</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Research and development</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
323</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
110</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
General and administrative</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
512</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
291</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total stock-based compensation expense</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
835</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
401</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The following table summarizes the weighted-average Black-Scholes
option pricing model assumptions used to estimate the fair value of
stock options granted under the equity incentive plans and the
shares purchasable under the 2016 ESPP during the periods
presented:</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Three Months Ended</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
March&nbsp;31,</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2018</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2017</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Equity Incentive Plans</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Expected term</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
6.01</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
5.99</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Expected volatility</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
85</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
86</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Risk-free interest</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
2.72</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
2.13</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Dividend yield</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
0</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
0</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
2016 ESPP</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Expected term</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
0.49</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
0.50</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Expected volatility</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
69</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
79</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Risk-free interest</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
2.00</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
0.68</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Dividend yield</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
0</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
0</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
7.&nbsp;Fair Value Measurements</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Company measures and reports certain financial instruments as
assets and liabilities at fair value on a recurring basis. The
following tables sets forth the fair value of the Company’s
financial assets and liabilities at fair value on a recurring basis
based on the three-tier fair value hierarchy (in thousands):</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="14" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
March&nbsp;31, 2018</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Level 1</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Level 2</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Level 3</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Total</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Financial Assets</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Money market funds</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,370</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,370</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Reverse repurchase agreements</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
6,250</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
6,250</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
U.S. government securities</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
32,715</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
32,715</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total financial assets</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,370</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
38,965</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
40,335</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
</table>
</div>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
11</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="14" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
December&nbsp;31, 2017</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Level 1</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Level 2</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Level 3</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Total</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Financial Assets</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Money market funds</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,674</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,674</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Reverse repurchase agreements</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
7,250</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
7,250</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
U.S. treasury securities</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,501</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,501</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
U.S. government securities</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
35,981</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
35,981</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total financial assets</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
3,175</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
43,231</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
—</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
46,406</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Company measures the fair value of money market funds on quoted
prices in active markets for identical asset or liabilities. The
Level 2 assets include reverse repurchase agreements and U.S.
government securities and are valued based on quoted prices for
similar assets in active markets and inputs other than quoted
prices that are derived from observable market data.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Company evaluates transfers between levels at the end of each
reporting period. There were no transfers between Level 1 and Level
2 during the periods presented.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
8.&nbsp;Net Loss Per Share</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Basic and diluted net loss per share is computed by dividing net
loss by the weighted-average number of common stock outstanding
during the period. For periods in which the Company generated a net
loss, the Company does not include the potential impact of dilutive
securities in diluted net loss per share, as the impact of these
items is anti-dilutive.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The following weighted-average equity instruments were excluded
from the calculation of diluted net loss per share because their
effect would have been anti-dilutive for the periods presented:</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Three Months Ended</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
March&nbsp;31,</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2018</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2017</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Unvested restricted common stock</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
32,066</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
74,013</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Options to purchase common stock</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
2,695,802</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,330,481</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
9.&nbsp;Research and License Agreements</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
University Research Agreement</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In December 2013, the Company entered into a research agreement
with the University of Texas at Austin (the “University”). Under
the terms of this research agreement, the Company engaged the
University to perform certain nonclinical research activities
related to the systemic depletion of amino acids for cancer and
rare disease therapy.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Under the research agreement, the Company was required to pay the
University an annual amount not to exceed $386,000 during the
one-year term of the agreement from the effective date. Pursuant to
subsequent amendments to the research agreement, the term and
maximum expenditure limitation were extended and <font style=
"letter-spacing:-0.1pt;">increased through August 31, 2018 for a
combined amount of $2.5 million. For each of the three months ended
March&nbsp;31, 2018 and 2017, the Company paid $188,000 to the
University under the research agreement.</font></p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
License Agreements</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In December 2013, two of the Company’s wholly owned subsidiaries,
AECase, Inc. (“AECase”) and AEMase, Inc. (“AEMase”), entered into
license agreements with the University under which the University
granted to AECase and AEMase exclusive, worldwide, sublicenseable
licenses. The University granted the AECase license under a patent
application relating to the right to use technology related to the
Company’s AEB3103 product candidate. The University granted the
AEMase license under a patent relating to the right to use
technology related to the Company’s AEB2109 product candidate.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
12</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU15" id=
"_AEIOULastRenderedPageBreakAEIOU15"></a><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In
January and December 2017, the Com</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pany
entered into and subsequently amended an Amended and Restated
Patent License Agreement (the “Restated License”) with the
University which consolidated the two license agreements, revised
certain obligations, and licensed additional patent
applications</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
and invention disclosures to the Company. Pursuant to the terms of
the Restated License, the Company may be required to pay the
University up to $6.4 million milestone payments based on the
achievement of certain development milestones, including
clinical</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
trials and regulatory approvals, the majority of which are due upon
the achievement of later development milestones, including a $5.0
million payment due on regulatory approval of a product and a
$500,000 payment payable on final regulatory approval of a</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
product for a second indication. In addition, the Company is
required to pay the University a low single-digit royalty on
worldwide-net sales of products covered under the Restated License,
together with a revenue share on non-royalty consideration
receive</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d
from sublicensees. The rate of the revenue share ranges from 6.5%
to 25% depending on the date the sublicense agreement is
signed.</font></p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
10.&nbsp;Related Party Transactions</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
One of the founders, a non-employee member of the Company’s board
of directors, entered into a consulting agreement with the Company
in 2014 under which the founder would receive $50,000 per year for
a fixed number of hours of consulting and advisory services and
receive equity incentive shares, which converted into 43,290
restricted stock awards and 13,852 stock options upon the LLC
Conversion, with the vesting contingent on time and performance
milestones being achieved. For the three months ended
March&nbsp;31, 2018 and 2017, there were no payments made to the
Founder under the consulting agreement. As of March&nbsp;31, 2018
and December&nbsp;31, 2017, the Company had no outstanding
liability to the related party.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
11. Subsequent Event</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In April 2018, the Company issued and sold 5,046,510 shares of
common stock in an underwritten public offering pursuant to a shelf
registration statement on Form S-3 at a public offering price of
$8.00 per share, including 546,510 shares of common stock issued
upon the partial exercise by the underwriters of their option to
purchase additional shares. The net proceeds to the Company from
this public offering were approximately $37.7 million, after
deducting underwriting discounts and commissions of $2.4 million
and estimated offering costs of $280,000.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
13</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;2.</font></p>
</td>
<td valign="top">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
<a name="_AEIOULastRenderedPageBreakAEIOU16" id=
"_AEIOULastRenderedPageBreakAEIOU16"></a><a name=
"ITEM_2_MANAGEMENTS_DISCUSSION_ANALYSIS_F" id=
"ITEM_2_MANAGEMENTS_DISCUSSION_ANALYSIS_F"></a><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_2_MANAGEMENTS_DISCUSSION_ANALYSIS_F"
id="ITEM_2_MANAGEMENTS_DISCUSSION_ANALYSIS_F"></a>MANAGEMENT’S
DISCUSSION AND ANALYSIS OF</font> <font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
FINANCIAL CONDITION AND RESU</font><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">LTS
OF OPERATIONS</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Arial;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">
You should read the following discussion and analysis of our
financial condition and results of operations in conjunction with
our unaudited condensed consolidated financial statements and
related notes included in Part I, Item&nbsp;1 of this Quarterly
Report as well as the audited consolidated financial statements and
notes and Management’s Discussion and Analysis of Financial
Condition and Results of Operations, included in our Annual Report
on Form 10-K for the year ended December 31, 2017 filed with the
SEC on March 13, 2018. This discussion and other parts of this
Quarterly Report contain forward-looking statements that involve
risks and uncertainties, such as statements of our plans,
objectives, expectations and intentions. Our actual results could
differ materially from those discussed in these forward-looking
statements. Factors that could cause or contribute to such
differences include, but are not limited to, those discussed in the
section of this report entitled “Risk Factors.”</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_Hlk511662350" id="_Hlk511662350"></a>Overview</p>
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We are a clinical-stage biotechnology company that designs and
develops innovative human enzyme therapeutics for patients with
rare genetic diseases and cancer. We believe our novel approach of
utilizing human enzymes offers advantages over bacterial
enzyme-based approaches including a more favorable safety profile
that may provide a greater likelihood of clinical success.</p>
<p style=
"Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our capabilities in enzyme engineering, preclinical disease
modelling, and drug development in both rare genetic disease and
cancer allow us to identify and advance innovative opportunities to
address important unmet medical needs for the benefit of patients.
Our programs and the decisions we make to progress assets into
clinical studies are driven by the following considerations:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
-</font></p>
</td>
<td valign="top">
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
Potential for enhancement of human enzymatic activity</p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
-</font></p>
</td>
<td valign="top">
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
Strong preclinical data and rationale</p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
-</font></p>
</td>
<td valign="top">
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
Limited or no competition</p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
-</font></p>
</td>
<td valign="top">
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
<font style="color:#000000;">Meaningful commercial
opportunities</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
-</font></p>
</td>
<td valign="top">
<p style=
"Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
Worldwide commercial rights</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We are a patient-focused organization conscious of the fact that
people with a rare genetic disease or cancer have limited treatment
options, and we recognize that their lives and well-being are
highly dependent upon our efforts to develop improved therapies.
For this reason, we are passionate about designing and developing
novel therapeutics to address significant unmet medical need for
rare genetic disease and cancer.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our lead product candidate, pegzilarginase, is engineered to
degrade the amino acid arginine and is being developed to treat two
extremes of arginine metabolism, including arginine excess in
patients with Arginase 1 Deficiency, a rare genetic disease, as
well as some cancers which have been shown to have a metabolic
dependence on arginine. Pegzilarginase is currently being evaluated
in three ongoing clinical trials, consisting of one Phase 1/2
clinical trial for the treatment of Arginase 1 Deficiency, one
Phase 1 clinical trial for the treatment of advanced solid tumors,
and one Phase 1/2 combination clinical trial of pegzilarginase with
pembrolizumab for the treatment of patients with small cell lung
cancer (SCLC). We are also building a pipeline of additional
product candidates targeting key amino acids and other metabolites,
including homocysteine (and the oxidized form homocystine), a
target for another rare genetic disease as well as cysteine, and
its oxidized form cystine, and methionine, for cancer
indications.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Since inception, we have devoted substantially all of our efforts
and resources to identifying and developing product candidates,
conducting nonclinical studies, initiating and conducting clinical
trials, recruiting personnel and raising capital. To date, we have
financed our operations primarily through private placements of our
preferred stock, the initial public offering, or IPO, of our common
stock, follow-on public offerings of our common stock, and
collection of a research grant.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We have incurred net losses in each year since inception. Our net
losses were $8.1 million and $6.2 million for the three months
ended March&nbsp;31, 2018 and 2017, respectively, and have resulted
from costs incurred in connection with our research and development
programs and from general and administrative expenses associated
with our operations. As of March&nbsp;31, 2018, we had an
accumulated deficit of $80.6 million. We expect to continue to
incur operating losses over the next several years. Our net losses
may fluctuate significantly from quarter to quarter and from year
to year. We anticipate that our expenses will increase
significantly as we continue our clinical and diagnostic
development activities for our lead product candidate,
pegzilarginase; concurrently develop our pipeline product
candidates; expand and protect our intellectual property portfolio;
hire additional personnel; and continue to operate as a public
company.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
14</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU17" id=
"_AEIOULastRenderedPageBreakAEIOU17"></a><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent
Developments</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
<a name="_Hlk508802189" id="_Hlk508802189"></a>Pegzilarginase in
Patients with Arginase 1 Deficiency</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In April 2018, we announced initial data that confirmed the utility
of standardized assessment tools in quantifying disease
manifestations and that we believe demonstrates clinically relevant
treatment effects with pegzilarginase in two Arginase 1 Deficiency
patients after eight weeks of dosing. Additionally, baseline data
in five patients indicated that clinical abnormalities in Arginase
1 Deficiency patients can be detected and quantified using
standardized assessment tools. Assessment tools used in the trial
include:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">Six-Minute Walk Test (6MWT) was
below age and gender match norms for all five patients</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">Berg Balance Scale demonstrated
impaired balance in two patients</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">Gross Motor Function Measure
(GMFM) total and Part E subscale (walking, running, and jumping)
was abnormal in four of the five patients</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">Purdue Pegboard test demonstrated
fine motor ability was also quantifiably impaired in all five
patients</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">All five patients had markedly
elevated plasma arginine and plasma guanidino compounds
(GC)</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">All patients had evidence of
growth impairment with height in the lowest 10% for age and gender
and protein intakes less than the prescribed restricted amounts,
which we believe likely reflects an aversion to protein caused by
the disease</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">One patient had abnormal baseline
ammonia and hepatic transaminases, which are also potentially
important disease related biochemical manifestations</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">Tests of neurocognition were
abnormal in all subjects indicating significant cognitive
impairment</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Data was available for the first two patients that we believe
demonstrated clinically relevant treatment effects using
standardized assessment tools:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">6MWT demonstrated that two
patients observed improvements on pegzilarginase. Patient 1
experienced a 31.4% improvement, from 102 to 134 meters, and
Patient 2 experienced a 23.4% improvement, from 261 to 322 meters.
Both observed improvements were well above the Minimal Clinically
Important Difference (MCID) of 9% at eight weeks, with continued
improvement, described above, measured at twenty weeks.</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">Berg Balance Scale measured a
clinically meaningful improvement in balance in Patient 1, who
transitioned from a high risk to a medium risk of fall category.
Patient 2 had a normal baseline assessment which precluded
demonstration of any improvement.</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">The GMFM–Part E subscale
demonstrated clinically important improvement after the initial
eight repeat doses with further improvement by twenty weeks in
Patient 1. Patient 2 was at the upper end of the scale at baseline,
and as expected, no significant change was observed.</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">Protein intake relative to the
prescribed amount improved during the initial eight weeks of repeat
dosing in the first two patients. Despite the increase in protein
intake, patients’ plasma arginine values were better controlled
with pegzilarginase as compared to baseline values with a protein
restricted diet and ammonia scavengers.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We expect to report additional pediatric and adult repeat dose data
in patients with Arginase 1 Deficiency in the third quarter of
2018. To date, we have identified more than 100 patients who have
Arginase 1 Deficiency worldwide.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Pegzilarginase in Patients with Advanced Solid Tumors</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In the first quarter of 2018, we initiated recruitment to cohort
expansions of approximately 12 patients each and dosed our first
patients with SCLC, uveal melanoma and cutaneous melanoma. The
primary endpoint of each cohort expansion is to assess the safety
of pegzilarginase in patients with each tumor type. Secondary
endpoints include the assessment of pharmacokinetics,
pharmacodynamics and clinical response. We will also use the data
to inform the viability of companion diagnostic development, which
has the potential to enrich patient populations with the greatest
likelihood of clinical success.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
15</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU18" id=
"_AEIOULastRenderedPageBreakAEIOU18"></a><font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">Pegzilarginase
with Pembrolizumab in Patients with Small Cell Lung
Cancer</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In the first quarter of 2018, we initiated a Phase 1 clinical
collaboration with Merck to evaluate the combination of
pegzilarginase with Merck’s anti-PD1 therapy, pembrolizumab, for
the treatment of patients with SCLC, with the primary objectives of
determining the safety and dose of pegzilarginase that can be
combined with pembrolizumab to be used in Phase 2. The Phase 2
primary objective is objective response rate (ORR) and secondary
objectives include safety, clinical benefit rate, time to response,
duration of response, progression free survival (PFS), overall
survival, pegzilarginase pharmacokinetics, and to explore the
correlation of tumor expression of ASS1 and PD-L1 with clinical
activity. We dosed the first patient in the first quarter of 2018,
expect to initiate Phase 2 in the third quarter of 2018, and expect
to report topline safety and clinical activity for Phase 1 in the
fourth quarter of 2018.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Stock Offering</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In April 2018, we sold an aggregate of 5,046,510 shares of common
stock in an underwritten public offering pursuant to a shelf
registration statement on Form S-3, including 546,510 shares of
common stock issued upon the partial exercise by the underwriters
of their option to purchase additional shares, for gross proceeds
of $40.4 million. The net proceeds to the Company from this public
offering were approximately $37.7 million after deducting
underwriting discounts and commissions and estimated offering
expenses.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Components of Operating Results</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Revenue</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
To date, we have recognized revenue solely from a research grant
from the Cancer Prevention and Research Institute of Texas, or
CPRIT, and have not generated any revenue from the sale of any of
our product candidates. Our ability to generate product revenues,
which we do not expect will occur for several years, if ever, will
depend heavily on the successful development, regulatory approval
and eventual commercialization of our product candidates.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In June 2015, we entered into a grant agreement with CPRIT, or the
Grant Contract, for $19.8 million for use in developing cancer
treatments by exploiting the metabolism of cancer cells. The Grant
Contract covers a four-year period from June 1, 2014 through May
31, 2018. The grant allows us to receive funds in advance of costs
and allowable expenses being incurred. We record the revenue as
qualifying costs are incurred and there is reasonable assurance
that the conditions of the award have been met for collection.
Proceeds received prior to the costs being incurred or the
conditions of the award being met are recognized as deferred
revenue until the services are performed and the conditions of the
award are met.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
On a quarterly basis, we are required to submit a financial
reporting package outlining the nature and extent of reimbursable
costs paid and requesting reimbursement under the grant. At the end
of each period, qualifying costs paid prior to reimbursement result
in the recognition of a grant receivable.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Research and development expenses</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Research and development expenses consist primarily of costs
incurred for the discovery and development of our product
candidates, most notably, our lead product candidate
pegzilarginase. Since we currently do not have internal
manufacturing capabilities, we contract with external providers for
manufacturing services. In addition, while we opened an internal
research laboratory in February 2017, we continue to contract with
external providers for nonclinical studies and clinical trials. Our
research and development expenses include:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">costs from acquiring clinical
trial materials and services performed for contracted services with
a contract manufacturing organization;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">fees paid to clinical trial sites,
clinical research organizations, contract research organizations,
contract manufacturing organizations, nonclinical research
companies, and academic institutions; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">employee and consultant-related
expenses incurred, which include salaries, benefits, travel and
stock-based compensation.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Research and development costs are expensed as incurred. Advance
payments for goods or services to be rendered in the future for use
in research and development activities are deferred and
capitalized. The capitalized amounts are expensed as the related
goods are delivered or the services are performed.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
16</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU19" id=
"_AEIOULastRenderedPageBreakAEIOU19"></a><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research
and development expenses have historically r</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">epresented
the largest component of our total operating expenses. We plan to
increase our research and development expenses for the foreseeable
future as we continue the development of our product
candidates.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our expenditures on current and future nonclinical and clinical
development programs are subject to numerous uncertainties in
timing and cost to completion. The duration, costs, and timing of
clinical trials and development of our product candidates will
depend on a variety of factors, including:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the scope, rate of progress, and
expenses of our ongoing research activities as well as any
additional clinical trials and other research and development
activities;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">future clinical trial
results;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">uncertainties in clinical trial
enrollment rates or drop-out or discontinuation rates of
patients;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">potential safety monitoring or
other studies requested by regulatory agencies;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">significant and changing
government regulation; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the timing and receipt of
regulatory approvals, if any.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The process of conducting the necessary clinical research to obtain
FDA and other regulatory approval is costly and time consuming and
the successful development of our product candidates is highly
uncertain. The risks and uncertainties associated with our research
and development projects are discussed more fully in Part II, Item
1A of this Quarterly Report titled “Risk Factors.” As a result of
these risks and uncertainties, we are unable to determine with any
degree of certainty the duration and completion costs of our
research and development projects, or if, when, or to what extent
we will generate revenues from the commercialization and sale of
any of our product candidates that obtain regulatory approval. We
may never succeed in achieving regulatory approval for any of our
product candidates.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
General and administrative expenses</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
General and administrative expenses consist primarily of salaries
and other related costs, including stock-based compensation, for
personnel in executive, finance, accounting, operations, and human
resources functions. Other significant costs include legal fees
relating to corporate matters and fees for insurance, accounting,
consulting, and recruiting services.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We expect that our general and administrative expenses will
increase in the future to support our continued research and
development activities, and the potential commercialization of our
product candidates. These increases will likely include higher
costs related to the hiring of additional personnel and fees to
outside consultants, lawyers and accountants, among other expenses.
Additionally, we have incurred and expect to continue to incur
increased costs associated with being a public company, including
expenses related to services associated with maintaining compliance
with Nasdaq listing rules and SEC requirements, insurance, and
investor relations costs.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Interest income</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Interest income consists of interest earned on our cash, cash
equivalents, and marketable securities.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Income taxes</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We serve as a holding company for our seven wholly-owned subsidiary
corporations and file consolidated corporate federal income tax
returns. We use the asset and liability method of accounting for
income taxes. Under this method, deferred tax assets and
liabilities are recognized for the expected future tax consequences
of temporary differences between the financial statements and the
tax bases of assets and liabilities. A valuation allowance is
established against the deferred tax assets to reduce their
carrying value to an amount that is more likely than not to be
realized. The deferred tax assets and liabilities are classified as
noncurrent along with the related valuation allowance. Due to our
lack of earnings history, the net deferred tax assets have been
fully offset by a valuation allowance.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We recognize benefits of uncertain tax positions if it is more
likely than not that such positions will be sustained upon
examination based solely on the technical merits, as the largest
amount of benefits that is more likely than not to be realized upon
the ultimate settlement. Our policy is to recognize interest and
penalties related to the unrecognized tax benefits as a component
of income tax expense.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
17</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU20" id=
"_AEIOULastRenderedPageBreakAEIOU20"></a><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Critical
Accounting Policies and Estimates</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our condensed consolidated financial statements are prepared in
accordance with generally accepted accounting principles in the
United States, or GAAP. The preparation of these condensed
consolidated financial statements requires us to make estimates and
assumptions that affect the reported amounts of assets,
liabilities, revenue, costs and expenses, and related disclosures.
These estimates form the basis for judgments we make about the
carrying values of our assets and liabilities, which are not
readily apparent from other sources. We base our estimates on
historical experience and on various other assumptions that we
believe are reasonable under the circumstances. On an ongoing
basis, we evaluate our estimates and assumptions. Our actual
results may differ materially from these estimates under different
assumptions or conditions.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our critical accounting policies are those policies which require
the most significant judgments and estimates in the preparation of
our consolidated financial statements. We believe that the
assumptions and estimates associated with our most critical
accounting policies are those relating to accrued research and
development costs and stock-based compensation.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
There have been no significant changes in our critical accounting
policies and estimates as compared to the critical accounting
policies and estimates disclosed in Management’s Discussion and
Analysis of Financial Condition and Operations included in our
Annual Report on Form 10-K for the year ended December 31,
2017.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Results of Operations</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Comparison of the Three Months Ended March&nbsp;31, 2018 and
2017</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The following table summarizes our results of operations for the
three months ended March&nbsp;31, 2018 and 2017, together with the
changes in those items in dollars and as a percentage:</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.36%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.68%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Three Months Ended</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.36%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.68%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
March&nbsp;31,</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.64%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Dollar</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.36%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2018</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2017</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.64%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Change</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
% Change</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.36%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="10" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.72%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
(dollars in thousands)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.36%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Revenues:</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.36%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Grant</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,510</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
982</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
528</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
54</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.36%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Operating expenses:</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.36%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Research and development</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
6,870</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
4,949</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
1,921</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
39</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.36%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
General and administrative</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
2,885</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
2,364</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
521</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
22</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.36%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Total operating expenses</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
9,755</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
7,313</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
2,442</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
33</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.36%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Loss from operations</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(8,245</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(6,331</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(1,914</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
30</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.36%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Interest income</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
143</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
95</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
48</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
51</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.36%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Other expense</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(17</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(11</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(6</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
55</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.36%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Net loss</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(8,119</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(6,247</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(1,872</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.12%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
30</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
%</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-style:italic;font-family:Arial;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">
Grant Revenues<font style="font-style:normal;">.&nbsp;&nbsp;Grant
revenues increased by $0.5 million, or 54%, to $1.5 million for the
three months ended March&nbsp;31, 2018 from $1.0 million for the
three months ended March&nbsp;31, 2017. The increase was primarily
due to additional research and development costs associated with
the clinical trials for pegzilarginase in cancer patients, for
which we recognized grant revenue pursuant to the Grant
Contract.&nbsp;&nbsp;</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Arial;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">
Research and Development Expenses<font style=
"font-style:normal;">.&nbsp;&nbsp;Research and development expenses
increased by $1.9 million, or 39%, to $6.8 million for the three
months ended March&nbsp;31, 2018 from $4.9 million for the three
months ended March&nbsp;31, 2017. The change in research and
development expenses was primarily due to:</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">Higher personnel-related expenses,
which increased by $0.7 million as a result of additional employee
headcount to strengthen our management team and expand our internal
regulatory, research laboratory, and clinical development
capabilities;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">Higher clinical development
expenses, which increased by $1.5 million as a result of advancing
our Phase 1/2 clinical trial for pegzilarginase in patients with
Arginase 1 Deficiency, initiating three single agent cohort
expansions for the Phase 1 trial in patients with advanced solid
tumors, and initiating our Phase 1/2 combination trial in patients
with small cell lung cancer; offset by</font></p>
</td>
</tr>
</table>
</div>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
18</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<a name="_AEIOULastRenderedPageBreakAEIOU21" id=
"_AEIOULastRenderedPageBreakAEIOU21"></a><font style=
"font-family:Arial;">Lower manufacturing expenses, which decreased
by $0.4 million as a result of a process scale-up for
pegzilargi</font><font style="font-family:Arial;">nase and
additional manufacturing activities for pipeline development in the
prior year.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Arial;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">
General and Administrative Expenses.<font style=
"font-style:normal;">&nbsp;&nbsp;&nbsp;&nbsp;General and
administrative expenses increased by $0.5 million, or 22%, to $2.8
million for the three months ended March&nbsp;31, 2018 from $2.3
million for the three months ended March&nbsp;31, 2017. The
increase in general and administrative expenses was primarily due
to additional employee headcount and compensation to strengthen our
management team and support expanding research and development
activities.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Arial;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">
Interest Income<font style="font-style:normal;">.&nbsp;&nbsp;&nbsp;
The increase in interest income to $143,000 for the three months
ended March&nbsp;31, 2018 from $95,000 for the three months ended
March&nbsp;31, 2017 was primarily due to increasing yield rates and
purchasing investments with greater maturity terms.</font></p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Liquidity and Capital Resources</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Sources of liquidity</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We are a clinical-stage biotechnology company with a limited
operating history, and due to our significant research and
development expenditures, we have generated operating losses since
our inception and have not generated any revenue from the sale of
any products. Since our inception and through March&nbsp;31, 2018,
we have funded our operations primarily by raising an aggregate of
$123.7 million of gross proceeds from the sale and issuance of
convertible preferred and common equity securities and collecting
$14.1 million in grant proceeds.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In May 2017, we filed a shelf registration statement on Form S-3
with the SEC for the offering, issuance and sale by us of up to
$150.0 million of our common stock, preferred stock, debt
securities, warrants to purchase common stock, preferred stock and
debt securities, subscription rights to purchase common stock and
units consisting of all or some of these securities.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In April 2018, we sold an aggregate of 5,046,510 shares of common
stock in an underwritten public offering pursuant to a shelf
registration statement on Form S-3 for gross proceeds of $40.4
million, resulting in net proceeds of approximately $37.7 million
after deducting underwriting discounts and commissions and
estimated offering expenses.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In June 2015, we entered into the Grant Contract with CPRIT, under
which CPRIT agreed to provide up to $19.8 million in grant funding
to fund our development of pegzilarginase. Through March&nbsp;31,
2018, we have collected $14.1 million in grant proceeds with $5.7
million available for future collection under the grant contract.
As of March&nbsp;31, 2018, we have a grant receivable outstanding
of $3.4 million.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our primary use of cash is to fund the development of our lead
product candidate, pegzilarginase. This includes both the research
and development costs and the general and administrative expenses
required to support those operations. Since we are a clinical-stage
biotechnology company, we have incurred significant operating
losses since our inception and we anticipate such losses, in
absolute dollar terms, to increase as we continue our clinical
trials in pegzilarginase and expand our development efforts in our
pipeline of nonclinical candidates.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Future funding requirements and operational plan</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our operational plan for the near future is to continue clinical
trials for our lead product candidate pegzilarginase in two
separate indications: Arginase 1 Deficiency and advanced solid
tumors, and to expand development for at least one additional
product candidate. As such, we plan to increase our research and
development expenditures for the foreseeable future with
nonclinical studies, clinical trials, manufacturing, and an
integrated biomarker strategy. We expect our principal expenditures
during this time period to include expenses for the following:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">funding the continuing development
of pegzilarginase;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">funding the advancement of
additional product candidates; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">funding working capital, including
general operating expenses.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU22" id=
"_AEIOULastRenderedPageBreakAEIOU22"></a>Due to our significant
research and development expenditures, we have generated
substantial losses in each period since inception. We have an
accumulated deficit of $80.6 million as of March&nbsp;31, 2018. We
anticipate that we will continue to generate losses into the
foreseeable future as we develop our product candidates, seek
regulatory approval of those candidates and begin to commercialize
any approved products. Until such time as we can generate
substantial product</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
19</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
revenue, we expect to finance our cash needs through a combination
of equity or debt financings, rese</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">arch
grants, collaborations, or other sources. We currently have no
debt, credit facility or additional committed capital. To the
extent that we raise additional equity, the ownership interest of
our stockholders will be diluted.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Based on our available cash, cash equivalents, and marketable
securities of $43.5 million as of March&nbsp;31, 2018, in
conjunction with the proceeds received from our stock offering in
April 2018, we believe that we have sufficient resources to fund
our operations through the middle of 2020. We have based this
estimate on assumptions that may prove to be incorrect, however,
and we could deplete our capital resources sooner than we
expect.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Cash flows</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The following table summarizes our cash flows for the periods
indicated (in thousands):</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="6" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
March&nbsp;31,</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2018</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
2017</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Net cash and cash equivalents (used in) provided by:</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Operating activities</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(7,447</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(5,432</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Investing activities</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
4,702</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(25,611</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Financing activities</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
688</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
96</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Net decrease in cash and cash equivalents</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(2,057</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
$</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style=
"text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(30,947</p>
</td>
<td valign="bottom" bgcolor="#CFF0FC" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
)</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Arial;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">
Cash used in operating activities</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Cash used in operating activities for the three months ended
March&nbsp;31, 2018 was $7.4 million and reflected a net loss of
$8.1 million. Our net loss was offset in part by non-cash expenses
of $0.8 million for stock-based compensation and $0.1 million for
depreciation and amortization with $0.2 million net decrease in
operating assets and liabilities during the three months ended
March&nbsp;31, 2018.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Cash used in operating activities for the three months ended
March&nbsp;31, 2017 was $5.4 million and reflected a net loss of
$6.2 million. Our net loss was offset in part by non-cash expenses
of $0.4 million for stock-based compensation and by a $0.4 million
change in operating assets and liabilities. The change in operating
assets and liabilities was primarily due to the collection and
recognition of $1.2 million and $1.0 million, respectively, in
grants accounts receivable under the Grant Contract during the
three months ended March 31, 2017 and increased manufacturing and
clinical activities resulted in decreased prepaid expenses of $0.2
million.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Arial;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">
Cash provided by (used in) investing activities</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Cash provided by investing activities for the three months ended
March&nbsp;31, 2018 was $4.7 million and consisted of $0.1 million
in purchases of property and equipment offset by $4.8 million in
maturities of marketable securities.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Cash used in investing activities for the three months ended
March&nbsp;31, 2017 was $25.6 million and primarily consisted of
$32.8 million in purchases of marketable securities and $0.3
million in purchases of property and equipment to develop an
internal research laboratory, offset by $7.4 million in maturities
of marketable securities.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Arial;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">
Cash provided by financing activities</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Cash provided by financing activities for the three months ended
March&nbsp;31, 2018 was $0.7 million as a result of proceeds
received from stock option exercises and the sale of common stock
under our 2016 Employee Stock Purchase Plan.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Cash provided by financing activities for the three months ended
March&nbsp;31, 2017 was $0.1 million and was a result of the sale
of common stock under our 2016 Employee Stock Purchase Plan and the
exercise of stock options.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
20</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU23" id=
"_AEIOULastRenderedPageBreakAEIOU23"></a><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Contractual
Obliga</font><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">tions
and Other Commitments</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We have entered into agreements in the normal course of business
with contract research organizations for clinical trials and
contract manufacturing organizations, and with vendors for
preclinical research studies and other services and products for
operating purposes. These contractual obligations are cancelable at
any time by us, generally upon 30 days’ prior written notice to the
vendor.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
There have been no material changes to the contractual obligations
during the three months ended March&nbsp;31, 2018 as compared to
those disclosed in our Annual Report on Form 10-K for the year
ended December 31, 2017.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Off-Balance Sheet Arrangements</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Through March&nbsp;31, 2018, we do not have any off-balance sheet
arrangements, as defined by applicable SEC regulations.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Recent Accounting Pronouncements</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic
842), which establishes a comprehensive new lease accounting model.
The new standard: (a) clarifies the definition of a lease; (b)
requires a dual approach to lease classification similar to current
lease classifications; and, (c) causes lessees to recognize leases
on the balance sheet as a lease liability with a corresponding
right-of-use asset for leases with a lease-term of more than twelve
months. The new standard is effective for fiscal years and interim
periods beginning after December 15, 2018 and requires modified
retrospective application. Early adoption is permitted. We are
currently evaluating the impact that the adoption of ASU 2016-02
will have on our consolidated financial statements, but expect the
impact to be limited to the operating lease agreement for office
and laboratory space in Austin, Texas.</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.06%;white-space:nowrap">
<p style=
"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;3.</font></p>
</td>
<td valign="top">
<p style=
"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
<a name="ITEM_3_QUANTITATIVE_QUALITATIVE_DISCLOSU" id=
"ITEM_3_QUANTITATIVE_QUALITATIVE_DISCLOSU"></a><a name=
"ITEM_3_QUANTITATIVE_QUALITATIVE_DISCLOSU" id=
"ITEM_3_QUANTITATIVE_QUALITATIVE_DISCLOSU"></a>Quantitative and
Qualitative Disclosures About Market Risk.</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We are exposed to market risks in the ordinary course of our
business. Our primary exposure to market risk is interest rate
sensitivity, which is affected by changes in the general level of
U.S. interest rates, particularly because our investments are in
marketable securities. Our marketable securities are subject to
interest rate risk and could fall in value if market interest rates
increase. However, we believe that our exposure to interest rate
risk is not significant as the majority of our investments are
short-term in duration and due to the low risk profile of our
investments, a 10% change in interest rates would not have a
material effect on the total market value of our investment
portfolio. We have the ability to hold our marketable securities
until maturity, and therefore we would not expect our operating
results or cash flows to be affected to any significant degree by
the effect of a change in market interest rates on our
investments.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
As of March&nbsp;31, 2018, we held $43.5&nbsp;million in cash, cash
equivalents, and marketable securities, all of which was
denominated in U.S. dollar assets, and consisting primarily of
investments in reverse repurchase agreements and
U.S.&nbsp;&nbsp;government securities.</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.06%;white-space:nowrap">
<p style=
"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;4.</font></p>
</td>
<td valign="top">
<p style=
"margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
<a name="ITEM_4_CONTROLS_PROCEDURES" id=
"ITEM_4_CONTROLS_PROCEDURES"></a><a name=
"ITEM_4_CONTROLS_PROCEDURES" id=
"ITEM_4_CONTROLS_PROCEDURES"></a>Controls and Procedures.</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Evaluation of Disclosure Controls and Procedures</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our management, with the participation of our principal executive
officer and our principal financial officer, evaluated, as of the
end of the period covered by this Quarterly Report on
Form&nbsp;10-Q, the effectiveness of our disclosure controls and
procedures. Based on that evaluation of our disclosure controls and
procedures as of March&nbsp;31, 2018, our principal executive
officer and principal financial officer concluded that our
disclosure controls and procedures as of such date are effective at
the reasonable assurance level. The term “disclosure controls and
procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the
Securities Exchange Act of 1934, as amended, or the Exchange Act,
means controls and other procedures of a company that are designed
to ensure that information required to be disclosed by a company in
the reports that it files or submits under the Exchange Act are
recorded, processed, summarized and reported within the time
periods specified in the SEC’s rules&nbsp;and
forms.&nbsp;Disclosure controls and procedures include, without
limitation, controls and procedures designed to ensure that
information required to be disclosed by us in the reports we file
or submit under the Exchange Act is accumulated and communicated to
our management, including our principal executive officer and
principal financial officer, as appropriate to allow timely
decisions regarding required disclosure. Management recognizes that
any controls and procedures, no matter how well designed and
operated, can provide only reasonable assurance of achieving their
objectives and our management necessarily applies its judgment in
evaluating the cost-benefit relationship of possible controls and
procedures.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
21</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU24" id=
"_AEIOULastRenderedPageBreakAEIOU24"></a><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Changes
in Internal Control over Financial Reporting</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
There have been no changes in our internal control over financial
reporting during our fiscal quarter ended March&nbsp;31, 2018 that
have materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="PART_II_OR_INFORMATION" id=
"PART_II_OR_INFORMATION"></a><a name="PART_II_OR_INFORMATION" id=
"PART_II_OR_INFORMATION"></a>PART II. – OTHER INFORMATION</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;1.</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
<a name="ITEM_1_LEGAL_PROCEEDINGS" id=
"ITEM_1_LEGAL_PROCEEDINGS"></a><a name="ITEM_1_LEGAL_PROCEEDINGS"
id="ITEM_1_LEGAL_PROCEEDINGS"></a>Legal Proceedings</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
From time to time, we may become involved in legal proceedings
relating to claims arising from the ordinary course of business.
Our management believes that there are currently no claims or
actions pending against us, the ultimate disposition of which could
have a material adverse effect on our results of operations,
financial condition or cash flows.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;1A.</font></p>
</td>
<td valign="top">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
<a name="ITEM_1A_RISK_FACTORS" id=
"ITEM_1A_RISK_FACTORS"></a><a name="ITEM_1A_RISK_FACTORS" id=
"ITEM_1A_RISK_FACTORS"></a>Risk Factors</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Arial;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">
Investing in our common stock involves a high degree of risk. You
should carefully consider the risks and uncertainties described
below, together with all of the other information in this quarterly
report on Form 10-Q, including our consolidated financial
statements and related notes and “Management’s Discussion and
Analysis of Financial Condition and Results of Operations,” before
investing in our common stock. The risks and uncertainties
described below are not the only ones we face. Additional risks and
uncertainties that we are unaware of, or that we currently believe
are not material, may also become important factors that affect us.
If any of the following risks occur, our business, operating
results and prospects could be materially harmed. In that event,
the price of our common stock could decline, and you could lose
part or all of your investment.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Risks Related to Our Business and Industry</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Our limited operating history may make it difficult for you to
evaluate the success of our business to date and to assess our
future viability.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We are a clinical-stage biotechnology company. We began operations
as a limited liability company in December 2013 and converted to a
Delaware corporation in March 2015. Our operations to date have
been limited to organizing and staffing our company, business
planning, raising capital, acquiring and developing our technology,
identifying potential product candidates, undertaking nonclinical
studies, and preparing for, commencing and conducting clinical
trials of our most advanced product candidate, pegzilarginase.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We have not yet demonstrated our ability to successfully complete
any clinical trials, including large-scale, pivotal clinical
trials, obtain marketing approvals, manufacture a commercial scale
product or arrange for a third party to do so on our behalf, or
conduct sales and marketing activities necessary for successful
product commercialization. Products, on average, take ten to 15
years to be developed from the time they are discovered to the time
they are approved and available for treating patients. Although we
have recruited a team that has experience with clinical trials, as
a company we have little experience in conducting clinical trials.
In part because of this lack of experience, we cannot be certain
that planned or ongoing clinical trials will begin or be completed
on time, if at all. Consequently, any predictions you make about
our future success or viability based on our short operating
history to date may not be as accurate as they could be if we had a
longer operating history or an established track record in
commercializing products or conducting clinical trials.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In addition, as a new business, we may encounter unforeseen
expenses, difficulties, complications, delays and other known and
unknown factors. We will need to transition from a company with a
research focus to a company capable of supporting commercial
activities. We may not be successful in such a transition.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We have no source of product revenue and we have incurred
significant losses since inception. We expect to incur losses for
the foreseeable future and may never achieve or maintain
profitability.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We have a limited operating history. We have no approved products
and have only begun clinical development of pegzilarginase. Our
ability to generate revenue and become profitable depends upon our
ability to successfully complete the development of any of our
product candidates, including pegzilarginase, for any of our target
indications and to obtain necessary regulatory approvals. To date,
we have recognized revenue solely from a government grant and have
not generated any product revenue. Even if we receive regulatory
approval for any of our product candidates, we do not know when
these product candidates will generate revenue for us, if at
all.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
22</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU25" id=
"_AEIOULastRenderedPageBreakAEIOU25"></a><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In
addition, since inception, we have incurred significant operating
losses. For the three months ended</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
March&nbsp;31, 2018, we reported a net loss of $8.1 million and
$6.2 million, respectively. For the years ended December 31, 2017
and 2016, we reported a net loss of $27.2 million and $21.7
million, respectively. As of March&nbsp;31, 2018, we had an
accumulated def</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">icit
of $80.6 million. We have financed our operations primarily through
private placements of our preferred stock, the initial public
offering, or IPO, of our common stock, follow-on public offerings
of our common stock, and collection of a research
grant</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.
We have devoted substantially all of our efforts to research and
development. Currently, we are only conducting clinical development
for pegzilarginase for the treatment of Arginase 1 Deficiency and
advanced solid tumors, including a combination clinical</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
trial of pegzilarginase with</font> <font style=
"color:#000000;">pembrolizumab</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.
We have not initiated clinical development of our other product
candidates and expect that it will be many years, if ever, before
we have a product candidate ready for commercialization. We expect
to continue to</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
incur significant expenses and increasing operating losses for the
foreseeable future, and the net losses we incur may fluctuate
significantly from quarter to quarter. We anticipate that our
expenses will increase substantially if and as we:</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">continue our research, nonclinical
and clinical development of our product candidates;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">seek to identify additional
product candidates;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">conduct additional nonclinical
studies and initiate clinical trials for our product
candidates;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">seek marketing approvals for any
of our product candidates that successfully complete clinical
trials, including pivotal trials;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">establish a sales, marketing and
distribution infrastructure to commercialize any product candidates
for which we may obtain marketing approval;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">maintain, expand and protect our
intellectual property portfolio;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">hire additional executive,
clinical, quality control and scientific personnel;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">add operational, financial and
management information systems and personnel, including personnel
to support our product development; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">acquire or in-license other
product candidates and technologies.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We are unable to predict the timing or amount of increased
expenses, or when, or if, we will be able to achieve or maintain
profitability because of the numerous risks and uncertainties
associated with product development. In addition, our expenses
could increase significantly beyond expectations if we are required
by the FDA, EMA, MHRA, or other relevant regulatory authorities, or
the Health Authorities, to modify protocols of our clinical trials
or perform studies in addition to those that we currently
anticipate. Even if pegzilarginase, or any of our other product
candidates, is approved for commercial sale, we anticipate
incurring significant costs associated with the commercial launch
of any product candidate.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
To become and remain profitable, we must develop and eventually
commercialize a product candidate or product candidates with
significant market potential. This will require us to be successful
in a range of challenging activities, including completing
nonclinical testing, initiating and completing clinical trials of
one or more of our product candidates, obtaining marketing approval
for these product candidates, manufacturing, marketing and selling
those product candidates for which we obtain marketing approval and
satisfying any post-marketing requirements. We may never succeed in
these activities and, even if we do, we may never generate revenues
that are significant or large enough to achieve profitability. We
are currently only conducting clinical development for
pegzilarginase for the treatment of Arginase 1 Deficiency and
advanced solid tumors, including a combination clinical trial of
pegzilarginase with <font style=
"color:#000000;">pembrolizumab</font> and are only in the
nonclinical development stages for our remaining product
candidates. If we do achieve profitability, we may not be able to
sustain or increase profitability on a quarterly or annual basis.
Our failure to become and remain profitable would decrease the
value of the company and could impair our ability to raise capital,
maintain or expand our research and development efforts, expand our
business or continue our operations. A decline in the value of our
company would also cause you to lose part or even all of your
investment.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We may not be successful in advancing the clinical development of
our product candidates, including pegzilarginase.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU26" id=
"_AEIOULastRenderedPageBreakAEIOU26"></a>In order to execute on our
strategy of advancing the clinical development of our product
candidates, we are currently conducting multiple clinical trials
for pegzilarginase, consisting of one Phase 1/2 clinical trial for
the treatment of Arginase 1 Deficiency, one Phase 1 clinical trial
for the treatment of patients with advanced solid tumors with
multiple cohort expansions, and one Phase 1/2 clinical trial to
evaluate the combination of pegzilarginase with <font style=
"color:#000000;">pembrolizumab</font> for the</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
23</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
treatment of patients with small cell lung cancer. We have recently
initiated the planned expansion cohorts of our Phase 1 trial of
pegzilarginase for the treatment of advanced solid
tum</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ors
to study small cell lung cancer, uveal melanoma, and cutaneous
melanoma, all of which have been shown in published literature and
preclinical studies to demonstrate a dependence on arginine. If our
product candidate fails to work as we expect, or if we</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
need to conduct additional studies to better understand the
relationship between our product candidate and clinical activity,
our ability to assess the therapeutic effect, seek regulatory
approval or otherwise begin or further clinical development,
could</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
be compromised. For instance, we discontinued clinical development
of pegzilarginase for the treatment of the hematological
malignancies acute myeloid leukemia (AML) and myelodysplastic
syndrome (MDS) in December 2017 due to lack of evidence of clinical
be</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">nefit.
Also, while there is an established link between seizures and
elevated levels of certain arginine metabolites, we may not be able
to determine the relationship between clinical activity and
arginine and its metabolites, if any, for the treatment of</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Arginase 1 Deficiency. Any such events may result in longer
development times, larger trials and a greater likelihood of
terminating the trial or not obtaining regulatory
approval.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In addition, as we pursue oncology-related applications of our
product candidates, because the natural history of different tumor
types is variable, we will need to study our product candidates,
including pegzilarginase, in clinical trials specific for a given
tumor type and this will result in increased time and cost. Even if
our product candidate demonstrates efficacy in a particular tumor
type, we cannot guarantee that any product candidate, including
pegzilarginase, will behave similarly in all tumor types, and we
will be required to obtain separate regulatory approvals for each
tumor type we intend a product candidate to treat. If any of our
ongoing or planned clinical trials are unsuccessful, our business
will suffer.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We or third parties may not be successful in developing companion
diagnostic assays for our product candidates.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In developing a product candidate, we expect that if we use a
biomarker-based test to identify and only enroll patients in
clinical trials with tumors that express the biomarker, the FDA
will require the development and regulatory approval of a companion
diagnostic assay as a condition to approval of the product
candidate. We do not have experience or capabilities in developing
or commercializing these companion diagnostics and plan to rely in
large part on third parties to perform these functions. Companion
diagnostic assays are subject to regulation by the FDA as medical
devices and require separate regulatory approval prior to the use
of such diagnostic assays with a therapeutic product candidate. If
we, or any third parties that we engage to assist us, are unable to
successfully develop companion diagnostic assays for use with our
product candidates, or experience delays in development, we may be
unable to identify patients with the specific profile targeted by
our product candidates for enrollment in our clinical trials.
Accordingly, further investment may be required to further develop
or obtain the required regulatory approval for the relevant
companion diagnostic assay, which would delay or substantially
impact our ability to conduct further clinical trials or obtain
regulatory approval. In addition, if a companion diagnostic is
necessary for any of our product candidates, the delay or failure
to obtain regulatory approval of the companion diagnostic would
delay or prevent the approval of the therapeutic product candidate.
EMA, MHRA or comparable foreign regulatory authorities may also
require the development and regulatory approval of a companion
diagnostic assay as a condition to approval of the product
candidate.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We will need substantial additional funding. If we are unable to
raise capital when needed, we would be compelled to delay, reduce
or eliminate our product development programs or commercialization
efforts.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We expect our expenses to increase in parallel with our ongoing
activities, particularly as we continue our discovery and
nonclinical development to identify new clinical candidates and
initiate and continue clinical trials of, and seek marketing
approval for, our product candidates. In addition, if we obtain
marketing approval for any of our product candidates, we expect to
incur significant commercialization expenses related to product
sales, marketing, manufacturing and distribution. Furthermore, we
expect to continue to incur additional costs associated with
operating as a public company. Accordingly, we will need to obtain
substantial additional funding in connection with our continuing
operations. If we are unable to raise capital when needed or on
acceptable terms, we would be forced to delay, reduce or eliminate
our discovery and nonclinical development programs, our ongoing
clinical development, or any future clinical development or
commercialization efforts.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
24</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU27" id=
"_AEIOULastRenderedPageBreakAEIOU27"></a><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based
upon our planned use of our cash, cash equivalents, and marketable
securities as of March&nbsp;31, 2018, we estimate</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
such funds will be sufficient for us to fund our ongoing Phase 1/2
clinical trial for the treatment of patients with Arginase 1
Deficiency, our ongoing Phase 1 clinical trial for the treatment of
patients with advanced solid tumors, including our three
si</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ngle
agent cohort expansions in small cell lung cancer, uveal melanoma,
and cutaneous melanoma, as well as our ongoing Phase 1/2
combination clinical trial of pegzilarginase with pembrolizumab for
the treatment of patients with small cell lung cancer. Our</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
future capital requirements will depend on many factors,
including:</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the costs associated with the
scope, progress and results of compound discovery, nonclinical
development, laboratory testing and clinical trials for our product
candidates;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the costs related to the extent to
which we enter into partnerships or other arrangements with third
parties in order to further develop our product
candidates;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the costs and fees associated with
the discovery, acquisition or in-license of product candidates or
technologies;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">our ability to establish
collaborations on favorable terms, if at all;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the costs of future
commercialization activities, if any, including product sales,
marketing, manufacturing and distribution, for any of our product
candidates for which we receive marketing approval;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">revenue, if any, received from
commercial sales of our product candidates, should any of our
product candidates receive marketing approval; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the costs of preparing, filing and
prosecuting patent applications, maintaining and enforcing our
intellectual property rights and defending intellectual
property-related claims.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our product candidates, if approved, may not achieve commercial
success. Our commercial revenues, if any, will be derived from
sales of product candidates that we do not expect to be
commercially available for many years, if at all. Accordingly, we
will continue to rely on additional financing to achieve our
business objectives, which may not be available to us on acceptable
terms, or at all.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Raising additional capital may cause dilution to our stockholders,
restrict our operations or require us to relinquish rights to our
technologies or product candidates.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Until such time, if ever, as we can generate substantial product
revenues, we expect to finance our cash needs through a combination
of equity or equity-linked offerings, debt financings, grants from
research organizations and license and collaboration agreements. We
do not have any committed external source of funds other than our
grant agreement with the Cancer Prevention and Research Institute
of Texas. To the extent that we raise additional capital through
the sale of equity or convertible debt securities, your ownership
interest will be diluted, and the terms of these securities may
rank senior to our common stock and include liquidation or other
preferences, covenants or other terms that adversely affect your
rights as a common stockholder. Further, any future sales of our
common stock by us or resale of our common stock by our existing
stockholders could cause the market price of our common stock to
decline. Debt financing and preferred equity financing, if
available, may involve agreements that include covenants limiting
or restricting our ability to take specific actions, such as
incurring additional debt, making capital expenditures or declaring
dividends.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
If we raise additional funds through collaborations, strategic
alliances or marketing, distribution or licensing arrangements with
third parties, we may have to relinquish valuable rights to our
technologies, future revenue streams, research programs or product
candidates or grant licenses on terms that may not be favorable to
us and/or that may reduce the value of our common stock.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
25</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU28" id=
"_AEIOULastRenderedPageBreakAEIOU28"></a><font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">We
depend heavily on the success of our most advanced product
candidate, pegzila</font><font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">rginase.
All of our product candidates, other than pegzilarginase, are still
in nonclinical development or nonclinical testing, and for
pegzilarginase, the early stages of clinical development. Existing
and future clinical trials of our product candidates,</font>
<font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
including pegzilarginase, may not be successful. If we are unable
to commercialize our product candidates or experience significant
delays in doing so, our business will be materially
harmed.</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We have invested a significant portion of our efforts and financial
resources in the nonclinical and clinical development and testing
of our most advanced product candidate, pegzilarginase, for the
treatment of patients with Arginase 1 Deficiency and advanced solid
tumors, including a combination clinical trial of pegzilarginase
with <font style="color:#000000;">prembrolizumab</font>. Our
ability to generate product revenues, which we do not expect will
occur for many years, if ever, will depend heavily on the
successful development and eventual commercialization of
pegzilarginase. The success of pegzilarginase and our other product
candidates will depend on many factors, including the
following:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">successful enrollment of patients
in, and the completion of, our ongoing and planned clinical
trials;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">receiving required regulatory
approvals for the development and commercialization of our product
candidates as monotherapy or in combination with other
products;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">establishing commercial
manufacturing capabilities or making arrangements with third-party
manufacturers;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">obtaining and maintaining patent
and trade secret protection and non-patent exclusivity for our
product candidates and their components;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">enforcing and defending
intellectual property rights and claims;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">achieving desirable therapeutic
properties for our product candidates’ intended
indications;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">launching commercial sales of our
product candidates, if and when approved, whether alone or in
collaboration with third parties;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">acceptance of our product
candidates, if and when approved, by patients, the medical
community and third-party payors;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">effectively competing with other
therapies; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">maintaining an acceptable safety
profile of our product candidates through clinical trials and
following regulatory approval.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
If we do not achieve one or more of these factors in a timely
manner or at all, we could experience significant delays or an
inability to successfully commercialize our product candidates,
which would materially harm our business.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Clinical drug development involves a lengthy and expensive process
with an uncertain outcome. We may experience delays in completing,
or ultimately be unable to complete, the development and
commercialization of any of our product candidates.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We have initiated clinical trials of our lead product candidate
pegzilarginase, and the risk of failure for all of our product
candidates is high. Before obtaining marketing approval from
regulatory authorities for the sale of any product candidate, we
must complete nonclinical development and then conduct extensive
clinical trials to demonstrate the safety and efficacy of our
product candidates in humans for the respective target indications.
Clinical testing is expensive, difficult to design and implement
and can take many years to complete, and its outcome is inherently
uncertain. Failure can occur at any time during the clinical trial
process.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU29" id=
"_AEIOULastRenderedPageBreakAEIOU29"></a>The results of nonclinical
studies and early clinical trials of our product candidates may not
be predictive of the results of later-stage clinical trials that
will likely differ in design and size from early-stage clinical
trials, and interim results of a clinical trial do not necessarily
predict final results. For example, while we have observed a
reduction in blood arginine and arginine metabolite levels due to
pegzilarginase in patients with Arginase 1 Deficiency, and a
reduction in blood arginine levels due to pegzilarginase in
patients with advanced solid tumors, this data may not necessarily
be predictive of the final results of all patients intended to be
enrolled in these ongoing clinical trials or in future trials, and
may also not be predictive of pegzilarginase’s ability to reduce
arginine or arginine metabolite levels for these patients over a
longer term. In addition, while we have announced interim data from
our ongoing clinical trials of pegzilarginase for the treatment of
Arginase 1 Deficiency and advanced solid tumors, such reports were
based on unaudited data provided by our clinical trial
investigators. An audit or subsequent review of this data may
change the conclusions drawn from this unaudited data provided by
our clinical trial investigators indicating less promising results
than we anticipate. In addition, our observations of clinically
relevant treatment effects in the first two patients in the Phase
1/2 open-label study of pegzilarginase in</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
26</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
patients with Arginase 1</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Deficiency after eight and twenty weeks of dosing may not be
representative of our observations with subsequently dosed patients
out to eight weeks or longer. Moreover, we have not discussed with
FDA the design of a pivotal trial of pegzilarginase for the</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
treatment of Arginase 1 Deficiency, including the endpoints for
such a study and the magnitude of treatment effect we would need to
demonstrate. We may design the pivotal trial before the Phase 1/2
clinical trial is complete and may not have all data
avail</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">able
from the fully enrolled trial prior to determining the design with
the FDA. Furthermore, our ongoing Phase 1/2 clinical trial for the
treatment of patients with Arginase 1 Deficiency and our Phase 1
clinical trials for the treatment of advanced solid</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
tumors will primarily evaluate the safety of our product
candidates, and we will not be evaluating the efficacy of our
product candidates in these early trials in a formal manner.
Moreover, nonclinical and clinical data are often susceptible to
varying int</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">erpretations
and analyses, and many companies that have believed their product
candidates performed satisfactorily in nonclinical studies and
clinical trials have nonetheless failed to obtain marketing
approval of their products. It is impossible to
predic</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">t
when or if any of our product candidates will prove effective or
safe in humans or will receive regulatory approval.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We may experience delays in our ongoing and planned clinical trials
and we do not know whether planned clinical trials will begin or
enroll subjects on time, whether enrolled subjects will complete
trials on time or at all, whether they will need to be redesigned
or whether they will be able to be completed on schedule, if at
all. There can be no assurance that the Health Authorities will
allow us to begin clinical trials or that they will not put any of
the trials for any of our product candidates that enter or have
entered clinical development on clinical hold in the future. We may
experience numerous unforeseen events during, or as a result of,
clinical trials that could delay or prevent our ability to receive
marketing approval or commercialize our product candidates.
Clinical trials may be delayed, suspended or prematurely terminated
because costs are greater than we anticipate or for a variety of
reasons, such as:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">delay or failure in reaching
agreement with the Health Authorities on a trial design that we are
able to execute;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">delay or failure in obtaining
authorization to commence a trial or inability to comply with
conditions imposed by a regulatory authority regarding the scope or
design of a clinical trial;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">delays in reaching, or failure to
reach, agreement on acceptable clinical trial contracts or clinical
trial protocols with planned trial sites;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">modifications to our ongoing and
planned clinical trial protocols due to regulatory requirements or
decisions made by regulatory authorities;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">reports of safety issues, side
effects or dose-limiting toxicities, or any additional or more
severe safety issues in addition to those observed to
date;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">inability, delay, or failure in
identifying and maintaining a sufficient number of trial sites,
many of which may already be engaged in other clinical
programs;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">delay or failure in recruiting and
enrolling suitable subjects to participate in one or more clinical
trials;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">delay or failure in having
subjects complete a trial or return for post-treatment follow-up.
For instance, in March 2018, a pediatric patient previously</font>
<font style="color:#000000;font-family:Arial;">dosed in Part 1 of
our Phase 1/2 clinical trial of pegzilarginase for the treatment of
Arginase 1 Deficiency withdrew from the trial due to personal
reasons</font><font style="font-family:Arial;">;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">clinical sites and investigators
deviating from the trial protocol, failing to conduct the trial in
accordance with regulatory requirements, or dropping out of a
trial;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">a clinical hold for any of our
ongoing or planned clinical trials, including for pegzilarginase,
where a clinical hold in a trial in one indication could result in
a clinical hold for clinical trials in other
indications;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">clinical trials of our product
candidates may produce negative or inconclusive results, and we may
decide, or regulators may require us, to conduct more clinical
trials than we anticipate or abandon product development programs;
for example, the FDA may determine that dose findings are
inadequate based on results from our Phase 1/2 trial or any future
Phase 3 trial in pegzilarginase for the treatment of
hyperargininemia secondary to Arginase 1 Deficiency and require
additional dose finding studies to inform instructions for use that
provide a safe dosing algorithm for pediatric patients.</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the number of patients required
for clinical trials of our product candidates may be larger than we
anticipate, enrollment in these clinical trials may be slower than
we anticipate or insufficient or participants may drop out of these
clinical trials at a higher rate than we anticipate;</font></p>
</td>
</tr>
</table>
</div>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
27</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<a name="_AEIOULastRenderedPageBreakAEIOU30" id=
"_AEIOULastRenderedPageBreakAEIOU30"></a><font style=
"font-family:Arial;">we may experience delays or difficulties in
the enrollment of patients with Arginase 1 Deficiency or patients
with tumors, including the identification of patients with Arginase
1 Defic</font><font style="font-family:Arial;">iency or development
or identification of a test, if needed, to screen for those cancer
patients;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">our third-party contractors may
fail to comply with regulatory requirements or meet their
contractual obligations to us in a timely manner, or at
all;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">we may have difficulty partnering
with experienced CROs that can screen for patients with tumors
dependent on arginine that pegzilarginase is designed to target and
with CROs that can run our clinical trials effectively;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">regulators may require that we or
our investigators suspend or terminate clinical research for
various reasons, including noncompliance with regulatory
requirements or a finding that the participants are being exposed
to unacceptable health risks;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the supply or quality of our
product candidates or other materials necessary to conduct clinical
trials of our product candidates may be insufficient or inadequate;
or</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">there may be changes in
governmental regulations or administrative actions.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
If we are required to modify our ongoing clinical trial protocols,
conduct additional clinical trials or other testing of our product
candidates beyond those that we currently contemplate, if we are
unable to successfully initiate or complete clinical trials of our
product candidates or other testing, if the results of these trials
or tests do not demonstrate sufficient clinical benefit or if our
product candidates do not have an acceptable safety profile, we
may:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">be delayed in obtaining marketing
approval for our product candidates;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">not obtain marketing approval at
all;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">cease development of our product
candidates;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">obtain approval for indications or
patient populations that are not as broad as intended or
desired;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">obtain approval with labeling that
includes significant use or distribution restrictions or safety
warnings that would reduce the potential market for our product
candidates or inhibit our ability to successfully commercialize our
product candidates;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">be subject to additional
post-marketing restrictions and/or testing requirements;
or</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">have the product removed from the
market after obtaining marketing approval.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We do not know whether any of our planned or current nonclinical
studies, or ongoing or planned clinical trials, will need to be
restructured or will be completed on schedule, or at all. For
example, we have previously delayed enrollment of pediatric
patients in our Phase 1/2 trial of pegzilarginase for the treatment
of Arginase 1 Deficiency due to a difference in opinion with the
FDA on data required to support inclusion of pediatric patients.
Although we have since reached an agreement with the FDA, the FDA
may require additional information or studies to be conducted, or
impose conditions that could further delay or restrict our other
planned clinical activities in the future. For example, we are
currently administering neuromotor and neurocognitive evaluations
in patients in this Phase 1/2 clinical trial, but the FDA may not
agree with the overall burden or relevance of including these
measures in a Phase 3 trial. In addition, we intend to study
surrogate endpoints, such as reduction in blood arginine levels, as
the primary endpoints in our Phase 3 clinical trial; however, we
may need to show some evidence of stabilization or improvement of
clinical signs and symptoms of Arginase 1 Deficiency, such as on
neuromotor outcomes and quality-of-life measurements, to support
the primary endpoint. We may face difficulties or delays in
enrolling any Phase 3 trial in Arginase 1 Deficiency if we restrict
enrollment to patients with baseline clinical abnormalities at a
level that provides an opportunity to demonstrate neuromotor and/or
neurocognitive outcomes. If we are unable to demonstrate consistent
trends on such clinical endpoints, FDA may determine that there is
inadequate justification to support that the surrogate endpoint is
reasonably likely to predict clinical benefit, which would prohibit
approval under the accelerated approval pathway. Significant
nonclinical or clinical trial delays also could shorten any periods
during which we may have the exclusive right to commercialize our
product candidates or allow our competitors to bring products to
market before we do and impair our ability to successfully
commercialize our product candidates and may materially harm our
business and results of operations.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
28</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU31" id=
"_AEIOULastRenderedPageBreakAEIOU31"></a><font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">We</font>
<font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
may not be able to submit INDs, or foreign equivalents outside of
the United States, to commence clinical trials for product
candidates on the timeframes we expect, and even if we are able to,
the Health Authorities may not permit us to proceed with
plann</font><font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">ed
clinical trials.</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We are currently conducting nonclinical development of our product
candidates other than our clinical trials for pegzilarginase for
the treatment of patients with Arginase 1 Deficiency and advanced
solid tumors, including a combination clinical trial of
pegzilarginase with <font style=
"color:#000000;">pembrolizumab</font>. Progression of any candidate
into clinical trials is inherently risky and dependent on the
results obtained in nonclinical programs, and other potential
results such as the results of other clinical programs and results
of third-party programs. If results are not available when expected
or problems are identified during therapy development, we may
experience significant delays in clinical development. This may
also impact our ability to achieve certain financial milestones and
the expected timeframes to market any of our product candidates.
Failure to submit or have effective INDs, CTAs or other comparable
foreign equivalents and commence clinical programs will
significantly limit our opportunity to generate revenue.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Our engineered human enzyme product candidates for our oncology
indications represent a novel approach to cancer treatment, which
could result in heightened regulatory scrutiny, delays in clinical
development, or delays in our ability to achieve regulatory
approval or commercialization of our product candidates.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Engineered human enzyme products are a new category of
therapeutics. Because this is a relatively new and expanding area
of novel therapeutic interventions, there can be no assurance as to
the length of the trial period, the manufacturing and quality
control standards required to be met by regulators, the number of
patients the Health Authorities will require to be enrolled in the
trials in order to establish the safety, efficacy, purity and
potency of engineered human enzyme products, or that the data
generated in these trials will be acceptable to the FDA or another
applicable regulatory authority to support marketing approval.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We have only initiated early-stage clinical trials for
pegzilarginase for the treatment of certain conditions. We have not
dosed any of our other product candidates in humans. Our existing
and future planned clinical trials may reveal significant adverse
events, toxicities or other side effects not seen in our
nonclinical studies and may result in a safety profile that could
inhibit regulatory approval or market acceptance of any of our
product candidates.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In order to obtain marketing approval for any of our product
candidates, we must demonstrate the safety and efficacy of the
product candidate for the relevant clinical indication or
indications through nonclinical studies and clinical trials as well
as additional supporting data. If our product candidates are
associated with undesirable side effects in nonclinical studies or
clinical trials, in monotherapy or combination therapy, or have
characteristics that are unexpected, we may need to interrupt,
delay or abandon their development or limit development to more
narrow uses or subpopulations in which the undesirable side effects
or other characteristics are less prevalent, less severe or more
acceptable from a risk-benefit perspective.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We are currently conducting clinical trials for pegzilarginase for
the treatment of patients with Arginase 1 Deficiency and advanced
solid tumors, including a combination clinical trial of
pegzilarginase with pembrolizumab. Given the nature of the patient
population enrolled in these trials, we have observed and expect to
continue to observe serious adverse events that could be related or
unrelated to pegzilarginase. In a Phase 1 trial of pegzilarginase
for the treatment of patients with advanced solid tumors and a
previously concluded trial of pegzilarginase for the treatment of
the patients with hematological malignancies AML and MDS, we have
observed serious adverse events in some patients, including death.
In December 2017, we reported topline results of the dose
escalation trial for the treatment of patients with advanced solid
tumors and the hematological malignancies AML and MDS in which we
observed serious adverse events that were considered possibly or
probably related to the administration of pegzilarginase including
nausea, diarrhea, vomiting, dehydration, dizziness, encephalopathy
manifest as acute agitation, failure to thrive, fatigue,
hypertension, asthenia, and intracranial hemorrhage. In our Phase
1/2 trial of pegzilarginase for the treatment of patients with
Arginase 1 Deficiency, we announced repeat dose data in March 2018
in which we observed three treatment-related serious adverse events
in one patient, including facial flushing, facial swelling, and
throat tightness. Subjects in our ongoing and planned clinical
trials with pegzilarginase may suffer minor, significant, serious,
or even life-threatening adverse events, including those that are
drug-related. Subjects in our ongoing and planned clinical trials
may also suffer side effects not yet observed in any of our prior
and ongoing clinical or nonclinical studies, including, but not
limited to, toxicities to the nervous system, liver, heart, lung,
kidney, blood, pulmonary or immune system. We have not dosed any of
our other product candidates in humans.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU32" id=
"_AEIOULastRenderedPageBreakAEIOU32"></a>Testing in animals, such
as our primate studies for pegzilarginase, may not uncover all side
effects in humans or any observed side effects in animals may be
more severe in humans. For example, it is possible that patients’
immune systems may recognize our engineered human enzymes as
foreign and trigger an immune response. This risk is</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
29</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
heightened in some patients who lack the target enzyme, as</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
is the case with patients with Arginase 1 Deficiency that we are
treating in our Phase 1/2 trial and our future trials for this rare
genetic disease. In addition, our product candidates such as
pegzilarginase break down target amino acids such as
arginine</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,
thereby releasing metabolites such as ornithine into the
bloodstream. Some patients may be sensitive to these metabolites,
increasing the risk of an adverse reaction due to treatment, which
risk may not be able to be mitigated through dosing. Finally,
al</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">though
our engineered human enzyme product candidates such as
pegzilarginase are engineered from the human genome, pegzilarginase
is produced in</font> <font style="font-style:italic;">E.
coli</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.
This manufacturing process could lead pegzilarginase to be more
likely to trigger an immune response t</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">han
we expect.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
To the extent significant adverse events or other side effects are
observed in any of our clinical trials, we may have difficulty
recruiting patients to the clinical trial, patients may drop out of
our trial, or we may be required to abandon the trial or our
development efforts of that product candidate altogether. Some
potential therapeutics developed in the biotechnology industry that
initially showed therapeutic promise in early-stage studies have
later been found to cause side effects that prevented their further
development. Even if the side effects do not preclude the drug from
obtaining or maintaining marketing approval, undesirable side
effects may inhibit market acceptance of the approved product due
to its tolerability versus other therapies. Any of these
developments could materially harm our business, financial
condition and prospects.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Further, toxicities associated with our product candidates may also
develop after regulatory approval and lead to the withdrawal of the
product from the market. We cannot predict whether our product
candidates will cause organ or other injury in humans that would
preclude or lead to the revocation of regulatory approval based on
nonclinical studies or early stage clinical testing.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
If we experience delays or difficulties in the enrollment of
patients in our ongoing or planned clinical trials, our receipt of
necessary regulatory approvals could be delayed or prevented.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We may not be able to initiate or continue our ongoing or planned
clinical trials if we are unable to locate and enroll a sufficient
number of eligible patients to participate in these trials as
required by the Health Authorities. More specifically, many of our
product candidates, including pegzilarginase, initially target
indications that may be characterized as orphan&nbsp;markets, which
can prolong the clinical trial&nbsp;timeline for the regulatory
process if sufficient patients cannot be enrolled in a timely
manner. <font style="color:#000000;">Arginase 1 Deficiency is a
rare disorder, and there are no published reports of disease
prevalence. Newborn screening data for two reliably detected urea
cycle disorders allowed disease experts to estimate the incidence
of Arginase 1 Deficiency at 1:950,000 births. Assuming a less than
normal life span, we believe that at least 600 individuals in
global addressable markets have Arginase 1 Deficiency. Presently,
only 34 U.S. states and jurisdictions screen for Arginase 1
Deficiency, and screening in Europe is not universal. D</font>ue to
screening requirements and enrollment restrictions in our amended
clinical trial protocol, or any additional restrictions that may be
imposed by regulatory agencies, not all pediatric patients may be
eligible for inclusion in our Phase 1/2 trial in the United States.
<font style="color:#000000;">To date, we have identified more than
100 patients worldwide.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Delays in patient enrollment could result in increased costs,
delays in advancing our product development, delays in testing the
effectiveness of our technology or termination of the clinical
trials altogether.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Patient enrollment is affected by factors including:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the severity of the disease under
investigation;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the design of the clinical trial
protocol;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the novelty of the product
candidate and acceptance by physicians;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the patient eligibility criteria
for the study in question;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the size of the total patient
population;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the design of the clinical
trials;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the perceived risks and benefits
of the product candidate under study;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the availability and efficacy of
competing therapies and clinical trials;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">our payments for conducting
clinical trials;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the patient referral practices of
physicians;</font></p>
</td>
</tr>
</table>
</div>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
30</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<a name="_AEIOULastRenderedPageBreakAEIOU33" id=
"_AEIOULastRenderedPageBreakAEIOU33"></a><font style=
"font-family:Arial;">the ability to monitor patients adequately
during and after treatment with the product candidate;
and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the proximity and availability of
clinical trial sites for prospective patients.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In addition, some patients with Arginase 1 Deficiency suffer from
heightened levels of ammonia, or hyperammonemia. Horizon Pharma plc
has gained approval for its products RAVICTI (glycerol
phenylbutyrate) <font style="color:#000000;">and BUPHENYL (sodium
phenylbutyrate)</font> to treat patients with urea cycle disorders
suffering from hyperammonemia. Some patients who may be eligible
for our ongoing or planned clinical trials may instead pursue
treatment for this effect of their condition by taking RAVICTI
(glycerol phenylbutyrate) or through dietary protein restriction.
Our inability to enroll a sufficient number of patients for any of
our clinical trials could result in significant delays and could
require us to abandon one or more clinical trials altogether.
Enrollment delays in our clinical trials may result in increased
development costs for our product candidates and in delays to
commercially launching our product candidates, if approved, which
would cause the value of our company to decline and limit our
ability to obtain additional financing.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
The safety or efficacy profile of pegzilarginase may differ in
combination therapy with other existing or future drugs, and
therefore may preclude its further development or approval, which
would materially harm our business.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
From time to time, our commercialization strategy may include the
combination of our product candidates with third-parties’ products
or product candidates. For example, we are currently conducting a
combination trial with Merck to evaluate the combination of
pegzilarginase with Merck’s anti-PD-1 therapy, KEYTRUDA
(pembrolizumab), for the treatment of patients with small cell lung
cancer. These combination studies involve additional risks due to
their reliance on circumstances outside our control, such as those
relating to the availability and marketability of the third-party
product involved in the study. Although Merck has agreed to provide
pembrolizumab in connection with our ongoing combination trial, we
may be unable to secure and maintain a sufficient supply of such
third-party products when needed on commercially reasonably terms.
Any such shortages could cause us to delay or terminate our
combination trials.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
It is also difficult to predict the way in which pegzilarginase
will interact with third-party products used in combination
clinical trials. As a result, such combination trials may
demonstrate reduced efficacy, increase or exacerbate side effects
that have been seen with pegzilarginase alone, or result in new
side effects that have not previously been identified with
pegzilarginase alone. In addition, data obtained from any
combination trials may be subject to a variety of interpretations.
For instance, positive data may not guarantee the ability to move
forward due to changes in the landscape for the treatment of
targeted indications, and failure to achieve our primary endpoints
may not necessarily preclude a viable commercial path. Any
undesirable side effects, lack of efficacy seen in combination
trials, differing interpretation of clinical data or other
unforeseen circumstances may affect our ability to continue with
and obtain regulatory approval for the combination therapy, as well
as our ability to continue with and obtain regulatory approval for
pegzilarginase monotherapy.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Further, evaluating pegzilarginase in combination with other
products in clinical development may require us to establish
collaborations, licensing arrangements or alliances with third
parties. There is no assurance that we will be able to enter into
such arrangements on favorable terms, or at all.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Even though we have obtained orphan drug designation for
pegzilarginase in the United States and Europe for the treatment of
hyperargininemia, we may not obtain or maintain orphan drug
exclusivity for pegzilarginase and we may not obtain orphan drug
designation or exclusivity for any of our other product candidates
or indications.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Regulatory authorities in some jurisdictions, including the United
States and Europe, may designate drugs or biologics for relatively
small patient populations as orphan drugs. Under the Orphan Drug
Act, the FDA may designate a product as an orphan drug if it is a
drug or biologic intended to treat a rare disease or condition,
which is generally defined as a patient population of fewer than
200,000 individuals in the United States. Similarly, the European
Commission may designate a product as an orphan drug under certain
circumstances.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Generally, if a product with an orphan drug designation
subsequently receives the first marketing approval for the
indication for which it has such designation, the product is
entitled to a period of marketing exclusivity, which precludes the
FDA or the EMA from approving another marketing application for the
same drug for the same disease for that time period. The applicable
period is seven years in the United States and ten years in the
European Union. The European exclusivity period can be reduced to
six years if a drug no longer meets the criteria for orphan drug
designation or if the drug is sufficiently profitable so that
market exclusivity is no longer justified. Orphan drug exclusivity
may be lost if the FDA or EMA determines that the request for
designation was materially defective or if the manufacturer is
unable to assure sufficient quantity of the drug to meet the needs
of patients with the rare disease or condition.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
31</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU34" id=
"_AEIOULastRenderedPageBreakAEIOU34"></a><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In
March 2015, we obtained orphan drug designation in the United
States for pegzilarginase for the treatment of patients with
Arginase 1 Deficiency. In July 2016, we also received orphan drug
designation in Europe for pegzilargi</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">nase
for the treatment of patients with Arginase 1 Deficiency. A company
that first obtains FDA or EMA approval for a designated orphan drug
for the designated rare disease or condition receives orphan drug
marketing exclusivity for that drug for the
desig</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">nated
disease for a period of seven years in the United States or ten
years in the European Union, respectively. This orphan drug
exclusivity prevents the FDA or EMA from approving another
application, including a Biologics License Application, or BLA,
in</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
the United States or a MAA in the European Union, to market a drug
containing the same principal molecular structural features for the
same orphan indication, except in very limited circumstances,
including when the FDA or the EMA concludes that the later</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
drug is safer, more effective or makes a major contribution to
patient care. In addition, a designated orphan drug may not receive
orphan drug exclusivity if it is approved for a use that is broader
than the indication for which it received orphan
designat</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ion.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Even though we have received orphan drug designation for
pegzilarginase for the treatment of Arginase 1 Deficiency, we may
not be the first to obtain marketing approval for the
orphan-designated indication due to the uncertainties associated
with developing pharmaceutical product candidates. Further, even if
we obtain orphan drug exclusivity for a product, that exclusivity
may not effectively protect the product from competition because
different drugs with different active moieties can be approved for
the same condition or a drug with the same principal molecular
structural features can be approved for a different indication.
Orphan drug designation neither shortens the development time or
regulatory review time of a drug nor gives the drug any advantage
in the regulatory review or approval process. In addition, even if
we intend to seek orphan drug designation for other product
candidates or indications, we may never receive such designations
or obtain orphan drug exclusivity.</p>
<p style=
"margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">
Failure to obtain marketing approval in international jurisdictions
would prevent our product candidates from being marketed
abroad.<font style=
"font-weight:normal;font-style:normal;">&nbsp;</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In order to market and sell our products in the European Union and
many other jurisdictions, we or our third-party collaborators must
obtain separate marketing approvals and comply with numerous and
varying regulatory requirements. The approval procedure varies
among countries and can involve additional testing and different
criteria for approval. The time required to obtain approval may
differ substantially from that required to obtain FDA approval. The
regulatory approval process outside the United States generally
includes all of the risks associated with obtaining FDA approval.
In addition, in many countries outside the United States, it is
required that the product be approved for reimbursement before the
product can be approved for sale in that country. We, or our
third-party collaborators, may not obtain approvals from regulatory
authorities outside the United States on a timely basis, if at all.
Approval by the FDA does not ensure approval by regulatory
authorities in other countries or jurisdictions, and approval by
one regulatory authority outside the United States does not ensure
approval by regulatory authorities in other countries or
jurisdictions or by the FDA. However, failure to obtain approval in
some countries or jurisdictions may compromise our ability to
obtain approval elsewhere. We may not be able to file for marketing
approvals and may not receive necessary approvals to commercialize
our products in any market.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
If the market opportunities for our product candidates are smaller
than we believe they are, our future product revenues may be
adversely affected and our business may suffer.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our understanding of both the number of people who suffer from
conditions such as Arginase 1 Deficiency or who have advanced solid
tumors dependent on arginine, as well as the potential subset of
those who have the potential to benefit from treatment with our
product candidates such as pegzilarginase, are based on estimates.
These estimates may prove to be incorrect and new studies may
reduce the estimated incidence or prevalence of these diseases. The
number of patients in the United States, Europe or elsewhere may
turn out to be lower than expected, may not be otherwise amenable
to treatment with our product candidates or patients may become
increasingly difficult to identify and access, all of which would
adversely affect our business, financial condition, results of
operations and prospects.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Further, there are several factors that could contribute to making
the actual number of patients who receive our potential product
candidates less than the potentially addressable market. These
include the lack of widespread availability of, and limited
reimbursement for, new therapies in many underdeveloped
markets.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
32</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU35" id=
"_AEIOULastRenderedPageBreakAEIOU35"></a><font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">Even
if any of our product candidates receives marketing approval, it
may fail to achieve the degree of market acceptance by physicians,
patients, third-party payors and others in the medical
c</font><font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">ommunity
necessary for commercial success.</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Even if any of our product candidates receives marketing approval,
it may nonetheless fail to gain sufficient market acceptance by
physicians, patients, third-party payors and others in the medical
community necessary for commercial success. For example, current
cancer treatments like chemotherapy and radiation therapy are well
established in the medical community, and physicians may continue
to rely on these treatments instead of adopting the use of
pegzilarginase for the treatment of patients with arginine
dependent cancers. In addition, many new drugs have been recently
approved and many more are in the pipeline to treat patients with
cancer. Additionally, current treatments for Arginase 1 Deficiency
include dietary protein restriction and, in some instances,
nitrogen-scavenging drugs such as RAVICTI (glycerol
phenylbutyrate). If our product candidates do not achieve an
adequate level of acceptance, we may never generate significant
product revenues and we may not become profitable. The degree of
market acceptance of our product candidates, if approved for
commercial sale, will depend on a number of factors, including:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">their efficacy, safety and other
potential advantages compared to alternative treatments;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">our ability to offer them for sale
at competitive prices;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">their convenience and ease of
administration compared to alternative treatments;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the willingness of the target
patient population to try new therapies and of physicians to
prescribe these therapies;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the strength of marketing and
distribution support;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the availability of third-party
coverage and adequate reimbursement for our product
candidates;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the prevalence and severity of
their side effects;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">any restrictions on the use of our
product candidates together with other medications;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">interactions of our product
candidates with other products patients are taking; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">inability of patients with certain
medical histories to take our product candidates.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We expect to expand our development and regulatory capabilities and
potentially implement sales, marketing and distribution
capabilities, and, as a result, we may encounter difficulties in
managing our growth, which could disrupt our operations.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We expect to experience significant growth in the number of our
employees and the scope of our operations, particularly in the
areas of product candidate development, regulatory affairs and, if
any of our product candidates receives marketing approval, sales,
marketing and distribution.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We currently do not have a marketing or sales team for the
marketing, sales and distribution of any of our product candidates
that are potentially able to obtain regulatory approval. In order
to commercialize any product candidates, we must build on a
territory-by-territory basis marketing, sales, distribution,
managerial and other non-technical capabilities or make
arrangements with third parties to perform these services, and we
may not be successful in doing so. If our product candidates
receive regulatory approval, we intend to establish an internal
sales or marketing team with technical expertise and supporting
distribution capabilities to commercialize our product candidates,
which will be expensive and time consuming and will require
significant attention of our executive officers to manage. Any
failure or delay in the development of our internal sales,
marketing and distribution capabilities would adversely impact the
commercialization of any of our product candidates that we obtain
approval to market. With respect to the commercialization of all or
certain of our product candidates, we may choose to collaborate,
either globally or on a territory-by-territory basis, with third
parties that have direct sales forces and established distribution
systems, either to augment our own sales force and distribution
systems or in lieu of our own sales force and distribution systems.
If we are unable to enter into such arrangements when needed on
acceptable terms, or at all, we may not be able to successfully
commercialize any of our product candidates that receive regulatory
approval or any such commercialization may experience delays or
limitations. If we are not successful in commercializing our
product candidates, either on our own or through collaborations
with one or more third parties, our future product revenue will
suffer and we may incur significant additional losses.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU36" id=
"_AEIOULastRenderedPageBreakAEIOU36"></a>To manage our anticipated
future growth, we must continue to implement and improve our
managerial, operational and financial systems, expand our
facilities and continue to recruit and train additional qualified
personnel. Due to our limited financial resources and the limited
experience of our management team in managing a public company with
such</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
33</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
anticipated growth, we may not be able to effectively manage the
expansion of our operat</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ions
or recruit and train additional qualified personnel. The expansion
of our operations may lead to significant costs and may divert our
management and business development resources. Any inability to
manage growth could delay the execution of our
busine</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ss
plans or disrupt our operations.</font></p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We face significant competition from other biotechnology and
pharmaceutical companies and our operating results will suffer if
we fail to compete effectively.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The biotechnology and pharmaceutical industries are intensely
competitive. We have competitors both in the United States and
internationally, including major multinational pharmaceutical
companies, biotechnology companies, universities and other research
institutions. Many of our competitors have substantially greater
financial, technical and other resources, such as larger research
and development staff and experienced marketing and manufacturing
organizations and well-established sales forces. Competition may
increase further as a result of advances in the commercial
applicability of technologies and greater availability of capital
for investment in these industries. Our competitors may succeed in
developing, acquiring or licensing, on an exclusive basis, product
candidates that are more effective or less costly than any product
candidate that we are currently developing or that we may
develop.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We face intense competition from companies developing products to
address urea cycle disorders. For example, Horizon Pharma plc has
gained approval for its drug RAVICTI (glycerol phenylbutyrate),
which is used to treat patients with urea cycle disorders suffering
from hyperammonemia, which may include patients suffering from
Arginase 1 Deficiency. Patients with Arginase 1 Deficiency may also
benefit from taking RAVICTI (glycerol phenylbutyrate). Erytech
Pharma announced a potential collaboration to explore preclinical
development of an Arginase 1 Deficiency candidate. We also face
intense competition from companies developing products and
therapies to treat cancer. For example, Polaris Group is conducting
numerous clinical trials of ADI-PEG 20, an enzyme derived from
mycoplasma, which degrades arginine in the blood.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our ability to compete successfully will depend largely on our
ability to leverage our experience in product candidate discovery
and development to:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">discover and develop product
candidates that are superior to other products in the
market;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">attract qualified management,
scientific, product development and commercial
personnel;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">obtain and maintain patent and/or
other proprietary protection for our product candidates and
technologies;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">obtain required regulatory
approvals; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">successfully collaborate with
research institutions or pharmaceutical companies in the discovery,
development and commercialization of new product
candidates.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The availability and price of our competitors’ products could limit
the demand, and the price we are able to charge, for any of our
product candidates, if approved. We will not achieve our business
plan if acceptance is inhibited by price competition or the
reluctance of physicians to switch from existing drug products or
other therapies to our product candidates, or if physicians switch
to other new drug products or choose to reserve our product
candidates for use in limited circumstances.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Established biotechnology companies may invest heavily to
accelerate discovery and development of products that could make
our product candidates less competitive. In addition, any new
product that competes with an approved product must demonstrate
compelling advantages in efficacy, convenience, tolerability and
safety in order to overcome price competition and to be
commercially successful. Accordingly, our competitors may succeed
in obtaining patent protection, receiving FDA or non-U.S.
regulatory approval or discovering, developing and commercializing
product candidates before we do, which would have a material
adverse impact on our business. Many of our competitors have
greater resources than we do and have established sales and
marketing capabilities, whether internally or through third
parties. We will not be able to successfully commercialize our
product candidates without establishing sales and marketing
capabilities internally or through strategic partners.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
The insurance coverage and reimbursement status of newly-approved
products is uncertain. Failure to obtain or maintain adequate
coverage and reimbursement for new or current product candidates
could limit our ability to market those product candidates and
decrease our ability to generate revenue.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU37" id=
"_AEIOULastRenderedPageBreakAEIOU37"></a>The availability and
extent of reimbursement by governmental and private payors is
essential for most patients to be able to afford expensive
treatments. Sales of any of our product candidates that receive
marketing approval will depend</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
34</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
substantially, bo</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">th
in the United States and internationally, on the extent to which
the costs of our product candidates will be paid by health
maintenance, managed care, pharmacy benefit and similar healthcare
management organizations, or reimbursed by government health
a</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">dministration
authorities, private health coverage insurers and other third-party
payors. If reimbursement is not available, or is available only to
limited levels, we may not be able to successfully commercialize
our product candidates. Even if coverage i</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s
provided, the approved reimbursement amount may not be high enough
to allow us to establish or maintain pricing sufficient to realize
a sufficient return on our investment.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
There is significant uncertainty related to the insurance coverage
and reimbursement of newly approved products. In the United States,
the principal decisions about reimbursement for new products are
typically made by the Centers for Medicare&nbsp;&amp; Medicaid
Services, or CMS, an agency within the U.S. Department of Health
and Human Services since CMS decides whether and to what extent a
new product will be covered and reimbursed under Medicare. Private
payors tend to follow CMS to a substantial degree. It is difficult
to predict what CMS will decide with respect to reimbursement for
novel products such as ours since there is no body of established
practices and precedents for these new products. Reimbursement
agencies in Europe may be more conservative than CMS. For example,
a number of cancer drugs have been approved for reimbursement in
the United States and have not been approved for reimbursement in
certain European countries.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Outside the United States, international operations are generally
subject to extensive governmental price controls and other market
regulations, and we believe the increasing emphasis on
cost-containment initiatives in Europe, Canada and other countries
has and will continue to put pressure on the pricing and usage of
therapeutics such as our product candidates. In many countries,
particularly the countries of the European Union, the prices of
medical products are subject to varying price control mechanisms as
part of national health systems. In these countries, pricing
negotiations with governmental authorities can take considerable
time after the receipt of marketing approval for a product. To
obtain reimbursement or pricing approval in some countries, we may
be required to conduct a clinical trial that compares the
cost-effectiveness of our product candidate to other available
therapies. In general, the prices of products under such systems
are substantially lower than in the United States. Other countries
allow companies to fix their own prices for products, but monitor
and control company profits. Additional foreign price controls or
other changes in pricing regulation could restrict the amount that
we are able to charge for our product candidates. Accordingly, in
markets outside the United States, the reimbursement for our
products may be reduced compared with the United States and may be
insufficient to generate commercially reasonable revenues and
profits.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Moreover, increasing efforts by governmental and third-party
payors, in the United States and internationally, to cap or reduce
healthcare costs may cause such organizations to limit both
coverage and level of reimbursement for new products approved and,
as a result, they may not cover or provide adequate payment for our
product candidates. The U.S. government has similarly expressed
concerns over the pricing of pharmaceutical products and there can
be no assurance as to how this scrutiny will impact future pricing
of pharmaceutical products generally. We expect to experience
pricing pressures in connection with the sale of any of our product
candidates due to the trend toward managed healthcare, the
increasing influence of health maintenance organizations and
additional legislative changes. The downward pressure on healthcare
costs in general, particularly prescription drugs and surgical
procedures and other treatments, has become very intense. As a
result, increasingly high barriers are being erected to the entry
of new products into the healthcare market.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In addition to CMS and private payors, professional organizations
such as the National Comprehensive Cancer Network and the American
Society of Clinical Oncology can influence decisions about
reimbursement for new products by determining standards for care.
In addition, many private payors contract with commercial vendors
who sell software that provide guidelines that attempt to limit
utilization of, and therefore reimbursement for, certain products
deemed to provide limited benefit to existing alternatives. Such
organizations may set guidelines that limit reimbursement or
utilization of our product candidates.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Furthermore, some of our target indications, including for Arginase
1 Deficiency for pegzilarginase, are orphan indications where
patient populations are small. In order for therapeutics that are
designed to treat smaller patient populations to be commercially
viable, the reimbursement for such therapeutics must be higher, on
a relative basis, to account for the lack of volume. Accordingly,
we will need to implement a coverage and reimbursement strategy for
any approved product candidate that accounts for the smaller
potential market size. If we are unable to establish or sustain
coverage and adequate reimbursement for any future product
candidates from third-party payors, the adoption of those products
and sales revenue will be adversely affected, which, in turn, could
adversely affect the ability to market or sell those product
candidates, if approved, and ultimately our financial results.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
35</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU38" id=
"_AEIOULastRenderedPageBreakAEIOU38"></a><font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">Our
future success depends on our ability to retain key executives and
to attract, retain and motivate qualified personnel.</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We are a clinical-stage biotechnology company with a limited
operating history, and, as of March&nbsp;31, 2018, had only 43
employees, including four executive officers. We are highly
dependent on the research and development, clinical and business
development expertise of our executive officers, as well as the
other principal members of our management, scientific and clinical
team. Any of our management team members may terminate their
employment with us at any time. We do not maintain “key person”
insurance for any of our executives or other employees.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Recruiting and retaining qualified scientific, clinical,
manufacturing and sales and marketing personnel will also be
critical to our success. The loss of the services of our executive
officers or other key employees could impede the achievement of our
research, development and commercialization objectives and
seriously harm our ability to successfully implement our business
strategy. Furthermore, replacing executive officers and key
employees may be difficult and may take an extended period of time
because of the limited number of individuals in our industry with
the breadth of skills and experience required to successfully
develop, facilitate regulatory approval of and commercialize
product candidates. Competition to hire from this limited pool is
intense, and we may be unable to hire, train, retain or motivate
these key personnel on acceptable terms given the competition among
numerous pharmaceutical and biotechnology companies for similar
personnel. For instance, we have appointed Dr. Anthony Quinn, a
member of our board of directors, as interim Chief Executive
Officer, and are currently in the process of searching for a
permanent Chief Executive Officer. There is no assurance that a
qualified individual will be found timely or engaged on acceptable
terms. We also experience competition for the hiring of scientific
and clinical personnel from universities and research
institutions.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In addition, we rely on consultants and advisors, including
scientific and clinical advisors such as our scientific advisory
board, to assist us in formulating our discovery and nonclinical
and clinical development and commercialization strategy. Our
consultants and advisors, including members of our scientific
advisory board, may be employed by employers other than us and may
have commitments under consulting or advisory contracts with other
entities that may limit their availability to us. If we are unable
to continue to attract and retain high quality personnel, our
ability to pursue our growth strategy will be limited.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Our product candidates for which we intend to seek approval as
biologic products may face competition sooner than anticipated.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
With the enactment of the Biologics Price Competition and
Innovation Act of 2009, or BPCIA, an abbreviated pathway for the
approval of biosimilar and interchangeable biological products was
created. The abbreviated regulatory pathway establishes legal
authority for the FDA to review and approve biosimilar biologics,
including the possible designation of a biosimilar as
interchangeable based on its similarity to an existing reference
product. Under the BPCIA, an application for a biosimilar product
cannot be approved by the FDA until 12 years after the original
branded product is approved under a BLA. On March&nbsp;6, 2015, the
FDA approved the first biosimilar product under the BPCIA. However,
the law is complex and is still being interpreted and implemented
by the FDA. As a result, its ultimate impact, implementation, and
meaning are subject to uncertainty. While it is uncertain when the
processes intended to implement BPCIA may be fully adopted by the
FDA, any such processes could have a material adverse effect on the
future commercial prospects for our biological products.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We believe that if any of our product candidates are approved as a
biological product under a BLA, it should qualify for the 12-year
period of exclusivity. However, there is a risk that the FDA will
not consider any of our product candidates to be reference products
for competing products, potentially creating the opportunity for
biosimilar competition sooner than anticipated. Additionally, this
period of regulatory exclusivity does not apply to companies
pursuing regulatory approval via their own traditional BLA, rather
than via the abbreviated pathway. Moreover, the extent to which a
biosimilar, once approved, will be substituted for any one of our
reference products that may be approved in a way that is similar to
traditional generic substitution for non-biological products is not
yet clear, and will depend on a number of marketplace and
regulatory factors that are still developing.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Our information technology systems, or those used by our CROs,
contractors or consultants, may fail or suffer security breaches,
which could harm our business and operations.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU39" id=
"_AEIOULastRenderedPageBreakAEIOU39"></a>Cyberattacks are
increasing in their frequency, sophistication and intensity, and
have become increasingly difficult to detect. Despite the
implementation of security measures, our information technology
systems and those of our strategic partners and third-parties on
whom we rely are vulnerable to cyberattacks, damage from computer
viruses, unauthorized access, natural disasters, terrorism, war and
telecommunication and electrical failures. Furthermore, we have
little or no control over the security measures and computer
systems of third parties including any CROs we may work with in
the</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
36</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
future. While we and, to our knowledge, our third-party strategic
partners have not experienced any such system failure, accident or
security breach to date, if such an event were to occur, it
could</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
result in material negative consequences for us including
interruptions in our operations, the operations of our strategic
partners, or our manufacturers or suppliers, misappropriation of
confidential business information and trade secrets, disclosure
of</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
corporate strategic plans, and result in material disruptions of
our product candidate development programs. For example, the loss
of clinical trial data from completed or ongoing or planned
clinical trials could result in delays in our regulatory
approval</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
efforts, and we may incur substantial costs to attempt to recover
or reproduce the data. If any disruption or security breach
resulted in a loss of or damage to our data or applications, or
inappropriate disclosure of confidential or proprietary
informati</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on,
we could incur liability or the further development of our product
candidates could be delayed.</font></p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We depend on our information technology and infrastructure.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We rely on the efficient and uninterrupted operation of information
technology systems to manage our operations, to process, transmit,
and store electronic and financial information, and to comply with
regulatory, legal and tax requirements. We also depend on our
information technology infrastructure for communications among our
personnel, contractors, consultants and suppliers. System failures
or outages could materially compromise our ability to perform these
functions in a timely manner, which could harm our ability to
conduct business or delay our financial reporting. In addition, we
depend on third parties to operate and support our information
technology systems. Failure by these providers to adequately
deliver the contracted services could have an adverse effect on our
business, which in turn may materially adversely affect our
operating results and financial condition.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Risks Related to Our Reliance on Third Parties</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We currently rely and will rely on third parties to conduct our
ongoing and future planned clinical trials, and those third parties
may not perform satisfactorily, including failing to meet deadlines
for the completion of such trials.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We currently rely and will continue to rely on third parties to
provide manufacturing and clinical development capabilities. For
example, we rely on a contract manufacturing organization, KBI
BioPharma, Inc., or KBI, to manufacture and supply nonclinical and
clinical trial quantities of the biological substance of our lead
product candidate, pegzilarginase and pipeline product candidates.
We also expect to rely on KBI to manufacture and supply commercial
quantities of pegzilarginase. In addition, we rely on Merck to
provide pembrolizumab for the conduct of our combination
trials.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We rely on third-party CROs to conduct our ongoing and future
planned clinical trials of pegzilarginase. We do not plan to
independently conduct clinical trials of our other product
candidates. These agreements might terminate for a variety of
reasons, including a failure to perform by the third parties. If we
need to enter into alternative arrangements, that would delay our
product development activities.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our reliance on these third parties for research and development
activities will reduce our control over these activities but will
not relieve us of our responsibilities. For example, we will remain
responsible for ensuring that each of our ongoing and future
planned clinical trials is conducted in accordance with the general
investigational plan and protocols for the trial. Moreover, the FDA
requires us to comply with regulatory standards, commonly referred
to as good clinical practices for conducting, recording and
reporting the results of clinical trials to assure that data and
reported results are credible and accurate and that the rights,
integrity and confidentiality of trial participants are protected.
Other countries’ regulatory agencies also have requirements for
clinical trials with which we must comply. We also will be required
to register ongoing clinical trials and post the results of
completed clinical trials on a government-sponsored database,
<font style="font-style:italic;">ClinicalTrials.gov</font>, within
specified timeframes. Failure to do so can result in fines, adverse
publicity and civil and criminal sanctions.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Furthermore, these third parties may also have relationships with
other entities, some of which may be our competitors. If these
third parties do not successfully carry out their contractual
duties, meet expected deadlines or conduct our ongoing and future
planned clinical trials in accordance with regulatory requirements
or our stated protocols, we will not be able to complete our
clinical trials, obtain, or may be delayed in obtaining, marketing
approvals for our product candidates and will not be able to, or
may be delayed in our efforts to, successfully commercialize our
product candidates.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
37</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU40" id=
"_AEIOULastRenderedPageBreakAEIOU40"></a><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We
also expect to rely on other third parties to store and distribute
drug sup</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">plies
for our clinical trials. Any performance failure on the part of our
distributors could delay clinical development or marketing approval
of our product candidates or commercialization of our product
candidates, producing additional losses and
deprivin</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">g
us of potential product revenue.</font></p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We contract with third parties for the manufacture of our product
candidates for nonclinical studies and our ongoing and future
planned clinical testing and expect to continue to do so for
commercialization. This reliance on third parties increases the
risk that we will not have sufficient quantities of our product
candidates at an acceptable cost and quality, which could delay,
prevent or impair our development or commercialization efforts.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We do not own or operate facilities for the manufacture of our
product candidates, and we do not have any manufacturing personnel.
We currently have no plans to build our own clinical or commercial
scale manufacturing capabilities. We rely, and expect to continue
to rely, on third parties, including KBI, for the manufacture of
our product candidates for nonclinical studies and for our existing
and future planned clinical trials. We also expect to rely on third
parties, including KBI, for commercial manufacture if any of our
product candidates receive marketing approval. This reliance on
third parties increases the risk that we will not have sufficient
quantities of our product candidates or such quantities at an
acceptable cost or quality, which could delay, prevent or impair
our development or commercialization efforts.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Any performance failure on the part of our existing or future
manufacturers could delay clinical development or marketing
approval. We do not currently have arrangements in place for
redundant supply or a source for bulk drug substance. Currently,
KBI is supplying, and is expected to continue to supply, the drug
substance requirements for our ongoing and planned clinical trials
with pegzilarginase. If KBI cannot supply us with sufficient
amounts, pursuant to product requirements as agreed, we may be
required to identify alternative manufacturers, which would lead us
to incur added costs and delays in identifying and qualifying any
replacement.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The formulation used in early studies is not a final formulation
for commercialization. If we are unable to demonstrate that our
commercial scale product is comparable to the product used in
clinical trials, we may not receive regulatory approval for that
product without additional clinical trials. We have contracted with
KBI for certain studies related to potential commercial scale
manufacturing of pegzilarginase at a separate KBI facility, but
there is no guarantee that such studies, the transfer of technology
to or any potential manufacturing at such facility, will be
completed successfully, on time, or at all. We also cannot
guarantee that we will be able to make any required modifications
within currently anticipated timeframes or that such modifications,
if and when made, will obtain regulatory approval or that the new
processes or modified processes will be successfully implemented by
or transferred to any third-party contract suppliers within
currently anticipated timeframes. These may require additional
studies, and may delay our clinical trials and/or
commercialization.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We expect to rely on third-party manufacturers, including KBI, or
third-party strategic partners for the manufacture of commercial
supply of any product candidates for which our strategic partners
or we obtain marketing approval. We may be unable to establish any
additional agreements with third-party manufacturers, including
KBI, or to do so on acceptable terms. Even if we are able to
establish agreements with third-party manufacturers on acceptable
terms, such third-party manufacturers may have limited experience
manufacturing pharmaceutical drugs for commercialization, and
reliance on third-party manufacturers for the commercial supply of
our products may expose us to various risks, including:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">possible noncompliance by the
third party with regulatory requirements and quality
assurance;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the possible breach of the
manufacturing agreement by the third party;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the possible misappropriation of
our proprietary information, including our trade secrets and
know-how; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the possible termination or
nonrenewal of the agreement by the third party at a time that is
costly or inconvenient for us.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Third-party manufacturers may not be able to comply with current
good manufacturing practices, or cGMP, or similar regulatory
requirements outside the United States. Although we do not have
day-to-day control over third-party manufacturers’ compliance with
these regulations and standards, we are responsible for ensuring
compliance with such regulations and standards. Our failure, or the
failure of our third-party manufacturers, to comply with applicable
regulations could result in sanctions being imposed on us,
including clinical holds, fines, injunctions, civil penalties,
delays, suspension or withdrawal of approvals, license revocation,
seizures or recalls of product candidates, operating restrictions
and criminal prosecutions, any of which would significantly and
adversely affect supplies of our product candidates and our
business. If a third-party manufacturer’s facilities do not pass a
pre-approval inspection or do not have a cGMP compliance status
acceptable to the FDA or a comparable foreign regulatory agency,
our product candidate will not be approved.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
38</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU41" id=
"_AEIOULastRenderedPageBreakAEIOU41"></a><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In
addition, the process of manufacturing and administering our
product candidates is complex and highly regulated. As a</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
result of the complexities, our manufacturing and supply costs are
likely to be higher than those at more traditional manufacturing
processes and the manufacturing process is less reliable and more
difficult to reproduce.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We also expect to rely on other third parties to store and
distribute drug supplies for our clinical trials. Any performance
failure on the part of our distributors could delay clinical
development or marketing approval of our product candidates or
commercialization of our product candidates, producing additional
losses and depriving us of potential product revenue.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our product candidates and any products that we may develop may
compete with other product candidates and products for access to
manufacturing facilities. There are a limited number of
manufacturers that operate under cGMP regulations and that might be
capable of manufacturing for us.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our current and anticipated future dependence upon others for the
manufacture of our product candidates may adversely affect our
future profit margins and our ability to commercialize any product
candidates that receive marketing approval on a timely and
competitive basis.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Failure of any future third-party collaborators to successfully
commercialize companion diagnostics developed for use with our
therapeutic product candidates for oncology indications could harm
our ability to commercialize these product candidates.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We do not plan to develop companion diagnostics internally and, as
a result, we are dependent on the efforts of our third-party
strategic partners to successfully commercialize any needed
companion diagnostics. Our strategic partners:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">may not perform their obligations
as expected;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">may encounter production
difficulties that could constrain the supply of the companion
diagnostics;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">may have difficulties gaining
acceptance of the use of the companion diagnostics in the clinical
community;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">may not pursue commercialization
of any companion diagnostics;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">may elect not to continue or renew
commercialization programs based on changes in the strategic
partners’ strategic focus or available funding, or external
factors, such as an acquisition, that divert resources or create
competing priorities;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">may not commit sufficient
resources to the marketing and distribution of such companion
diagnostic product candidates; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">may terminate their relationship
with us.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
If companion diagnostics needed for use with our therapeutic
product candidates in oncology fail to gain market acceptance, our
ability to derive revenues from sales of these therapeutic product
candidates could be harmed. If our strategic partners fail to
commercialize these companion diagnostics, it could adversely
affect and delay the development or commercialization of our
therapeutic product candidates.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We may not be successful in finding strategic partners for
continuing development of certain of our product candidates or
successfully commercializing or competing in the market for certain
indications.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We may seek to develop strategic partnerships for developing
certain of our product candidates, due to capital costs required to
develop the product candidates or manufacturing constraints. We may
not be successful in our efforts to establish such a strategic
partnership or other alternative arrangements for our product
candidates because our research and development pipeline may be
insufficient, our product candidates may be deemed to be at too
early of a stage of development for collaborative effort or third
parties may not view our product candidates as having the requisite
potential to demonstrate safety and efficacy. In addition, we may
be restricted under existing collaboration agreements from entering
into future agreements with potential strategic partners. We cannot
be certain that, following a strategic transaction or license, we
will achieve an economic benefit that justifies such
transaction.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU42" id=
"_AEIOULastRenderedPageBreakAEIOU42"></a>If we are unable to reach
agreements with suitable strategic partners on a timely basis, on
acceptable terms or at all, we may have to curtail the development
of a product candidate, reduce or delay its development program,
delay its potential commercialization, reduce the scope of any
sales or marketing activities or increase our expenditures and
undertake development or commercialization activities at our own
expense. If we elect to fund development or</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
39</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
commercialization activities on our own, we may need to obtain
additional expertise and additional capital, which may not be
available to us on acceptable terms or at all. If we fail to enter
into collaborations and do not have sufficient funds or
experti</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">se
to undertake the necessary development and commercialization
activities, we may not be able to further develop our product
candidates and our business, financial condition, results of
operations and prospects may be materially and adversely
affected.</font></p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Our employees may engage in misconduct or other improper
activities, including non-compliance with regulatory standards and
requirements, which could cause significant liability for us and
harm our reputation.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We are exposed to the risk of employee fraud or other misconduct,
including intentional failures to (i) comply with FDA regulations
or similar regulations of comparable non-U.S. regulatory
authorities, (ii) provide accurate information to the FDA or
comparable non-U.S. regulatory authorities, (iii) comply with
manufacturing standards we have established, (iv) comply with the
Foreign Corrupt Practices Act and federal and state healthcare
fraud and abuse laws and regulations and similar laws and
regulations established and enforced by comparable non-U.S.
regulatory authorities, or (v) report financial information or data
accurately or disclose unauthorized activities to us. Employee
misconduct could also involve the improper use of information
obtained in the course of clinical trials, which could result in
regulatory sanctions and serious harm to our reputation. It is not
always possible to identify and deter employee misconduct, and the
precautions we take to detect and prevent this activity may not be
effective in controlling unknown or unmanaged risks or losses or in
protecting us from governmental investigations or other actions or
lawsuits stemming from a failure to be in compliance with such
laws, standards or regulations. If any such actions are instituted
against us, and we are not successful in defending ourselves or
asserting our rights, those actions could have a significant impact
on our business and results of operations, including the imposition
of significant fines or other sanctions.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We may be subject to claims by third parties asserting that our
employees or we have misappropriated their intellectual property,
or claiming ownership of what we regard as our own intellectual
property.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Many of our employees were previously employed at universities or
other biotechnology or pharmaceutical companies, including our
competitors or potential competitors. Although we try to ensure
that our employees do not use the proprietary information or
know-how of others in their work for us, we may be subject to
claims that these employees or we have used or disclosed
intellectual property, including trade secrets or other proprietary
information, of any such employee’s former employer. Litigation may
be necessary to defend against these claims.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In addition, while it is our policy to require our employees and
contractors who may be involved in the development of intellectual
property to execute agreements assigning such intellectual property
to us, we may be unsuccessful in executing such an agreement with
each party who in fact develops intellectual property that we
regard as our own. Our and their assignment agreements may not be
self-executing or may be breached, and we may be forced to bring
claims against third parties, or defend claims they may bring
against us, to determine the ownership of what we regard as our
intellectual property.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
If we fail in prosecuting or defending any such claims, in addition
to paying monetary damages, we may lose valuable intellectual
property rights or personnel. Even if we are successful in
prosecuting or defending against such claims, litigation could
result in substantial costs and be a distraction to management.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We and our strategic partners that we rely on may be adversely
affected by natural disasters, and our business continuity and
disaster recovery plans may not adequately protect us from a
serious disaster.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Natural disasters could severely disrupt our operations or the
operations of KBI’s manufacturing facilities and have a material
adverse effect on our business, financial condition, results of
operations and prospects. If a natural disaster, power outage or
other event occurred that prevented us from using all or a
significant portion of our headquarters, that damaged critical
infrastructure, such as KBI’s manufacturing facilities, or that
otherwise disrupted operations, it may be difficult or, in certain
cases, impossible for us to continue our business for a substantial
period of time. The disaster recovery and business continuity plans
we have in place currently are limited and may not prove adequate
in the event of a serious disaster or similar event. Substantially
all of our current supply of product candidates are located at KBI’
s manufacturing facilities, and we do not have any existing back-up
facilities in place or plans for such back-up facilities. We may
incur substantial expenses as a result of the limited nature of our
disaster recovery and business continuity plans, which could have a
material adverse effect on our business, financial condition,
results of operations and prospects.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
40</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU43" id=
"_AEIOULastRenderedPageBreakAEIOU43"></a><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks
Related to Government R</font><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">egulation</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
If we are not able to obtain, or if there are delays in obtaining,
required regulatory approvals in the United States or in foreign
jurisdictions, we will not be able to commercialize our product
candidates, and our ability to generate revenue will be materially
impaired.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our product candidates must be approved by the FDA pursuant to a
BLA in the United States, and by the EMA pursuant to a MAA, and by
other comparable regulatory authorities outside the United States
prior to commercialization. The process of obtaining marketing
approvals, both in the United States and internationally, is
expensive and takes many years, if approval is obtained at all, and
can vary substantially based upon a variety of factors, including
the type, complexity and novelty of the product candidates
involved. The approval procedure varies among countries and can
involve additional testing. The time required to obtain approval in
Europe or another non-U.S. jurisdiction may differ substantially
from that required to obtain FDA approval. The regulatory approval
process outside the United States generally includes all of the
risks associated with obtaining FDA approval. In addition, in many
countries outside the United States, it is required that the
product be approved for reimbursement before the product can be
approved for sale in that country. We or our third-party strategic
partners may not obtain approvals from regulatory authorities
outside the United States on a timely basis, if at all. Approval by
the FDA does not ensure approval by regulatory authorities in other
countries or jurisdictions, and approval by one regulatory
authority outside the United States does not ensure approval by
regulatory authorities in other countries or jurisdictions or by
the FDA. We may not be able to file for marketing approvals and may
not receive necessary approvals to commercialize our product
candidates in any market.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Failure to obtain marketing approval for a product candidate will
prevent us from commercializing the product candidate. We have not
received approval to market any of our product candidates from
regulatory authorities in any jurisdiction. We have no experience
in filing and supporting the applications necessary to gain
marketing approvals and expect to rely on third-party CROs to
assist us in this process. Securing marketing approval requires the
submission of extensive nonclinical and clinical data and
supporting information to regulatory authorities for each
therapeutic indication to establish the product candidate’s safety
and efficacy. Securing marketing approval also requires the
submission of information about the product manufacturing process
to, and inspection of manufacturing facilities by, the regulatory
authorities. Our product candidates may not be effective, may be
only moderately effective or may prove to have undesirable or
unintended side effects, toxicities or other characteristics that
may preclude our obtaining marketing approval or prevent or limit
commercial use. Regulatory authorities have substantial discretion
in the approval process and may refuse to accept any application or
may decide that our data are insufficient for approval and require
additional nonclinical, clinical or other studies. In addition,
varying interpretations of the data obtained from nonclinical and
clinical testing could delay, limit or prevent marketing approval
of a product candidate. Changes in marketing approval policies
during the development period, changes in or the enactment of
additional statutes or regulations, or changes in regulatory review
for each submitted product application, may also cause delays in or
prevent the approval of an application.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Approval of our product candidates may be delayed or refused for
many reasons, including the following:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the Health Authorities may
disagree with the design or implementation of our clinical
trials;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">we may be unable to demonstrate to
the satisfaction of the Health Authorities that our product
candidates are safe and effective for any of their proposed
indications;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the results of clinical trials may
not meet the level of statistical significance required by the
Health Authorities for approval;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">we may be unable to demonstrate
that our product candidates’ clinical and other benefits outweigh
their safety risks;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the Health Authorities may
disagree with our interpretation of data from preclinical programs
or clinical trials;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the data collected from clinical
trials of our product candidates may not be sufficient to the
satisfaction of the Health Authorities to support the submission of
a BLA, MAA or other comparable submission in other jurisdictions or
to obtain regulatory approval in the United States or
elsewhere;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the facilities of the third-party
manufacturers with which we partner may not be adequate to support
approval of our product candidates; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the approval policies or
regulations of the Health Authorities may significantly change in a
manner rendering our clinical data insufficient for
approval.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
41</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU44" id=
"_AEIOULastRenderedPageBreakAEIOU44"></a><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">New
products for the treatment of cancer frequently are initially
indicated only for</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
patient populations that have not responded to an existing therapy
or have relapsed. If any of our product candidates receives
marketing approval, the approved labeling may limit the use of our
product candidates in this way, which could limit sales of
th</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e
product.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Any marketing approval we ultimately obtain may be limited or
subject to restrictions or post-approval commitments that render
the approved product not commercially viable. If we experience
delays in obtaining approval or if we fail to obtain approval of
our product candidates, the commercial prospects for our product
candidates may be harmed and our ability to generate revenues will
be materially impaired.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Any Fast Track Designation by the FDA, even if granted for any of
our product candidates, may not lead to a faster development or
regulatory review or approval process, and does not increase the
likelihood that our product candidates will receive marketing
approval.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We have received Fast Track Designation from the FDA for our lead
product candidate pegzilarginase for the treatment of
hyperargininemia secondary to Arginase 1 Deficiency, and may seek
such designation for some or all of our product candidates. If a
drug or biologic is intended for the treatment of a serious or
life-threatening condition and the drug or biologic demonstrates
the potential to address unmet medical needs for this condition,
the drug or biologic sponsor may apply for FDA Fast Track
Designation. The FDA has broad discretion whether or not to grant
this designation. Even if we believe a particular product candidate
is eligible for this designation, we cannot assure you that the FDA
would decide to grant it. Even though we have received Fast Track
Designation for pegzilarginase for the treatment of
hyperargininemia secondary to Arginase 1 Deficiency, and even if we
receive Fast Track Designation for other product candidates or
indications in the future, we may not experience a faster
development process, review or approval compared to conventional
FDA procedures. The FDA may withdraw Fast Track Designation if it
believes that the designation is no longer supported by data from
our clinical development program. Many drugs or biologics that have
received Fast Track Designation have failed to obtain approval.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We may also seek accelerated approval for products. Under the FDA’s
accelerated approval program, the FDA may approve a drug or
biologic for a serious or life-threatening illness that provides
meaningful therapeutic benefit to patients over existing treatments
based upon a surrogate endpoint that is reasonably likely to
predict clinical benefit, or on a clinical endpoint that can be
measured earlier than irreversible morbidity or mortality, that is
reasonably likely to predict an effect on irreversible morbidity or
mortality or other clinical benefit, taking into account the
severity, rarity, or prevalence of the condition and the
availability or lack of alternative treatments. For drugs or
biologics granted accelerated approval, post-marketing confirmatory
trials are required to describe the anticipated effect on
irreversible morbidity or mortality or other clinical benefit.
These confirmatory trials must be completed with due diligence and,
in some cases, the FDA may require that the trial be designed
and/or initiated prior to approval. Moreover, the FDA may withdraw
approval of our product candidate or indication approved under the
accelerated approval pathway if, for example:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the trial or trials required to
verify the predicted clinical benefit of our product candidate fail
to verify such benefit or do not demonstrate sufficient clinical
benefit to justify the risks associated with the drug;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">other evidence demonstrates that
our product candidate is not shown to be safe or effective under
the conditions of use;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">we fail to conduct any required
post-approval trial of our product candidate with due diligence;
or</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">we disseminate false or misleading
promotional materials relating to the relevant product
candidate.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
A Breakthrough Therapy Designation by the FDA, even if granted for
any of our product candidates, may not lead to a faster development
or regulatory review or approval process, and does not increase the
likelihood that our product candidates will receive marketing
approval.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We do not currently have Breakthrough Therapy Designation for any
of our product candidates, but may seek such designation. A
Breakthrough Therapy is defined as a drug or biologic that is
intended, alone or in combination with one or more other drugs, to
treat a serious or life-threatening disease or condition, and
preliminary clinical evidence indicates that the drug or biologic
may demonstrate substantial improvement over existing therapies
with respect to one or more clinically significant endpoints, such
as substantial treatment effects observed early in clinical
development. For drugs or biologics that have been designated as
Breakthrough Therapies, interaction and communication between the
FDA and the sponsor can help to identify the most efficient path
for development.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
42</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU45" id=
"_AEIOULastRenderedPageBreakAEIOU45"></a><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Designation
as a Breakthrough Th</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">erapy
is within the discretion of the FDA. Accordingly, even if we
believe, after completing early clinical trials, that one of our
product candidates meets the criteria for designation as a
Breakthrough Therapy, the FDA may disagree and instead
determine</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
not to make such designation. In any event, the receipt of a
Breakthrough Therapy designation for a product candidate may not
result in a faster development process, review or approval compared
to drugs or biologics considered for approval under
convention</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">al
FDA procedures and does not assure ultimate approval by the FDA. In
addition, even if one or more of our product candidates qualify as
Breakthrough Therapies, the FDA may later decide that such product
candidates no longer meet the conditions for
qualif</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ication.</font></p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Any product candidate for which we obtain marketing approval will
be subject to extensive post-marketing regulatory requirements and
could be subject to post-marketing restrictions or withdrawal from
the market, and we may be subject to penalties if we fail to comply
with regulatory requirements or if we experience unanticipated
problems with our product candidates, when and if any of them are
approved.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our product candidates and the activities associated with their
development and commercialization, including their testing,
manufacture, recordkeeping, labeling, storage, approval,
advertising, promotion, sale and distribution, are subject to
comprehensive regulation by the FDA and other regulatory
authorities. These requirements include submissions of safety and
other post-marketing information and reports, registration and
listing requirements, cGMP, requirements relating to manufacturing,
quality control, quality assurance and corresponding maintenance of
records and documents, including periodic inspections by the FDA
and other regulatory authorities, requirements regarding the
distribution of samples to physicians and recordkeeping.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The FDA may also impose requirements for costly post-marketing
studies or clinical trials and surveillance to monitor the safety
or efficacy of any approved product. The FDA closely regulates the
post-approval marketing and promotion of drugs and biologics to
ensure drugs and biologics are marketed only for the approved
indications and in accordance with the provisions of the approved
labeling. The FDA imposes stringent restrictions on manufacturers’
communications regarding use of their products and if we promote
our product candidates beyond their approved indications, we may be
subject to enforcement action for off-label promotion. Violations
of the Federal Food, Drug, and Cosmetic Act relating to the
promotion of prescription drugs may lead to investigations alleging
violations of federal and state healthcare fraud and abuse laws, as
well as state consumer protection laws.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In addition, later discovery of previously unknown adverse events
or other problems with our product candidates, manufacturers or
manufacturing processes, or failure to comply with regulatory
requirements, may yield various results, including:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">restrictions on such product
candidates, manufacturers or manufacturing processes;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">restrictions on the labeling or
marketing of a product;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">restrictions on product
distribution or use;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">requirements to conduct
post-marketing studies or clinical trials;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">warning or untitled
letters;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">withdrawal of any approved product
from the market;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">refusal to approve pending
applications or supplements to approved applications that we
submit;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">recall of product
candidates;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">fines, restitution or disgorgement
of profits or revenues;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">suspension or withdrawal of
marketing approvals;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">refusal to permit the import or
export of our product candidates;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">product seizure; or</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">injunctions or the imposition of
civil or criminal penalties.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Non-compliance with European requirements regarding safety
monitoring or pharmacovigilance, and with requirements related to
the development of products for the pediatric population, can also
result in significant financial penalties. Similarly, failure to
comply with Europe’s requirements regarding the protection of
personal information can also lead to significant penalties and
sanctions.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
43</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU46" id=
"_AEIOULastRenderedPageBreakAEIOU46"></a><font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">Our
relationships with customers and third-party payors will be subject
to applicable anti-kickback, fraud and abuse and other healthcare
laws and regulations, which could expos</font><font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">e
us to criminal sanctions, civil penalties, contractual damages,
reputational harm and diminished profits and future
earnings.</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Healthcare providers, physicians and third-party payors will play a
primary role in the recommendation and prescription of any product
candidates for which we obtain marketing approval. Our future
arrangements with third-party payors and customers may expose us to
broadly applicable fraud and abuse and other healthcare laws and
regulations that may constrain the business or financial
arrangements and relationships through which we market, sell and
distribute any product candidates for which we obtain marketing
approval. Restrictions under applicable U.S. federal and state
healthcare laws and regulations include the following:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the federal Anti-Kickback Statute
prohibits, among other things, persons from knowingly and willfully
soliciting, offering, receiving or providing remuneration, directly
or indirectly, in cash or in kind, to induce or reward, or in
return for, either the referral of an individual for, or the
purchase, order or recommendation of, any good or service, for
which payment may be made under a federal healthcare program such
as Medicare and Medicaid;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the federal False Claims Act
imposes criminal and civil penalties, including civil whistleblower
or&nbsp;</font><font style=
"font-style:italic;font-family:Arial;">qui tam</font><font style=
"font-family:Arial;">&nbsp;actions, against individuals or entities
for knowingly presenting, or causing to be presented, to the
federal government, claims for payment that are false or fraudulent
or making a false statement to avoid, decrease or conceal an
obligation to pay money to the federal government;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the federal Health Insurance
Portability and Accountability Act of 1996, or HIPAA, imposes
criminal and civil liability for executing a scheme to defraud any
healthcare benefit program or making false statements relating to
healthcare matters;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">HIPAA, as amended by the Health
Information Technology for Economic and Clinical Health Act and its
implementing regulations, also imposes obligations, including
mandatory contractual terms, with respect to safeguarding the
privacy, security and transmission of individually identifiable
health information;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">federal law requires applicable
manufacturers of covered drugs to report payments and other
transfers of value to physicians and teaching hospitals, which
includes annual data collection and reporting obligations. The
information was made publicly available on a searchable website in
September 2014 and is disclosed on an annual basis; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">analogous state and foreign laws
and regulations, such as state anti-kickback and false claims laws,
may apply to sales or marketing arrangements and claims involving
healthcare items or services reimbursed by non-governmental
third-party payors, including private insurers.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Some state laws require pharmaceutical companies to comply with the
pharmaceutical industry’s voluntary compliance guidelines and the
relevant compliance guidance promulgated by the federal government
and may require drug manufacturers to report information related to
payments and other transfers of value to physicians and other
healthcare providers or marketing expenditures. State and foreign
laws also govern the privacy and security of health information in
some circumstances, many of which differ from each other in
significant ways and often are not preempted by HIPAA, thus
complicating compliance efforts.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Efforts to ensure that our business arrangements with third parties
will comply with applicable healthcare laws and regulations will
involve substantial costs. It is possible that governmental
authorities will conclude that our business practices may not
comply with current or future statutes, regulations or case law
involving applicable fraud and abuse or other healthcare laws and
regulations. If our operations are found to be in violation of any
of these laws or any other governmental regulations that may apply
to us, we may be subject to significant civil, criminal and
administrative penalties, damages, fines, imprisonment, exclusion
of product candidates from government funded healthcare programs,
such as Medicare and Medicaid, and the curtailment or restructuring
of our operations. If any of the physicians or other healthcare
providers or entities with whom we expect to do business is found
to be not in compliance with applicable laws, they may be subject
to criminal, civil or administrative sanctions, including
exclusions from government funded healthcare programs.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We are subject to a variety of privacy and data security laws, and
our failure to comply with them could harm our business.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU47" id=
"_AEIOULastRenderedPageBreakAEIOU47"></a>We maintain a large
quantity of sensitive information, including confidential business
and patient health information in connection with our clinical
trials, and are subject to laws and regulations governing the
privacy and security of such information. In the United States,
there are numerous federal and state privacy and data security laws
and regulations governing the collection, use, disclosure and
protection of personal information, including federal and state
health</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
44</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
information privacy laws, federal and state</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
security breach notification laws, and federal and state consumer
protection laws. Each of these laws is subject to varying
interpretations and constantly evolving. In May 2018, a new privacy
regime, the General Data Protection Regulation (GDPR) will
take</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
effect in the European Economic Area (EEA). The GDPR increases our
obligation with respect to clinical trials conducted in the EEA by
expanding the definition of personal data and requiring changes to
informed consent practices, as well as more detailed
n</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">otices
for clinical trial subjects and investigators. In addition, the
GDPR increases the scrutiny of transfers of personal data from
clinical trial sites located in the EEA to the United States, and
imposes substantial fines for breaches and violations.
C</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ompliance
with these privacy and data security laws and regulations is a
rigorous and time-intensive process and if we fail to comply with
any such laws or regulations, we may face significant fines and
penalties that could adversely affect our business,
f</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">inal
condition and results of operations.</font></p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Recently enacted and future legislation may increase the difficulty
and cost for us to obtain marketing approval of and commercialize
our product candidates and affect the prices we may obtain.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In the United States and some foreign jurisdictions, there have
been a number of legislative and regulatory changes and proposed
changes regarding the healthcare system that could prevent or delay
marketing approval of our product candidates, restrict or regulate
post-approval activities and affect our ability to profitably sell
any product candidates for which we obtain marketing approval.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In the United States, the Medicare Prescription Drug, Improvement,
and Modernization Act of 2003, or the MMA, changed the way Medicare
covers and pays for pharmaceutical products. The legislation
expanded Medicare coverage for drug purchases by the elderly and
introduced a new reimbursement methodology based on average sales
prices for physician-administered drugs. In addition, this
legislation provided authority for limiting the number of drugs
that will be covered in any therapeutic class. Cost reduction
initiatives and other provisions of this legislation could decrease
the coverage and price that we receive for any approved product
candidates. While the MMA only applies to drug benefits for
Medicare beneficiaries, private payors often follow Medicare
coverage policy and payment limitations in setting their own
reimbursement rates. Therefore, any reduction in reimbursement that
results from the MMA may result in a similar reduction in payments
from private payors.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The Patient Protection and Affordable Care Act, as amended by the
Health Care and Education Reconciliation Act, or collectively the
ACA, is a sweeping law intended to broaden access to health
insurance, reduce or constrain the growth of healthcare spending,
enhance remedies against fraud and abuse, add transparency
requirements for the healthcare and health insurance industries,
impose new taxes and fees on the health industry and impose
additional health policy reforms.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Among the provisions of the ACA of importance to our potential
product candidates are the following:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">an annual, nondeductible fee on
any entity that manufactures or imports specified branded
prescription drugs and biologic agents;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">an increase in the statutory
minimum rebates a manufacturer must pay under the Medicaid Drug
Rebate Program;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">expansion of healthcare fraud and
abuse laws, including the False Claims Act and the Anti-Kickback
Statute, new government investigative powers, and enhanced
penalties for noncompliance;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">a Medicare Part&nbsp;D coverage
gap discount program, in which manufacturers must agree to offer
50% point-of-sale discounts off negotiated prices;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">extension of manufacturers’
Medicaid rebate liability to managed care utilization;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">expansion of eligibility criteria
for Medicaid programs;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">expansion of the entities eligible
for discounts under the Public Health Service pharmaceutical
pricing program;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">requirements to report financial
arrangements with physicians and teaching hospitals;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">a requirement to annually report
drug samples that manufacturers and distributors provide to
physicians; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">a Patient-Centered Outcomes
Research Institute to oversee, identify priorities in, and conduct
comparative clinical effectiveness research, along with funding for
such research.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
45</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU48" id=
"_AEIOULastRenderedPageBreakAEIOU48"></a><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In
addition, other legislative changes have been proposed and adopted
since the ACA was enacted. These changes included aggregate
reductions to Medicare payments to providers of up to 2%&nbsp;per
fiscal ye</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ar,
starting in 2013. In January 2013, the American Taxpayer Relief Act
of 2012 was signed into law, which, among other things, reduced
Medicare payments to several providers, and increased the statute
of limitations period for the government to recover
ov</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">erpayments
to providers from three to five years. On January 20, 2017, federal
agencies with authorities and responsibilities under the ACA were
directed to waive, defer, grant exemptions from, or delay the
implementation of any provision of the ACA that
w</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ould
impose a fiscal burden on states or a cost, fee, tax, penalty or
regulatory burden on individuals, healthcare providers, health
insurers, or manufacturers of pharmaceuticals or medical devices.
More recently, the Tax Cuts and Jobs Act was signed into</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
law, which eliminated certain requirements of the ACA, including
the individual mandate, and plans to repeal all or portions of the
ACA have also been suggested. We cannot predict whether these
challenges will continue or whether other proposals will be
ma</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">de
or adopted, or what impact these efforts may have on us.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We expect that the ACA, as well as other healthcare reform measures
that may be adopted in the future, may result in more rigorous
coverage criteria and in additional downward pressure on the price
that we receive for any approved product. Any reduction in
reimbursement from Medicare or other government programs may result
in a similar reduction in payments from private payors. The
implementation of cost containment measures or other healthcare
reforms may prevent us from being able to generate revenue, attain
profitability, or commercialize our product candidates.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Legislative and regulatory proposals have been made to expand
post-approval requirements and restrict sales and promotional
activities for pharmaceutical products. We cannot be sure whether
additional legislative changes will be enacted, or whether FDA
regulations, guidance or interpretations will be changed, or what
the impact of such changes on the marketing approvals of our
product candidates, if any, may be. In addition, increased scrutiny
by the U.S. Congress of the FDA’s approval process may
significantly delay or prevent marketing approval, as well as
subject us to more stringent product labeling and post-marketing
testing and other requirements.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Comprehensive tax reform bills could increase the tax burden on our
orphan drug programs and adversely affect our business and
financial condition.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The U.S. government has recently enacted comprehensive tax
legislation that includes significant changes to the taxation of
business entities. These changes include, among others, (i)&nbsp;a
permanent reduction to the corporate income tax rate, (ii)&nbsp;a
partial limitation on the deductibility of business interest
expense, (iii)&nbsp;a shift of the U.S. taxation of multinational
corporations from a tax on worldwide income to a territorial system
(along with certain rules designed to prevent erosion of the U.S.
income tax base) and (iv)&nbsp;a one-time tax on accumulated
offshore earnings held in cash and illiquid assets, with the latter
taxed at a lower rate.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Further, the newly enacted comprehensive tax legislation, among
other things, reduces the orphan drug credit from 50% to 25% of
qualifying expenditures. When and if we become profitable, this
reduction in tax credits may result in an increased federal income
tax burden on our orphan drug programs as it may cause us to pay
federal income taxes earlier under the revised tax law than under
the prior law and, despite being partially off-set by a reduction
in the corporate tax rate from a top marginal rate of 35% to a flat
rate of 21%, may increase our total federal tax liability
attributable to such programs.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Notwithstanding the reduction in the corporate income tax rate, the
overall impact of this tax reform is uncertain, and our business
and financial condition could be adversely affected. In addition,
it is uncertain if and to what extent various states will conform
to the newly enacted federal tax law.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
If we fail to comply with environmental, health and safety laws and
regulations, we could become subject to fines or penalties or incur
costs that could harm our business.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We are subject to numerous environmental, health and safety laws
and regulations, including those governing laboratory procedures
and the handling, use, storage, treatment and disposal of hazardous
materials and wastes. Our operations involve the use of hazardous
and flammable materials, including chemicals and biological
materials. Our operations also produce hazardous waste products. We
generally contract with third parties for the disposal of these
materials and wastes. We cannot eliminate the risk of contamination
or injury from these materials. In the event of contamination or
injury resulting from our use of hazardous materials, we could be
held liable for any resulting damages, and any liability could
exceed our resources. We also could incur significant costs
associated with civil or criminal fines and penalties for failure
to comply with such laws and regulations.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
46</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU49" id=
"_AEIOULastRenderedPageBreakAEIOU49"></a><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Although
we maintain worke</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rs’
 compensation insurance that we believe is consistent with industry
norms to cover us for costs and expenses we may incur due to
injuries to our employees resulting from the use of hazardous
materials, we cannot assure you that it will be sufficient
to</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
cover our liability in such cases. We do not maintain insurance for
environmental liability or toxic tort claims that may be asserted
against us in connection with our storage or disposal of
biological, hazardous or radioactive materials.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In addition, we may incur substantial costs in order to comply with
current or future environmental, health and safety laws and
regulations. These current or future laws and regulations may
impair our discovery, nonclinical and clinical development or
production efforts. Our failure to comply with these laws and
regulations also may result in substantial fines, penalties or
other sanctions.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Risks Related to Our Intellectual Property</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
If we are unable to obtain and maintain intellectual property
protection for our technology and product candidates, or if the
scope of the intellectual property protection obtained is not
sufficiently broad, our competitors could develop and commercialize
technology and product candidates similar or identical to ours, and
our ability to successfully commercialize our technology and
product candidates may be impaired.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We rely upon a combination of patents, trade secret protection and
confidentiality agreements to protect the intellectual property
related to our technology and product candidates.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In particular, our success depends in large part on our ability,
and our licensors’ ability, to obtain and maintain patent
protection in the United States and other countries with respect to
our proprietary technology and product candidates, including any
companion diagnostic developed by us or a third-party strategic
partner. We seek to protect our proprietary position by filing
patent applications in the United States and abroad related to our
novel technologies and product candidates, and rely on our
licensors to obtain patent protection for our licensed intellectual
property. Our patent portfolio includes patents and patent
applications we own or we exclusively license from the University
of Texas at Austin. This patent portfolio includes issued patents
and pending patent applications covering compositions of matter and
methods of use.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The patent prosecution process is expensive and time-consuming, and
we may not be able to file, prosecute, maintain, enforce or license
all necessary or desirable patent applications at a reasonable cost
or in a timely manner, or in all jurisdictions. We may choose not
to seek patent protection for certain innovations and may choose
not to pursue patent protection in certain jurisdictions, and under
the laws of certain jurisdictions, patents or other intellectual
property rights may be unavailable or limited in scope. It is also
possible that we will fail to identify patentable aspects of our
discovery and nonclinical and clinical development output before it
is too late to obtain patent protection. Moreover, the risks
pertaining to our patents and intellectual property rights also
apply to the intellectual property rights that we license from
third parties. In some circumstances, we do not have the right to
control the preparation, filing and prosecution of patent
applications, or to maintain the patents, covering technology that
we license from third parties. We may also require the cooperation
of our licensors in order to enforce the licensed patent rights,
and such cooperation may not be provided. Therefore, these patents
and applications may not be prosecuted and enforced in a manner
consistent with the best interests of our business and the rights
we have licensed may be reduced or eliminated.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU50" id=
"_AEIOULastRenderedPageBreakAEIOU50"></a>The patent position of
biotechnology and pharmaceutical companies generally is highly
uncertain, involves complex legal and factual questions and has in
recent years been the subject of much litigation. The U.S. Patent
and Trademark Office, or U.S. PTO, has not established a consistent
policy regarding the breadth of claims that it will allow in
biotechnology patents. In addition, the laws of foreign
jurisdictions may not protect our rights to the same extent as the
laws of the United States. For example, India does not allow
patents for methods of treating the human body or medical use
claims as in other jurisdictions. Publications of discoveries in
the scientific literature often lag behind the actual discoveries,
and patent applications in the United States and other
jurisdictions are typically not published until 18 months after
filing, or in some cases not at all. Therefore, we cannot know with
certainty whether we were the first to make the inventions claimed
in our owned or licensed patents or pending patent applications, or
that we were the first to file for patent protection of such
inventions, nor can we know whether those from whom we license
patents were the first to make the inventions claimed or were the
first to file. As a result, the issuance, scope, validity,
enforceability and commercial value of our patent rights are highly
uncertain. Our pending and future patent applications may not
result in patents being issued that protect our technology or
product candidates, in whole or in part, or which effectively
prevent others from commercializing competitive technologies and
product candidates. Changes in either the patent laws or
interpretation of the patent laws in the United States and other
countries may diminish the value of our patents or narrow the scope
of our patent protection. In addition, during prosecution of any
patent application, the issuance of any patents based on an</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
47</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
application may depend upon our ability to generate additional
preclinical or clinical data that supports the
patenta</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">bility
of our proposed claims. We may not be able to generate such data on
a timely basis, to the satisfaction of the U.S. PTO, or at
all.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Moreover, we may be subject to a third-party preissuance submission
of prior art to the U.S. PTO or patent offices in foreign
jurisdictions, or become involved in opposition, derivation,
reexamination, inter partes review, post-grant review or
interference proceedings challenging our patent rights or the
patent rights of others. An adverse determination in any such
submission, proceeding or litigation could reduce the scope of, or
invalidate, our patent rights, allow third parties to commercialize
our technology or product candidates and compete directly with us,
without payment to us, or result in our inability to manufacture or
commercialize product candidates without infringing third-party
patent rights. In addition, if the breadth or strength of
protection provided by our patents and patent applications is
threatened, it could dissuade companies from collaborating with us
to license, develop or commercialize current or future product
candidates.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Even if our owned and licensed patent applications issue as
patents, they may not issue in a form that will provide us with any
meaningful protection, prevent competitors from competing with us
or otherwise provide us with any competitive advantage. Our
competitors may be able to circumvent our owned or licensed patents
by developing similar or alternative technologies or product
candidates in a non-infringing manner.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The issuance of a patent, while given the presumption of validity
under the law, is not conclusive as to its inventorship, scope,
validity or enforceability, and our owned and licensed patents may
be challenged in the courts or patent offices in the United States
and abroad. Such challenges may result in loss of exclusivity or
freedom to operate or in patent claims being narrowed, invalidated
or held unenforceable, in whole or in part, which could limit our
ability to stop others from using or commercializing similar or
identical technology and product candidates, or limit the duration
of the patent protection of our technology and product candidates.
In addition, patents have a limited lifespan. In the United States,
the natural expiration of a patent is generally 20 years after the
first non-provisional filing in the patent family. Given the amount
of time required for the development, testing and regulatory review
of new product candidates, patents protecting such candidates might
expire before or shortly after such candidates are commercialized.
As a result, our owned and licensed patent portfolio may not
provide us with sufficient rights to exclude others from
commercializing product candidates similar or identical to
ours.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Any inability on our part to adequately protect our intellectual
property may have a material adverse effect on our business,
operating results and financial position.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Obtaining and maintaining our patent protection depends on
compliance with various procedural, document submission, fee
payment and other requirements imposed by governmental patent
agencies, and our patent protection could be reduced or eliminated
for non-compliance with these requirements.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Periodic maintenance fees, renewal fees, annuity fees and various
other governmental fees on patents and/or applications will be due
to be paid to the U.S. PTO and various governmental patent agencies
outside the United States in several stages over the lifetime of
the patents and/or applications. We have systems in place to remind
us to pay these fees, and we employ an outside firm and rely on our
outside counsel to pay these fees due to non-U.S. patent agencies.
The U.S. PTO and various non-U.S. governmental patent agencies
require compliance with a number of procedural, documentary, fee
payment and other similar provisions during the patent application
process. We employ reputable law firms and other professionals to
help us comply, and in many cases, an inadvertent lapse can be
cured by payment of a late fee or by other means in accordance with
the applicable rules. However, in some cases we rely on licensors
to effect such payments with respect to the patents and patent
applications that we in-license. Moreover, there are situations in
which non-compliance can result in abandonment or lapse of the
patent or patent application, resulting in partial or complete loss
of patent rights in the relevant jurisdiction. In such an event,
our competitors might be able to enter the market and this
circumstance would have a material adverse effect on our
business.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Third parties may initiate legal proceedings alleging that we are
infringing their intellectual property rights, the outcome of which
would be uncertain and could have a material adverse effect on the
success of our business.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our commercial success depends upon our ability, and the ability of
our collaborators, to develop, manufacture, market and sell our
product candidates and use our proprietary technologies without
infringing the proprietary rights of third parties. There is
considerable intellectual property litigation in the biotechnology
and pharmaceutical industries. We may become party to, or
threatened with, future adversarial proceedings or litigation
regarding intellectual property rights with respect to our product
candidates and technology, including interference or derivation
proceedings before the U.S. PTO and similar bodies in other
jurisdictions. Third parties may assert infringement claims against
us based on existing patents or patents that may be granted in the
future.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
48</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU51" id=
"_AEIOULastRenderedPageBreakAEIOU51"></a><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">It
is also pos</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">sible
that we have failed to identify relevant third-party patents or
applications. For example, applications filed before November 29,
2000 and certain applications filed after that date that will not
be filed outside the United States remain confidential</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
until patents issue. Moreover, it is difficult for industry
participants, including us, to identify all third-party patent
rights that may be relevant to our product candidates and
technologies because patent searching is imperfect due to
differences in t</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">erminology
among patents, incomplete databases and the difficulty in assessing
the meaning of patent claims. We may fail to identify relevant
patents or patent applications or may identify pending patent
applications of potential interest but incorrectly
p</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">redict
the likelihood that such patent applications may issue with claims
of relevance to our technology. In addition, we may be unaware of
one or more issued patents that would be infringed by the
manufacture, sale or use of a current or future product
ca</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ndidate,
or we may incorrectly conclude that a third-party patent is
invalid, unenforceable or not infringed by our activities.
Additionally, pending patent applications that have been published
can, subject to certain limitations, be later amended in a
ma</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">nner
that could cover our technologies, our products or the use of our
products.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
If we are found to infringe a third party’s intellectual property
rights, we could be required to obtain a license from such third
party to continue developing and marketing our product candidates
and technology. However, we may not be able to obtain any required
license on commercially reasonable terms or at all. Even if we were
able to obtain a license, it could be non-exclusive, thereby giving
our competitors access to the same technologies licensed to us. We
could be forced, including by court order, to cease commercializing
the infringing technology or product. In addition, we could be
found liable for monetary damages, including treble damages and
attorneys’ fees, if we are found to have willfully infringed a
patent. A finding of infringement could prevent us from
commercializing our product candidates or force us to cease some of
our business operations, which could materially harm our business.
Claims that we have misappropriated the confidential information or
trade secrets of third parties could have a similar negative impact
on our business.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We may be subject to claims that our employees, consultants or
independent contractors have wrongfully used or disclosed
confidential information or trade secrets of third parties or that
our employees, consultants or independent contractors have
wrongfully used or disclosed alleged trade secrets of former or
other employers.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Many of our employees, independent contractors and consultants,
including our senior management, have been previously employed or
retained by universities or other biotechnology or pharmaceutical
companies, including our competitors or potential competitors.
Further, many of our consultants are currently retained by other
biotechnology or pharmaceutical companies and may be subject to
conflicting obligations to these third parties. Although we try to
ensure that our employees, consultants and independent contractors
do not use the proprietary information or know-how of third parties
in their work for us, and do not perform work for us that is in
conflict with their obligations to another employer or any other
entity, we may be subject to claims that we or our employees,
consultants or independent contractors have inadvertently or
otherwise improperly used or disclosed confidential information,
including trade secrets or other proprietary information, of a
former employer or other third parties. We may also be subject to
claims that an employee, advisor, consultant, or independent
contractor performed work for us that conflicts with that person's
obligations to a third party, such as an employer, and thus, that
the third party has an ownership interest in the intellectual
property arising out of work performed for us. We are not aware of
any threatened or pending claims related to these matters, but in
the future litigation may be necessary to defend against such
claims.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In addition, while it is our policy to require our employees,
independent contractors and consultants who may be involved in the
development of intellectual property to execute agreements
assigning such intellectual property to us, we may be unsuccessful
in timely obtaining such an agreement with each party who in fact
develops intellectual property that we regard as our own. Even if
timely obtained, such agreements may be breached, and we may be
forced to bring claims against third parties, or defend claims they
may bring against us, to determine the ownership of what we regard
as our intellectual property.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
If we fail in defending any such claims, in addition to paying
monetary damages, we may lose valuable personnel or intellectual
property rights, such as exclusive ownership of, or right to use,
valuable intellectual property. As a result, we may also elect to
enter into license agreements in order to settle patent
infringement claims or to resolve disputes prior to litigation, and
any such license agreements may require us to pay royalties and
other fees that could be significant. Such an outcome could have a
material adverse effect on our business. Even if we are successful
in defending against such claims, litigation could result in
substantial costs and be a distraction to management.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Any lawsuits relating to infringement of intellectual property
rights necessary to defend ourselves or enforce our rights will be
costly and time consuming, and could be unsuccessful.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU52" id=
"_AEIOULastRenderedPageBreakAEIOU52"></a>Because competition in our
industry is intense, competitors may infringe or otherwise violate
our issued patents, patents of our licensors or other intellectual
property. To counter infringement or unauthorized use, we may be
required to file infringement claims, which can be expensive and
time consuming. Any claims we assert against perceived
infringers</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
49</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
could provoke these parties to assert counterclaims against us
alleging, among other claims, that we infringe their patents. In
addition, in a patent infri</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ngement
proceeding there are many grounds upon which a party may assert
invalidity or unenforceability of a patent, and a court may decide
that a patent of ours is invalid or unenforceable, in whole or in
part, construe the patent’s claims narrowly or
refu</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">se
to stop the other party from using the technology at issue on the
grounds that our patents do not cover the technology in question.
Litigation is uncertain and we cannot predict whether we would be
successful in any such litigation. Such litigation or
p</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">roceedings
could substantially increase our operating losses and reduce the
resources available for development activities or any future sales,
marketing or distribution activities. We may not have sufficient
financial, managerial or other resources to ade</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">quately
conduct such litigation or proceedings. Some of our competitors may
be able to sustain the costs of such litigation or proceedings more
effectively than we can because of their greater financial,
managerial and other resources. Uncertainties
result</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ing
from the initiation and continuation of patent litigation or other
proceedings could have a material adverse effect on our business.
Furthermore, because of the substantial amount of discovery
required in connection with intellectual property
litigatio</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n,
there is a risk that some of our confidential information could be
compromised by disclosure.</font></p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Intellectual property disputes could cause us to spend substantial
resources and distract our personnel from their normal
responsibilities.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Even if resolved in our favor, litigation or other legal
proceedings relating to intellectual property claims may cause us
to incur significant expenses, and could distract our technical
and/or management personnel from their normal responsibilities. In
addition, there could be public announcements of the results of
hearings, motions or other interim proceedings or developments and
if securities analysts or investors perceive these results to be
negative, it could have a substantial adverse effect on the market
price of our common stock. In some cases, we may choose not to
pursue litigation against those that have infringed on our patents,
or used them without authorization, due to the associated expenses
and time commitment of monitoring these activities. If we fail to
protect or to enforce our intellectual property rights
successfully, our competitive position could suffer, which could
harm our results of operations.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We may not be successful in obtaining or maintaining necessary
rights for our development pipeline through acquisitions and
in-licenses.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Presently we have rights to intellectual property to develop our
product candidates, including patents and patent applications we
own or exclusively license from the University of Texas at Austin.
Because our programs may involve additional product candidates that
may require the use of proprietary rights held by third parties,
the growth of our business may depend in part on our ability to
acquire, in-license or use these proprietary rights. We may be
unable to acquire or in-license any compositions, methods of use,
processes or other third-party intellectual property rights from
third parties that we identify as necessary for our product
candidates. The licensing and acquisition of third-party
intellectual property rights is a competitive area, and a number of
more established companies are also pursuing strategies to license
or acquire third-party intellectual property rights that we may
consider attractive. These established companies may have a
competitive advantage over us due to their size, cash resources and
greater clinical development and commercialization capabilities. In
addition, companies that perceive us to be a competitor may be
unwilling to assign or license rights to us. We also may be unable
to license or acquire third-party intellectual property rights on
terms that would allow us to make an appropriate return on our
investment. If we are unable to successfully obtain rights to
required third-party intellectual property rights, our business,
financial condition and prospects for growth could suffer.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
If we are not able to prevent disclosure of our trade secrets and
other proprietary information, the value of our technology and
product candidates could be significantly diminished.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU53" id=
"_AEIOULastRenderedPageBreakAEIOU53"></a>We rely on trade secret
protection to protect our interests in proprietary know-how and in
processes that are unpatentable or for which patents are difficult
to obtain or enforce. We may not be able to protect our trade
secrets adequately. We have a policy of requiring our consultants,
advisors and strategic partners to enter into confidentiality
agreements and our employees to enter into invention,
non-disclosure and non-compete agreements. However, no assurance
can be given that we have entered into appropriate agreements with
all parties that have had access to our trade secrets, know-how or
other proprietary information, or that such agreements will provide
for a meaningful protection of our trade secrets, know-how or other
proprietary information in the event of any unauthorized use or
disclosure of information. Enforcing a claim that a party illegally
disclosed or misappropriated a trade secret is difficult, expensive
and time-consuming, and the outcome is unpredictable. Even if we
are successful in prosecuting such claims, any remedy awarded may
be insufficient to fully compensate us for the improper disclosure
or misappropriation. Furthermore, although we seek to preserve the
integrity and confidentiality of our data, trade secrets and
know-how by maintaining physical security of our premises and
physical and electronic security of our information technology
systems, it is also</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
50</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
possible that our trade secrets, know-how or other proprietary
information could be obtained by third parties as a result of
breaches of such systems.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Any disclosure of confidential information into the public domain
or to third parties could allow our competitors to learn our trade
secrets and use the information in competition against us. In
addition, others may independently discover or develop our trade
secrets and proprietary information or substantially equivalent
techniques. Any action to enforce our rights is likely to be time
consuming and expensive, and may ultimately be unsuccessful, or may
result in a remedy that is not commercially valuable. These risks
are accentuated in foreign countries where laws or law enforcement
practices may not protect proprietary rights as fully as in the
United States or Europe. Any unauthorized disclosure of our trade
secrets or confidential information could harm our competitive
position.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We may not be able to protect our intellectual property rights
throughout the world.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Filing, prosecuting and defending patents on all of our product
candidates throughout the world would be prohibitively expensive,
and our patent rights in some countries outside the United States
can be less extensive than those in the United States. The
requirements for patentability may differ in certain countries,
particularly developing countries. For example, unlike other
countries, China has a heightened requirement for patentability and
specifically requires a detailed description of medical uses of a
claimed therapeutic. In addition, the laws of some foreign
countries do not protect intellectual property rights to the same
extent as federal and state laws in the United States.
Consequently, we may not be able to prevent third parties from
practicing our inventions in all countries outside the United
States, or from selling or importing products made using our
inventions in and into the United States or other
jurisdictions.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
As part of ordinary course prosecution and maintenance activities,
we determine whether to seek patent protection outside the United
States and in which countries. This also applies to patents we have
acquired or in-licensed from third parties. In some cases, this
means that we, or our predecessors in interest or licensors of
patents within our portfolio, have sought patent protection in a
limited number of countries for patents covering our product
candidates. Competitors may use our technologies in jurisdictions
where we have not pursued and obtained patent protection to develop
their own products and, further, may export otherwise infringing
products to territories where we have patent protection but where
enforcement is not as strong as in the United States. These
products may compete with our products in jurisdictions where we do
not have any issued patents and, even in jurisdictions where we
have or are able to obtain issued patents, our patent claims or
other intellectual property rights may not be effective or
sufficient to prevent them from so competing. Many companies have
encountered significant problems in protecting and defending
intellectual property rights in foreign jurisdictions. The legal
systems of certain countries, particularly certain developing
countries, do not favor the enforcement of patents and other
intellectual property protection, particularly those relating to
biopharmaceuticals, which could make it difficult for us to stop
the infringement of our patents or marketing of competing products
in violation of our proprietary rights generally. Proceedings to
enforce our patent rights in foreign jurisdictions could result in
substantial cost and divert our efforts and attention from other
aspects of our business, could put our patents at risk of being
invalidated or interpreted narrowly and our patent applications at
risk of not issuing and could provoke third parties to assert
claims against us. We may not prevail in any lawsuits that we
initiate and the damages or other remedies awarded, if any, may not
be commercially meaningful. In addition, certain countries in
Europe and certain developing countries, including India and China,
have compulsory licensing laws under which a patent owner may be
compelled to grant licenses to third parties. In those countries,
we may have limited remedies if our patents are infringed or if we
are compelled to grant a license to our patents to a third party,
which could materially diminish the value of those patents. In
addition, there may be patent law reforms in foreign jurisdictions
that could increase the uncertainties and costs surrounding the
prosecution of our patent applications and the enforcement or
defense of our issued patents in those foreign jurisdictions. This
could limit our potential revenue opportunities.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Accordingly, our efforts to obtain, register, and enforce our
intellectual property rights around the world may be inadequate to
obtain a significant commercial advantage from the intellectual
property that we own or license. Moreover, patent protection must
ultimately be sought on a country-by-country basis, which is an
expensive and time-consuming process with uncertain outcomes.
Accordingly, we may choose not to seek patent protection in certain
countries, and we will not have the benefit of patent protection in
such countries.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
If we breach any of the agreements under which we license patent
rights to use, develop and commercialize our product candidates or
our technologies from third parties or, in certain cases, we fail
to meet certain development deadlines, we could lose license rights
that are important to our business.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU54" id=
"_AEIOULastRenderedPageBreakAEIOU54"></a>We are a party to a number
of license agreements under which we are granted rights to
intellectual property that are important to our business and we
expect that we may need to enter into additional license agreements
in the future.&nbsp;&nbsp;In particular, we partner with the
University of Texas at Austin, which is a U.S. academic
institution, in order to accelerate our discovery and nonclinical
development work under a Sponsored Research Agreement. Under the
Sponsored Research</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
51</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Agreement, we made payments of $188,000 for each of the three
months ended March&nbsp;31, 2018 and 2017, to sponsor research in
the laboratory of our director, Dr.&nbsp;George Georgiou, at the
Univ</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ersity
of Texas at Austin on the engineering, optimization and initial
animal validation of human enzymes to determine the systemic
depletion of amino acids for cancer therapy and to analyze enzyme
replacement for the treatment of patients having inborn
me</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tabolic
defects.</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The University of Texas at Austin has provided us with an option to
negotiate a royalty-bearing, exclusive license to any invention or
discovery that is conceived or reduced to practice during the term
of the Sponsored Research Agreement. Regardless of such right of
first negotiation for intellectual property, we may be unable to
negotiate a license within the specified time frame or under terms
that are acceptable to us. If we are unable to do so, the
institution may offer the intellectual property rights to other
parties, potentially blocking our ability to pursue a program based
on that technology.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In December 2013, our wholly-owned subsidiaries AECase, Inc. and
AEMase, Inc. each entered into an exclusive, worldwide license
agreement, including the right to grant sublicenses,&nbsp;with the
University of Texas at Austin for certain intellectual property
owned by the University of Texas at Austin related to our product
candidates AEB3103 and AEB2109. In January and December, 2017, we
and the University of Texas at Austin entered into and subsequently
amended an Amended and Restated Patent License Agreement which
consolidated the two license agreements, revised certain
obligations, and licensed additional patent applications and
invention disclosures to us, or the Restated License. The
intellectual property licensed under the Restated License includes
an invention that was made with U.S. government support. The U.S.
government therefore has certain rights in such inventions under
the applicable funding agreements and under applicable law. In
addition, we are subject to a requirement that the products covered
by the applicable patents that are sold or used in the United
States must be manufactured substantially in the United States
unless a written waiver is obtained in advance from the U.S
government. The Restated License obligates us to make certain
payments at the achievement of certain milestones and at regular
intervals throughout the life of the license. The University of
Texas at Austin may terminate the Restated License under certain
circumstances, including for a breach by us that is not cured
within 30 or 60 days of notice (depending on the type of breach),
or if we or any of our affiliates or sublicensees participate in
any proceeding to challenge the licensed patent rights (unless,
with respect to sublicensees, we terminate the applicable
sublicense).&nbsp;&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Licensing of intellectual property is of critical importance to our
business and involves complex legal, business and scientific
issues. Any other licenses or other intellectual property
agreements we may enter into may impose various diligence,
milestone payment, royalty and other obligations on us. If disputes
arise between us and our licensor or if we fail to comply with our
obligations under current or future intellectual property
agreements, potentially giving our counterparties the right to
terminate these agreements, we might not be able to develop,
manufacture or market any product that is covered by the agreement
or face other penalties under the agreement. Such an occurrence
could materially adversely affect the value of the product
candidate being developed under any such agreement. Termination of
these agreements or reduction or elimination of our rights under
these agreements may result in our having to negotiate new or
reinstated agreements with less favorable terms, or cause us to
lose our rights under these agreements, including our rights to
important intellectual property or technology.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The loss of any one of our current licenses, or any other license
we may acquire in the future, could prevent or impair our ability
to successfully develop and commercialize the affected product
candidates and thus materially harm our business, prospects,
financial condition and results of operations.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Intellectual property rights do not necessarily address all
potential threats to our competitive advantage.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The degree of future protection afforded by our intellectual
property rights is uncertain because intellectual property rights
have limitations, and may not adequately protect our business,
provide a barrier to entry against our competitors or potential
competitors, or permit us to maintain our competitive advantage.
Moreover, if a third party has intellectual property rights that
cover the practice of our technology or product candidates, we may
not be able to fully exercise or extract value from our
intellectual property rights. The following examples are
illustrative:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">others may be able to make
compounds that are similar to our product candidates but that are
not covered by the claims of the patents that we own or
license;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">we or our licensors or
collaborators might not have been the first to make the inventions
covered by an issued patent or pending patent application that we
own or license;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">we or our licensors or
collaborators might not have been the first to file patent
applications covering an invention;</font></p>
</td>
</tr>
</table>
</div>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
52</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<a name="_AEIOULastRenderedPageBreakAEIOU55" id=
"_AEIOULastRenderedPageBreakAEIOU55"></a><font style=
"font-family:Arial;">others may independently develop similar or
alternative technologies or duplicate any of our technologies
without infringing or mi</font><font style=
"font-family:Arial;">sappropriating our intellectual property
rights;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">pending patent applications that
we own or license may not lead to issued patents;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">issued patents that we own or
license may not provide us with any competitive advantages, or may
be narrowly construed or held invalid or unenforceable, as a result
of legal challenges by our competitors;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">our competitors might conduct
research and development activities in countries where we do not
have patent rights and then use the information learned from such
activities to develop competitive products for sale in our major
commercial markets;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">we may not develop or in-license
additional proprietary technologies that are patentable;
and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the patents of others may have an
adverse effect on our business.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Any of these events could significantly harm our business, results
of operations and prospects.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Changes in U.S. patent law could diminish the value of patents in
general, thereby impairing our ability to protect our products, and
recent patent reform legislation could increase the uncertainties
and costs surrounding the prosecution of our patent applications
and the enforcement or defense of our issued patents.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
As is the case with other biotechnology companies, our success is
heavily dependent on patents. Obtaining and enforcing patents in
the biotechnology industry involve both technological and legal
complexity, and is therefore costly, time-consuming and inherently
uncertain. In addition, the United States has recently enacted and
is currently implementing wide-ranging patent reform legislation.
Recent U.S. Supreme Court rulings have narrowed the scope of patent
protection available in certain circumstances and weakened the
rights of patent owners in certain situations. In addition to
increasing uncertainty with regard to our ability to obtain patents
in the future, this combination of events has created uncertainty
with respect to the value of patents, once obtained. Depending on
decisions by the U.S. Congress, the federal courts, and the U.S.
PTO, the laws and regulations governing patents could change in
unpredictable ways that would weaken our ability to obtain new
patents or to enforce our existing patents and patents that we
might obtain in the future.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
For our U.S. patent applications containing a claim not entitled to
priority before March&nbsp;16, 2013, there is a greater level of
uncertainty in the patent law. On September&nbsp;16, 2011, the
Leahy-Smith America Invents Act, or the Leahy-Smith Act, was signed
into law. The Leahy-Smith Act includes a number of significant
changes to U.S. patent law, which affect both the way patent
applications will be prosecuted and potentially patent litigation.
The U.S. PTO has promulgated regulations and developed procedures
to govern administration of the Leahy-Smith Act, and many of the
substantive changes to patent law associated with the Leahy-Smith
Act (in particular, the first to file provisions) did not come into
effect until March&nbsp;16, 2013. Accordingly, it is not yet clear
what, if any, impact the Leahy-Smith Act will have on the operation
of our business. However, the Leahy-Smith Act and its
implementation could increase the uncertainties and costs
surrounding the prosecution of our patent applications and the
enforcement or defense of our issued patents, all of which could
have a material adverse effect on our business and financial
condition.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
An important change introduced by the Leahy-Smith Act is that, as
of March&nbsp;16, 2013, the United States transitioned to a
"first-to-file" system for deciding which party should be granted a
patent when two or more patent applications are filed by different
parties claiming the same invention. A third party that files a
patent application in the U.S. PTO after that date but before us
could therefore be awarded a patent covering an invention of ours
even if we had made the invention before it was made by the third
party. This will require us to be cognizant going forward of the
time from invention to filing of a patent application. Furthermore,
our ability to obtain and maintain valid and enforceable patents
depends on whether the differences between our technology and the
prior art allow our technology to be patentable over the prior art.
Since patent applications in the United States and most other
countries are confidential for a period of time after filing, we
cannot be certain that we were the first to either (i)&nbsp;file
any patent application related to our product candidates or
(ii)&nbsp;invent any of the inventions claimed in our patents or
patent applications.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU56" id=
"_AEIOULastRenderedPageBreakAEIOU56"></a>Among some of the other
changes introduced by the Leahy-Smith Act are changes that limit
where a patentee may file a patent infringement suit and that allow
third parties to challenge any issued patent, whether issued before
or after March&nbsp;16, 2013, in the U.S. PTO. Because of a lower
evidentiary standard in U.S. PTO proceedings compared to the
evidentiary standard in United States federal court necessary to
invalidate a patent claim, a third party could potentially provide
evidence in a U.S. PTO proceeding sufficient for the U.S. PTO to
hold a claim invalid even though the same evidence would be
insufficient to invalidate the claim if first presented in a
district court action. Accordingly, a third party</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
53</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
may attempt to use the U.S. PTO procedures to invalidate our patent
claims that would not have been</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
invalidated if first challenged by the third party as a defendant
in a district court action.</font></p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
If we do not obtain patent term extensions in the United States
under the Hatch-Waxman Act and in foreign countries under similar
legislation, thereby potentially extending the term of our
marketing exclusivity for our product candidates, our business may
be materially harmed.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Depending upon the timing, duration and specifics of FDA marketing
approval of our product candidates, if any, one of the U.S. patents
covering each of such approved product(s) or the use thereof may be
eligible for up to five years of patent term restoration under the
Hatch-Waxman Act. The Hatch-Waxman Act allows a maximum of one
patent to be extended per FDA-approved product. Patent term
extension also may be available in certain foreign countries upon
regulatory approval of our product candidates. Nevertheless, we may
not be granted patent term extension either in the United States or
in any foreign country because of, for example, failing to apply
within applicable deadlines, failing to apply prior to expiration
of relevant patents or otherwise failing to satisfy applicable
requirements. Moreover, the term of extension, as well as the scope
of patent protection during any such extension, afforded by the
governmental authority could be less than we request. In addition,
if a patent we wish to extend is owned by another party and
licensed to us, we may need to obtain approval and cooperation from
our licensor to request the extension.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
If we are unable to obtain patent term extension or restoration, or
the term of any such extension is less than we request, the period
during which we will have the right to exclusively market our
product will be shortened and our competitors may obtain approval
of competing products following our patent expiration, and our
revenue could be reduced, possibly materially.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Risks Related to Our Common Stock</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Our executive officers, directors and principal stockholders, if
they choose to act together, will continue to have the ability to
control all matters submitted to stockholders for approval.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We have a concentrated stockholder base and our executive officers
and directors, combined with our stockholders who, to our
knowledge, each owned more than 5% of our outstanding common stock,
in the aggregate, beneficially own shares representing a majority
of our capital stock as of March&nbsp;31, 2018. As a result, if
these stockholders were to choose to act together, they would be
able to control all matters submitted to our stockholders for
approval, as well as our management and affairs. For example, these
persons, if they choose to act together, would control the election
of directors and approval of any merger, consolidation or sale of
all or substantially all of our assets. This concentration of
ownership control may:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">delay, defer or prevent a change
in control;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">entrench our management and the
board of directors; or</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">impede a merger, consolidation,
takeover or other business combination involving us that other
stockholders may desire or may result in you obtaining a premium
for your shares.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Our internal control over financial reporting does not currently
meet the standards required by Section&nbsp;404 of the
Sarbanes-Oxley Act, and failure to achieve and maintain effective
internal control over financial reporting in accordance with
Section&nbsp;404 of the Sarbanes-Oxley Act could have a material
adverse effect on our business and stock price.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Pursuant to Section 404, we have been required to furnish a report
by our management on our internal control over financial reporting
beginning with the year ended December 31, 2017. However, while we
remain an emerging growth company, we will not be required to
include an attestation report on internal control over financial
reporting issued by our independent registered public accounting
firm. Internal control over financial reporting is a process
designed to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements
in accordance with generally accepted accounting principles in the
United States. We may encounter problems or delays in implementing
any changes necessary to make a favorable assessment of our
internal control over financial reporting. If we cannot favorably
assess the effectiveness of our internal control over financial
reporting, or if our independent registered public accounting firm
is unable to provide an unqualified attestation report on our
internal controls when required, investors could lose confidence in
our financial information and the price of our common stock could
decline.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU57" id=
"_AEIOULastRenderedPageBreakAEIOU57"></a>Additionally, the
existence of any&nbsp;material weakness&nbsp;or significant
deficiency would require management to devote significant time and
incur significant expense to remediate any such material weaknesses
or significant deficiencies and management may not be able to
remediate any such material weaknesses or significant deficiencies
in a timely manner. The existence of any&nbsp;material
weakness&nbsp;in our internal control over financial reporting
could also result in errors in our</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
54</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
financial statements that could require us to restate our financial
statements causing us to fail to meet our reporting obligations and
cause stockholders to lose confidence in our reported financial
information, all of which could m</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">aterially
and adversely affect us.</font></p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Provisions in our corporate charter documents and under Delaware
law could make an acquisition of our company, which may be
beneficial to our stockholders, more difficult and may prevent
attempts by our stockholders to replace or remove our current
management.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Provisions in our certificate of incorporation and our bylaws may
discourage, delay or prevent a merger, acquisition or other change
in control of our company that stockholders may consider favorable,
including transactions in which you might otherwise receive a
premium for your shares. These provisions could also limit the
price that investors might be willing to pay in the future for
shares of our common stock, thereby depressing the market price of
our common stock. In addition, because our board of directors is
responsible for appointing the members of our management team,
these provisions may frustrate or prevent any attempts by our
stockholders to replace or remove our current management by making
it more difficult for stockholders to replace members of our board
of directors. Among other things, these provisions:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">establish a classified board of
directors such that only one of three classes of directors is
elected each year;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">allow the authorized number of our
directors to be changed only by resolution of our board of
directors;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">limit the manner in which
stockholders can remove directors from our board of
directors;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">establish advance notice
requirements for stockholder proposals that can be acted on at
stockholder meetings and nominations to our board of
directors;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">require that stockholder actions
must be effected at a duly called stockholder meeting and prohibit
actions by our stockholders by written consent;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">limit who may call stockholder
meetings;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">authorize our board of directors
to issue preferred stock without stockholder approval, which could
be used to institute a “poison pill” that would work to dilute the
stock ownership of a potential hostile acquirer, effectively
preventing acquisitions that have not been approved by our board of
directors; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">require the approval of the
holders of at least two-thirds of the votes that all our
stockholders would be entitled to cast to amend or repeal specified
provisions of our certificate of incorporation or
bylaws.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Moreover, we are governed by the provisions of Section&nbsp;203 of
the Delaware General Corporation Law, which prohibits a person who
owns in excess of 15% of our outstanding voting stock from merging
or combining with us for a period of three years after the date of
the transaction in which the person acquired in excess of 15% of
our outstanding voting stock, unless the merger or combination is
approved in a prescribed manner.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Any of these provisions of our charter documents or Delaware law
could, under certain circumstances, depress the market price of our
common stock.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Our amended and restated certificate of incorporation designates
the Court of Chancery of the State of Delaware as the sole and
exclusive forum for certain types of actions and proceedings that
may be initiated by our stockholders, which could limit our
stockholders’ ability to obtain a favorable judicial forum for
disputes with us or our directors, officers, employees or
agents.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU58" id=
"_AEIOULastRenderedPageBreakAEIOU58"></a>Our amended and restated
certificate of incorporation provides that, unless we consent in
writing to an alternative forum, the Court of Chancery of the State
of Delaware will be the sole and exclusive forum for any derivative
action or proceeding brought on our behalf, any action asserting a
claim of breach of a fiduciary duty owed by any of our directors,
officers, employees or agents to us or our stockholders, any action
asserting a claim arising pursuant to any provision of the DGCL,
our amended and restated certificate of incorporation or our
amended and restated bylaws or any action asserting a claim that is
governed by the internal affairs doctrine, in each case subject to
the Court of Chancery having personal jurisdiction over the
indispensable parties named as defendants therein and the claim not
being one which is vested in the exclusive jurisdiction of a court
or forum other than the Court of Chancery or for which the Court of
Chancery does not have subject matter jurisdiction. Any person
purchasing or otherwise acquiring any interest in any shares of our
capital stock shall be deemed to have notice of and to have
consented to this provision of our amended and restated certificate
of incorporation. This choice of forum provision may limit our
stockholders’ ability to bring a claim in a judicial</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
55</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
forum that it finds fa</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">vorable
for disputes with us or our directors, officers, employees or
agents, which may discourage such lawsuits against us and our
directors, officers, employees and agents even though an action, if
successful, might benefit our stockholders. Stockholders</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
who do bring a claim in the Court of Chancery could face additional
litigation costs in pursuing any such claim, particularly if they
do not reside in or near Delaware. The Court of Chancery may also
reach different judgments or results than would other
c</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ourts,
including courts where a stockholder considering an action may be
located or would otherwise choose to bring the action, and such
judgments or results may be more favorable to us than to our
stockholders. Alternatively, if a court were to find this</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
provision of our amended and restated certificate of incorporation
inapplicable to, or unenforceable in respect of, one or more of the
specified types of actions or proceedings, we may incur additional
costs associated with resolving such matters in other</font>
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
jurisdictions, which could have a material adverse effect on our
business, financial condition or results of operations.</font></p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
The price of our common stock may be volatile and fluctuate
substantially, which could result in substantial losses for
purchasers of our common stock.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our stock price is volatile. The stock market in general and the
market for smaller biotechnology companies in particular have
experienced extreme volatility that has often been unrelated to the
operating performance of particular companies. The market price for
our common stock may be influenced by many factors, including:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the success or failure of
competitive products or technologies;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">results of ongoing or planned
clinical trials of our product candidates or those of our
competitors;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">regulatory or legal developments
in the United States and other countries;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">developments or disputes
concerning patent applications, issued patents or other proprietary
rights;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the recruitment or departure of
key personnel;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the level of expenses related to
any of our product candidates or clinical development
programs;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the results of our efforts to
discover, develop, acquire or in-license additional product
candidates or products;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">actual or anticipated changes in
estimates as to financial results, development timelines or
recommendations by securities analysts;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">operating results that fail to
meet expectations of securities analysts that cover our
company;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">variations in our financial
results or those of companies that are perceived to be similar to
us;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">changes in the structure of
healthcare payment systems;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">market conditions in the
pharmaceutical and biotechnology sectors;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">general economic and market
conditions; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">the other factors described in
this “Risk Factors” section.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We may be subject to securities litigation, which is expensive and
could divert management attention.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our stock price is volatile, and in the past companies that have
experienced volatility in the market price of their stock have been
subject to an increased incidence of securities class action
litigation. We may be the target of this type of litigation in the
future. Securities litigation against us could result in
substantial costs and divert our management’s attention from other
business concerns, which could seriously harm our business.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
If securities or industry analysts do not publish research or
reports about our business, or publish negative reports about our
business, our stock price and trading volume could decline.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The trading market for our common stock will depend in part on the
research and reports that securities or industry analysts publish
about us or our business. We do not have any control over these
analysts. There can be no assurance that analysts will cover us or
provide favorable coverage. If one or more of the analysts who
cover us downgrade our stock or change their opinion of our stock,
our stock price would likely decline. If one or more of these
analysts cease coverage of our company or fail to regularly publish
reports on us, we could lose visibility in the financial markets,
which could cause our stock price or trading volume to decline.
&nbsp;</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
56</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU59" id=
"_AEIOULastRenderedPageBreakAEIOU59"></a><font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">We
have broad discretion in the use of the net proceeds from our
public offerings and may not use them effectively.</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Our management has broad discretion in the application of the net
proceeds from our public offerings, and you will not have the
opportunity as part of your investment decision to assess whether
the net proceeds are being used appropriately. Our management could
spend the net proceeds from our public offerings in ways that do
not improve our results of operations or enhance the value of our
common stock. The failure by our management to apply these funds
effectively could result in financial losses that could have a
material adverse effect on our business, cause the price of our
common stock to decline and delay the development of our product
candidates. Pending their use, we may invest the net proceeds from
our public offerings in a manner that does not produce income or
that loses value.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Future sales of our common stock in the public market could cause
the market price of our common stock to drop significantly, even if
our business is doing well.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Sales of a substantial number of shares of our common stock in the
public market, or the perception in the market that the holders of
a large number of shares intend to sell shares, could reduce the
market price of our common stock and make it more difficult for you
to sell your common stock at a time and price that you deem
appropriate.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Certain holders of our common stock have rights, subject to
conditions, to require us to file registration statements covering
their shares or to include their shares in Securities Act
registration statements that we may file for ourselves or other
stockholders. Once we register these shares, they can be freely
sold in the public market. Moreover, we have also registered under
the Securities Act shares of common stock that we may issue under
our equity compensation plans.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In addition, on May 1, 2017, we filed a shelf registration
statement on Form S-3 for the potential offering, issuance and sale
by us of up to $150.0 million of our common stock, preferred stock,
debt securities, warrants to purchase our common stock, preferred
stock and debt securities, subscription rights to purchase our
common stock, preferred stock and debt securities, and units
consisting of all or some of these securities. The shelf
registration statement was declared effective by the SEC on May 30,
2017. In June 2017 and April 2018, we sold 3,000,000 and 5,046,510
shares of our common stock in underwritten public offerings
pursuant to the shelf registration statement for aggregate gross
proceeds of $12.3 million and $40.4 million, respectively. In
addition, common stock with an aggregate offering price of up to
$20.0 million may be issued and sold pursuant to an “at-the-market”
offering of our common stock pursuant to a sales agreement between
us and JonesTrading Institutional Services LLC, or JonesTrading.
Subject to certain limitations in the sales agreement and
compliance with applicable law, we have the discretion to deliver a
placement notice to JonesTrading at any time throughout the term of
the sales agreement, which has a term equal to the term of the
registration statement on Form S-3 unless otherwise terminated
earlier by us or JonesTrading pursuant to the terms of the sales
agreement. The number of shares that are sold by JonesTrading after
delivering a placement notice will fluctuate based on the market
price of our common stock during the sales period and limits we set
with JonesTrading. Because the price per share of each share sold
will fluctuate based on the market price of our common stock during
the sales period, it is not possible at this stage to predict the
number of shares that will be ultimately issued. Issuances of such
shares pursuant to the sales agreement will have a dilutive effect
on our existing stockholders. Further, if we sell common stock,
preferred stock, convertible securities and other equity securities
in other transactions pursuant to our shelf registration statement
on Form S-3, existing investors may be materially diluted by such
subsequent sales and new investors could gain rights superior to
our existing stockholders.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;letter-spacing:-0.1pt;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
In addition, in the future, we may issue additional shares of
common stock or other equity or debt securities convertible into
common stock in connection with a financing, acquisition,
litigation settlement, employee arrangements or otherwise. Any such
issuance could result in substantial dilution to our existing
stockholders and could cause our stock price to decline.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
57</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU60" id=
"_AEIOULastRenderedPageBreakAEIOU60"></a><font style=
"font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">We
are an “emerging growth company,” and the reduced disclosure
requirements applicable to emerging growth companies may make our
common stock less attractive to investors.</font></p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We are an “emerging growth company,” as defined in the Jumpstart
Our Business Startups Act of 2012, or the JOBS Act, and may remain
an emerging growth company for up to five years. For so long as we
remain an emerging growth company, we are permitted and intend to
rely on exemptions from certain disclosure requirements that are
applicable to other public companies that are not emerging growth
companies. These exemptions include:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">being permitted to provide only
two years of audited financial statements, in addition to any
required unaudited interim financial statements, with
correspondingly reduced “Management’s Discussion and Analysis of
Financial Condition and Results of Operations”
disclosure;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">not being required to comply with
the auditor attestation requirements in the assessment of our
internal control over financial reporting of Section 404(b) of the
Sarbanes-Oxley Act;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">not being required to comply with
any requirement that may be adopted by the Public Company
Accounting Oversight Board regarding mandatory audit firm rotation
or a supplement to the auditor’s report providing additional
information about the audit and the financial
statements;</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">reduced disclosure obligations
regarding executive compensation; and</font></p>
</td>
</tr>
</table>
</div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
•</font></p>
</td>
<td valign="top">
<p style=
"margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;">
<font style="font-family:Arial;">exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not
previously approved.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The JOBS Act provides that an emerging growth company can take
advantage of an extended transition period for complying with new
or revised accounting standards. This allows an emerging growth
company to delay the adoption of these accounting standards until
they would otherwise apply to private companies. We have
irrevocably elected not to avail ourselves of this exemption and,
therefore, we will be subject to the same new or revised accounting
standards as other public companies that are not emerging growth
companies.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
We will continue to incur increased costs as a result of operating
as a public company, and our management will be required to devote
substantial time to new compliance initiatives and corporate
governance practices.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
As a public company, and particularly after we are no longer an
emerging growth company, we incur significant legal, accounting and
other expenses that we did not incur as a private company. The
Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and
Consumer Protection Act, the listing requirements of The Nasdaq
Global Market and other applicable securities rules and regulations
impose various requirements on public companies, including
establishment and maintenance of effective disclosure and financial
controls and corporate governance practices. Our management and
other personnel will need to devote a substantial amount of time to
these compliance initiatives. Moreover, these rules and regulations
will continue to increase our legal and financial compliance costs
and will make some activities more time-consuming and costly. For
example, we expect that these rules and regulations may make it
more difficult and more expensive for us to obtain and maintain
director and officer liability insurance, which in turn could make
it more difficult for us to attract and retain qualified members of
our board of directors.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We are evaluating these rules and regulations, and cannot predict
or estimate the amount of additional costs we may incur or the
timing of such costs. These rules and regulations are often subject
to varying interpretations, in many cases due to their lack of
specificity, and, as a result, their application in practice may
evolve over time as new guidance is provided by regulatory and
governing bodies. This could result in continuing uncertainty
regarding compliance matters and higher costs necessitated by
ongoing revisions to disclosure and governance practices.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
58</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU61" id=
"_AEIOULastRenderedPageBreakAEIOU61"></a><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant
to</font> <font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Section&nbsp;404, we have been required to furnish a report by our
management on our internal control over financial reporting
beginning with the year ending December&nbsp;31, 2017. As discussed
above, if we cease to be an emerging growth company, we will be
require</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d
to include an attestation report on internal control over financial
reporting issued by our independent registered public accounting
firm as required by Section&nbsp;404(b). To achieve compliance with
Section&nbsp;404 within the prescribed period, we will be
engag</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ed
in a process to document and evaluate our internal control over
financial reporting, which is both costly and challenging. In this
regard, we will need to continue to dedicate internal resources,
potentially engage outside consultants and adopt a
detail</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ed
work plan to assess and document the adequacy of internal control
over financial reporting, continue steps to improve control
processes as appropriate, validate through testing that controls
are functioning as documented and implement a continuous
repor</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ting
and improvement process for internal control over financial
reporting. Despite our efforts, there is a risk that we will not be
able to conclude, within the prescribed timeframe or at all, that
our internal control over financial reporting is
effectiv</font><font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e
as required by Section&nbsp;404. If we identify one or more
material weaknesses, it could result in an adverse reaction in the
financial markets due to a loss of confidence in the reliability of
our consolidated financial statements.</font></p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Our ability to use our net operating loss carryforwards and certain
other tax attributes may be limited.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Under Section&nbsp;382 of the Internal Revenue Code of 1986, as
amended, if a corporation undergoes an “ownership change,”
generally defined as a greater than 50% change (by value) in its
equity ownership over a three-year period, the corporation’s
ability to use its pre-change net operating loss carryforwards, or
NOLs, and other pre-change tax attributes (such as research tax
credits) to offset its post-change income or taxes may be limited.
It is possible that we may have triggered an “ownership change”
limitation. We may also experience ownership changes in the future
as a result of subsequent shifts in our stock ownership (some of
which are outside of our control). As a result, if we earn net
taxable income, our ability to use our pre-change NOLs and other
pre-change tax attributes to offset U.S. federal taxable income or
taxes may be subject to limitations, which could potentially result
in increased future tax liability to us. Our NOLs and other tax
attributes arising before our conversion from a Delaware limited
liability company to a Delaware corporation in 2015 also may be
limited by the Separate Return Limitation Year rule, which could
increase our U.S. federal tax liability. In addition, at the state
level, there may be periods during which the use of NOLs is
suspended or otherwise limited, which could accelerate or
permanently increase state taxes owed.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Since we do not anticipate paying any cash dividends on our capital
stock in the foreseeable future, stock price appreciation, if any,
will be your sole source of gain.</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
We have never declared or paid cash dividends on our capital stock.
We currently intend to retain all of our future earnings, if any,
to finance the growth and development of our business. In addition,
the terms of any future debt agreements may preclude us from paying
dividends. As a result, appreciation, if any, in the market price
of our common stock will be your sole source of gain for the
foreseeable future.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;2.</font></p>
</td>
<td valign="top">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
<a name="ITEM_2_UNREGISTERED_SALES_EQUITY_SECURIT" id=
"ITEM_2_UNREGISTERED_SALES_EQUITY_SECURIT"></a><a name=
"ITEM_2_UNREGISTERED_SALES_EQUITY_SECURIT" id=
"ITEM_2_UNREGISTERED_SALES_EQUITY_SECURIT"></a>Unregistered Sales
of Equity Securities and Use of Proceeds.</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Recent Sales of Unregistered Equity Securities</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
None.</p>
<p style=
"margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Arial;font-size:10pt;text-transform:none;font-variant: normal;">
Use of Proceeds</p>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
On April 6, 2016, our Registration Statement on Form S-1 (File No.
333-200501) relating to the IPO of our common stock was declared
effective by the SEC.&nbsp;&nbsp;</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
There has been no material change in our planned use of the net
proceeds from the IPO, as described in our final prospectus filed
with the SEC on April 7, 2016.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;3.</font></p>
</td>
<td valign="top">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
<a name="ITEM_3_DEFAULTS_UPON_SENIOR_SECURITIES" id=
"ITEM_3_DEFAULTS_UPON_SENIOR_SECURITIES"></a><a name=
"ITEM_3_DEFAULTS_UPON_SENIOR_SECURITIES" id=
"ITEM_3_DEFAULTS_UPON_SENIOR_SECURITIES"></a>Defaults Upon Senior
Securities.</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Not applicable.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:9.06%;text-indent:-9.06%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:9.06%;text-indent:-9.06%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;4.</font></p>
</td>
<td valign="top">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
<a name="ITEM_4_MINE_SAFETY_DISCLOSURES" id=
"ITEM_4_MINE_SAFETY_DISCLOSURES"></a><a name=
"ITEM_4_MINE_SAFETY_DISCLOSURES" id=
"ITEM_4_MINE_SAFETY_DISCLOSURES"></a>Mine Safety Disclosures.</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Not applicable.</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
59</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:9.06%;text-indent:-9.06%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:9.06%;text-indent:-9.06%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;5.</font></p>
</td>
<td valign="top">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
<a name="ITEM_5_OR_INFORMATION" id=
"ITEM_5_OR_INFORMATION"></a><a name="ITEM_5_OR_INFORMATION" id=
"ITEM_5_OR_INFORMATION"></a>Other Information.</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
None.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:9.07%;text-indent:-9.07%;font-family:Times New Roman;font-weight:bold;;font-size:9pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
60</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
Item&nbsp;6.</font></p>
</td>
<td valign="top">
<p style=
"margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
<a name="_AEIOULastRenderedPageBreakAEIOU62" id=
"_AEIOULastRenderedPageBreakAEIOU62"></a><a name="ITEM_6_EXHIBITS"
id="ITEM_6_EXHIBITS"></a><a name="_ITEM_6_EXHIBITS" id=
"_ITEM_6_EXHIBITS"></a><a name="ITEM_6_EXHIBITS" id=
"ITEM_6_EXHIBITS"></a><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_ITEM_6_EXHIBITS"
id="_ITEM_6_EXHIBITS"></a>E</font><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">xhibits.</font></p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
The exhibits filed or furnished as part of this Quarterly Report on
Form 10-Q are set forth below.</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Exhibit</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%; border-bottom:solid 0.75pt #000000;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Number</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%; border-bottom:solid 0.75pt #000000;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
Description</p>
</td>
</tr>
<tr>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%; border-top:solid 0.75pt #000000;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%; border-top:solid 0.75pt #000000;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;&nbsp;10.1*</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a href=
"http://www.sec.gov/Archives/edgar/data/0001636282/000156459018005405/agle-ex992_59.htm">
<font style="text-decoration:underline;">2018 Equity Inducement
Plan</font></a></p>
</td>
</tr>
<tr>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;&nbsp;31.1</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a href="agle-ex311_6.htm"><font style=
"text-decoration:underline;">Certification of the Principal
Executive Officer pursuant to Rule&nbsp;13a-14(a)&nbsp;or
15d-14(a)&nbsp;of the Securities Exchange Act of
1934.</font></a></p>
</td>
</tr>
<tr>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;&nbsp;31.2</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a href="agle-ex312_11.htm"><font style=
"text-decoration:underline;">Certification of the Principal
Financial Officer pursuant to Rule&nbsp;13a-14(a)&nbsp;or
15d-14(a)&nbsp;of the Securities Exchange Act of
1934.</font></a></p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;&nbsp;32.1(1)</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a href="agle-ex321_9.htm"><font style=
"text-decoration:underline;">Certification of the Principal
Executive Officer pursuant to 18 U.S.C. Section&nbsp;1350, as
adopted pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of
2002.</font></a></p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="top" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;&nbsp;32.2(1)</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<a href="agle-ex322_7.htm"><font style=
"text-decoration:underline;">Certification of the Principal
Financial Officer pursuant to 18 U.S.C. Section&nbsp;1350, as
adopted pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of
2002.</font></a></p>
</td>
</tr>
<tr>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="bottom" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
101.INS</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
XBRL Instance Document</p>
</td>
</tr>
<tr>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
101.SCH</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
XBRL Taxonomy Extension Schema Document</p>
</td>
</tr>
<tr>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
101.CAL</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
XBRL Taxonomy Extension Calculation Linkbase Document</p>
</td>
</tr>
<tr>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
101.DEF</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
XBRL Taxonomy Extension Definition Linkbase Document</p>
</td>
</tr>
<tr>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
101.LAB</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
XBRL Taxonomy Extension Label Linkbase Document</p>
</td>
</tr>
<tr>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
101.PRE</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
</td>
<td valign="middle" bgcolor="#FFFFFF" style=
"padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:86.22%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
XBRL Taxonomy Extension Presentation Linkbase Document</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">
&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:2pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
*</font></p>
</td>
<td valign="top">
<p style=
"margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
Incorporated by reference to Exhibit 99.2 to the Registrant’s
Registration Statement on Form S-8 (File No. 333-223614) filed with
the SEC on March 13, 2018.</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-top:2pt;margin-bottom:0pt;margin-left:4.54%;text-indent:-4.54%;font-family:Times New Roman;">
&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style=
"border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style=
"margin-top:2pt;margin-bottom:0pt;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<font style=
"font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
(1)</font></p>
</td>
<td valign="top">
<p style=
"margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Arial;font-size:10pt;">
The certifications on Exhibit&nbsp;32 hereto are deemed not “filed”
for purposes of Section&nbsp;18 of the Exchange Act or otherwise
subject to the liability of that Section.&nbsp; Such certifications
will not be deemed incorporated by reference into any filing under
the Securities Act or the Exchange Act.</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">
&nbsp;</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
61</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU63" id=
"_AEIOULastRenderedPageBreakAEIOU63"></a><a name="SIGNATURES" id=
"SIGNATURES"></a><a name="Signatures_212433" id=
"Signatures_212433"></a><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="SIGNATURES"
id="SIGNATURES"></a>SIGNAT</font><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="Signatures_212433"
id="Signatures_212433"></a>URES</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Pursuant to the requirements of Section&nbsp;13 or 15(d)&nbsp;of
the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Date: May 8, 2018</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:55%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="top" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td colspan="3" valign="top" style="width:3%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
AEGLEA BIOTHERAPEUTICS, INC.</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:55%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
</td>
<td valign="top" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
</td>
<td colspan="3" valign="bottom" style="width:3%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" style=
"width:55%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="top" style=
"width:1%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style=
"width:3%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
By:</p>
</td>
<td valign="top" style=
"width:1%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style=
"width:40%; border-bottom:solid 0.75pt #000000;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
/s/ Anthony G. Quinn, M.B Ch.B, Ph.D.</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:55%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="top" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:3%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="top" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:40%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Anthony G. Quinn, M.B Ch.B, Ph.D.</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:55%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="top" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:3%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="top" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:40%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-family:Arial;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">
Interim Chief Executive Officer and Director</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:55%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="top" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:3%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="top" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:40%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-family:Arial;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">
(Principal Executive Officer)</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">
&nbsp;</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
62</p>
<hr style="page-break-after:always;width:100%;" />
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">
&nbsp;</p>
<p style=
"text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">
<a name="_AEIOULastRenderedPageBreakAEIOU64" id=
"_AEIOULastRenderedPageBreakAEIOU64"></a><font style=
"font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</font></p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Pursuant to the requirements of Section&nbsp;13 or 15(d)&nbsp;of
the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.</p>
<p style=
"margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Date: May 8, 2018</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center"
style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:55%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td colspan="3" valign="bottom" style="width:3%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
AEGLEA BIOTHERAPEUTICS, INC.</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:55%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:3%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:40%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">
&nbsp;</p>
</td>
</tr>
<tr>
<td valign="bottom" style=
"width:55%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style=
"width:1%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style=
"width:3%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
By:</p>
</td>
<td valign="bottom" style=
"width:1%; border-bottom:solid 0.75pt transparent;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style=
"width:40%; border-bottom:solid 0.75pt #000000;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
/s/ Charles N. York II</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:55%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:3%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:40%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
Charles N. York II</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:55%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:3%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:40%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-family:Arial;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">
Chief Financial Officer and Vice President</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:55%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:3%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:1%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">
&nbsp;</p>
</td>
<td valign="bottom" style="width:40%;">
<p style=
"margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-family:Arial;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">
(Principal Accounting Officer and Principal Financial Officer and
duly Authorized Signatory)</p>
</td>
</tr>
</table>
</div>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">
&nbsp;</p>
<p style=
"margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">
&nbsp;</p>
<p style=
"text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
63</p>
</body>
</html>

